| 1 |
García-Marín R, Cabal VN, Fernández-Cedrón Bermejo C, Riobello C, Suárez-Fernández L, Codina-Martínez H, Navarro-García A, Lorenzo-Guerra SL, García-Martínez J, Vivanco B, López F, Llorente JL, Hermsen MA. A Novel External Auditory Canal Squamous Cell Carcinoma Cell Line Sensitive to CDK4/6 Inhibition. Otolaryngol Head Neck Surg 2023;168:729-37. [PMID: 35349366 DOI: 10.1177/01945998221089186] [Reference Citation Analysis]
|
| 2 |
Brandt A, Thiele B, Schultheiß C, Daetwyler E, Binder M. Circulating Tumor DNA in Head and Neck Squamous Cell Carcinoma. Cancers 2023;15:2051. [DOI: 10.3390/cancers15072051] [Reference Citation Analysis]
|
| 3 |
Shrivastava N, Chavez CG, Li D, Mehta V, Thomas C, Fulcher CD, Kawachi N, Bottalico DM, Prystowsky MB, Basu I, Guha C, Ow TJ. CDK4/6 Inhibition Induces Senescence and Enhances Radiation Response by Disabling DNA Damage Repair in Oral Cavity Squamous Cell Carcinoma. Cancers 2023;15:2005. [DOI: 10.3390/cancers15072005] [Reference Citation Analysis]
|
| 4 |
Li H, Ye M, Hu Z, Lu H, Zheng D, Wu M, Ge T, Xu S, Ge Z, Zhang S, Xu G, Chen H. IKZF3 is a novel prognostic biomarker for head and neck squamous cell carcinoma: A study based on bioinformatics analysis. Medicine (Baltimore) 2023;102:e33124. [PMID: 36930079 DOI: 10.1097/MD.0000000000033124] [Reference Citation Analysis]
|
| 5 |
Zhou MJ, Yang JJ, Ma TY, Feng GX, Wang XL, Wang LY, Ge YZ, Gao R, Liu HL, Shan L, Kong L, Chen XH. Increased retinoic acid signaling decreases lung metastasis in salivary adenoid cystic carcinoma by inhibiting the noncanonical Notch1 pathway. Exp Mol Med 2023. [PMID: 36879115 DOI: 10.1038/s12276-023-00957-7] [Reference Citation Analysis]
|
| 6 |
Khalil MI, Yang C, Vu L, Chadha S, Nabors H, Welbon C, James CD, Morgan IM, Spanos WC, Pyeon D. HPV upregulates MARCHF8 ubiquitin ligase and inhibits apoptosis by degrading the death receptors in head and neck cancer. PLoS Pathog 2023;19:e1011171. [PMID: 36867660 DOI: 10.1371/journal.ppat.1011171] [Reference Citation Analysis]
|
| 7 |
Yeh TJ, Luo CW, Du JS, Huang CT, Wang MH, Chuang TM, Gau YC, Cho SF, Liu YC, Hsiao HH, Chen LT, Pan MR, Wang HC, Moi SH. Deciphering the Functions of Telomerase Reverse Transcriptase in Head and Neck Cancer. Biomedicines 2023;11:691. [PMID: 36979671 DOI: 10.3390/biomedicines11030691] [Reference Citation Analysis]
|
| 8 |
Alam MM, Fermin JM, Knackstedt M, Noonan MJ, Powell T, Goodreau L, Daniel EK, Rong X, Moore-Medlin T, Khandelwal AR, Nathan CO. Everolimus downregulates STAT3/HIF-1α/VEGF pathway to inhibit angiogenesis and lymphangiogenesis in TP53 mutant head and neck squamous cell carcinoma (HNSCC). Oncotarget 2023;14:85-95. [PMID: 36745547 DOI: 10.18632/oncotarget.28355] [Reference Citation Analysis]
|
| 9 |
Papalouka C, Adamaki M, Batsaki P, Zoumpourlis P, Tsintarakis A, Goulielmaki M, Fortis SP, Baxevanis CN, Zoumpourlis V. DNA Damage Response Mechanisms in Head and Neck Cancer: Significant Implications for Therapy and Survival. Int J Mol Sci 2023;24. [PMID: 36769087 DOI: 10.3390/ijms24032760] [Reference Citation Analysis]
|
| 10 |
Rajendra S, Sharma P. Causal Link of Human Papillomavirus in Barrett Esophagus and Adenocarcinoma: Are We There Yet? Cancers (Basel) 2023;15. [PMID: 36765833 DOI: 10.3390/cancers15030873] [Reference Citation Analysis]
|
| 11 |
Li Q, Wang K, Shen Y, Lin C, Miao J, Hu X. Bioinformatics based exploration of hsa-miR-194-5p regulation of CHD4 through PI3K/AKT signal pathway to enhance tumor resistance to apoptosis due to loss of nests and participate in poor prognosis of oral squamous cell carcinoma. Ann Transl Med 2023;11:107. [PMID: 36819582 DOI: 10.21037/atm-22-6332] [Reference Citation Analysis]
|
| 12 |
Pomella S, Cassandri M, Melaiu O, Marampon F, Gargari M, Campanella V, Rota R, Barillari G. DNA Damage Response Gene Signature as Potential Treatment Markers for Oral Squamous Cell Carcinoma. Int J Mol Sci 2023;24. [PMID: 36768994 DOI: 10.3390/ijms24032673] [Reference Citation Analysis]
|
| 13 |
Guo M, Niu Y, Xie M, Liu X, Li X. Notch signaling, hypoxia, and cancer. Front Oncol 2023;13:1078768. [PMID: 36798826 DOI: 10.3389/fonc.2023.1078768] [Reference Citation Analysis]
|
| 14 |
Yan Y, Gauthier MA, Malik A, Fotiadou I, Ostrovski M, Dervovic D, Ghadban L, Tsai R, Gish G, Loganathan SK, Schramek D. The NOTCH-RIPK4-IRF6-ELOVL4 Axis Suppresses Squamous Cell Carcinoma. Cancers (Basel) 2023;15. [PMID: 36765696 DOI: 10.3390/cancers15030737] [Reference Citation Analysis]
|
| 15 |
Baldan F, Gnan C, Lazarevic M, Nikolic N, Mio C, Tepavcevic Z, Robiony M, Milasin J, Damante G. Somatic genomic imbalances in 'tumour-free' surgical margins of oral cancer. Int J Oral Maxillofac Surg 2023:S0901-5027(22)00521-5. [PMID: 36639343 DOI: 10.1016/j.ijom.2022.12.008] [Reference Citation Analysis]
|
| 16 |
Coleman N, Marcelo KL, Hopkins JF, Khan NI, Du R, Hong L, Park E, Balsara B, Leoni M, Pickering C, Myers J, Heymach J, Albacker LA, Hong D, Gillison M, Le X. HRAS Mutations Define a Distinct Subgroup in Head and Neck Squamous Cell Carcinoma. JCO Precis Oncol 2023;7:e2200211. [PMID: 36603172 DOI: 10.1200/PO.22.00211] [Reference Citation Analysis]
|
| 17 |
O’leary B. Understanding Head and Neck Cancer Evolution to Guide Therapeutic Approaches. Critical Issues in Head and Neck Oncology 2023. [DOI: 10.1007/978-3-031-23175-9_6] [Reference Citation Analysis]
|
| 18 |
Pérez JMT, García-Cosío M, García-Castaño A, Gomà M, Mesia-Nin R, Ruiz-Bravo E, Soria-Rivas A, Castillo P, Braña-García I, Alberola-Ferranti M. Recommendations for the use of biomarkers for head and neck cancer, including salivary gland tumours: A Consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology. Rev Esp Patol 2023;56:45-57. [PMID: 36599600 DOI: 10.1016/j.patol.2022.06.003] [Reference Citation Analysis]
|
| 19 |
Doerstling S, Winski D, Katsoulakis E, Agarwal P, Poonnen PJ, Snowdon JL, Jackson GP, Weeraratne D, Kelley MJ, Vashistha V. Mutational profiles of head and neck squamous cell carcinomas based upon human papillomavirus status in the Veterans Affairs National Precision Oncology Program. J Cancer Res Clin Oncol 2023;149:69-77. [PMID: 36117189 DOI: 10.1007/s00432-022-04358-7] [Reference Citation Analysis]
|
| 20 |
Kim E, Han DJ, Kim BH, Yoo J, Kim HJ, Wu HG, Kim KS, Kim HS, Han I, Moon KC, Park JH, Song S, Kim TM, Chang JH. Whole-Genome Sequencing Reveals Mutational Signatures Related to Radiation-Induced Sarcomas and DNA-Damage-Repair Pathways. Mod Pathol 2023;36:100004. [PMID: 36788076 DOI: 10.1016/j.modpat.2022.100004] [Reference Citation Analysis]
|
| 21 |
Xiaoxian Xu, Tao Feng, Dan Li, Hanmei Lou, Huiyin Lan. Prevalent distribution and survival outcome of HPV infection in patients with early-stage cervical cancer in Hangzhou, China. BMC Infect Dis 2022;22:941. [PMID: 36522614 DOI: 10.1186/s12879-022-07888-0] [Reference Citation Analysis]
|
| 22 |
Kirtane K, St John M, Fuentes-Bayne H, Patel SP, Mardiros A, Xu H, Ng EW, Go WY, Wong DJ, Sunwoo JB, Welch JS. Genomic Immune Evasion: Diagnostic and Therapeutic Opportunities in Head and Neck Squamous Cell Carcinomas. J Clin Med 2022;11. [PMID: 36555876 DOI: 10.3390/jcm11247259] [Reference Citation Analysis]
|
| 23 |
Shah PA, Sambandam V, Fernandez AM, Zhao H, Mazumdar T, Shen L, Wang Q, Ahmed KM, Ghosh S, Frederick MJ, Wang J, Johnson FM. Sustained Aurora Kinase B Expression Confers Resistance to PI3K Inhibition in Head and Neck Squamous Cell Carcinoma. Cancer Res 2022;82:4444-56. [PMID: 36169922 DOI: 10.1158/0008-5472.CAN-22-1175] [Reference Citation Analysis]
|
| 24 |
Kaushik M, Tiku AB. Molecular pathways modulated by phytochemicals in head and neck cancer. J Cell Commun Signal 2022. [DOI: 10.1007/s12079-022-00711-0] [Reference Citation Analysis]
|
| 25 |
Kitamura K, Suzuki H, Abe R, Inohara H, Kaneda Y, Takahashi H, Nimura K. Dual function of SF3B2 on chromatin and RNA to regulate transcription in head and neck squamous cell carcinoma. Cell Biosci 2022;12:92. [DOI: 10.1186/s13578-022-00812-8] [Reference Citation Analysis]
|
| 26 |
Nathan CO, Hayes DN, Karrison T, Harismendy O, Flores JM, Moore-Medlin T, Vokes EE, Gutkind JS, Neupane P, Mills G, Sargi Z, Seiwert T, Grilley-Olson J, Day T, Gillison M, Wade JL, Feldman L, Jha G, Kozloff M, O'Leary M, Worden FP, Cohen EEW. A Randomized Multi-institutional Phase II Trial of Everolimus as Adjuvant Therapy in Patients with Locally Advanced Squamous Cell Cancer of the Head and Neck. Clin Cancer Res 2022;28:5040-8. [PMID: 36194164 DOI: 10.1158/1078-0432.CCR-21-4290] [Reference Citation Analysis]
|
| 27 |
Ward BJH, Schaal DL, Nkadi EH, Scott RS. EBV Association with Lymphomas and Carcinomas in the Oral Compartment. Viruses 2022;14. [PMID: 36560704 DOI: 10.3390/v14122700] [Reference Citation Analysis]
|
| 28 |
Cao Y, Dong H, Li G, Wei H, Xie C, Tuo Y, Chen N, Yu D. Temporal and spatial characteristics of tumor evolution in a mouse model of oral squamous cell carcinoma. BMC Cancer 2022;22:1209. [DOI: 10.1186/s12885-022-10256-5] [Reference Citation Analysis]
|
| 29 |
Mezi S, Pomati G, Zizzari IG, Di Filippo A, Cerbelli B, Cirillo A, Fiscon G, Amirhassankhani S, Valentini V, De Vincentiis M, Corsi A, Di Gioia C, Tombolini V, Della Rocca C, Polimeni A, Nuti M, Marchetti P, Botticelli A. Genomic and Immune Approach in Platinum Refractory HPV-Negative Head and Neck Squamous Cell Carcinoma Patients Treated with Immunotherapy: A Novel Combined Profile. Biomedicines 2022;10:2732. [DOI: 10.3390/biomedicines10112732] [Reference Citation Analysis]
|
| 30 |
Wang LL, Zheng W, Liu XL, Yin F. Somatic mutations in FAT cadherin family members constitute an underrecognized subtype of colorectal adenocarcinoma with unique clinicopathologic features. World J Clin Oncol 2022; 13(10): 779-788 [DOI: 10.5306/wjco.v13.i10.779] [Reference Citation Analysis]
|
| 31 |
Olivares D, Cabañas ML, Vázquez A, Benítez L, Núñez Ó, Gauna C, González ML. Perfiles mutacionales de carcinoma escamoso de pene en cuatro pacientes paraguayos. RevOnco 2022;27. [DOI: 10.56969/oc.v27i1.1] [Reference Citation Analysis]
|
| 32 |
Pennarubia F, Ito A, Takeuchi M, Haltiwanger RS. Cancer-associated Notch receptor variants lead to O-fucosylation defects that deregulate Notch signaling. J Biol Chem 2022;298:102616. [PMID: 36265581 DOI: 10.1016/j.jbc.2022.102616] [Reference Citation Analysis]
|
| 33 |
Chen Z, John J, Wang JH. Why responses to immune checkpoint inhibitors are heterogeneous in head and neck cancers: Contributions from tumor-intrinsic and host-intrinsic factors. Front Oncol 2022;12:995434. [DOI: 10.3389/fonc.2022.995434] [Reference Citation Analysis]
|
| 34 |
Du Z, Chen X, Zhu P, Sun W, Lv Q, Cheng S, Yang X, Yu X, Want M. SOX8 Knockdown Overcomes Enzalutamide Resistance in Castration-Resistant Prostate Cancer by Inhibiting the Notch Signaling Pathway. BioMed Research International 2022;2022:1-15. [DOI: 10.1155/2022/9235837] [Reference Citation Analysis]
|
| 35 |
Tabansky I, Tanaka AJ, Wang J, Zhang G, Dujmovic I, Mader S, Jeganathan V, Deangelis T, Funaro M, Harel A, Messina M, Shabbir M, Nursey V, Degouvia W, Laurent M, Blitz K, Jindra P, Gudesblatt M, King A, Drulovic J, Yunis E, Brusic V, Shen Y, Keskin DB, Najjar S, Stern JNH; Regeneron Genetics Center. Rare variants and HLA haplotypes associated in patients with neuromyelitis optica spectrum disorders. Front Immunol 2022;13:900605. [DOI: 10.3389/fimmu.2022.900605] [Reference Citation Analysis]
|
| 36 |
Errazquin R, Page A, Suñol A, Segrelles C, Carrasco E, Peral J, Garrido-Aranda A, Del Marro S, Ortiz J, Lorz C, Minguillon J, Surralles J, Belendez C, Alvarez M, Balmaña J, Bravo A, Ramirez A, Garcia-Escudero R. Development of a mouse model for spontaneous oral squamous cell carcinoma in Fanconi anemia. Oral Oncol 2022;134:106184. [PMID: 36191479 DOI: 10.1016/j.oraloncology.2022.106184] [Reference Citation Analysis]
|
| 37 |
Jiang H, Bian W, Sui Y, Li H, Zhao H, Wang W, Li X. FBXO42 facilitates Notch signaling activation and global chromatin relaxation by promoting K63-linked polyubiquitination of RBPJ. Sci Adv 2022;8:eabq4831. [PMID: 36129980 DOI: 10.1126/sciadv.abq4831] [Reference Citation Analysis]
|
| 38 |
Islam SMA, Díaz-Gay M, Wu Y, Barnes M, Vangara R, Bergstrom EN, He Y, Vella M, Wang J, Teague JW, Clapham P, Moody S, Senkin S, Li YR, Riva L, Zhang T, Gruber AJ, Steele CD, Otlu B, Khandekar A, Abbasi A, Humphreys L, Syulyukina N, Brady SW, Alexandrov BS, Pillay N, Zhang J, Adams DJ, Martincorena I, Wedge DC, Landi MT, Brennan P, Stratton MR, Rozen SG, Alexandrov LB. Uncovering novel mutational signatures by de novo extraction with SigProfilerExtractor. Cell Genom 2022;2:None. [PMID: 36388765 DOI: 10.1016/j.xgen.2022.100179] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 39 |
Johnson FM, Janku F, Gouda MA, Tran HT, Kawedia JD, Schmitz D, Streefkerk H, Lee JJ, Andersen CR, Deng D, Rawal S, Shah PA, El-Naggar AK, Johnson JM, Frederick MJ. Inhibition of the Phosphatidylinositol-3 Kinase Pathway Using Bimiralisib in Loss-of-Function NOTCH1-Mutant Head and Neck Cancer. Oncologist 2022;27:1004-e926. [PMID: 36124629 DOI: 10.1093/oncolo/oyac185] [Reference Citation Analysis]
|
| 40 |
Khalil MI, Yang C, Vu L, Chadha S, Welbon C, James CD, Morgan IM, Spanos WC, Pyeon D. HPV E6 upregulates MARCHF8 ubiquitin ligase and inhibits apoptosis by degrading the death receptors in head and neck cancer.. [DOI: 10.1101/2022.09.07.507063] [Reference Citation Analysis]
|
| 41 |
Zhang W, Huang X, Huang R, Zhu H, Ye P, Lin X, Zhang S, Wu M, Jiang F, Krishnan SS. MMP1 Overexpression Promotes Cancer Progression and Associates with Poor Outcome in Head and Neck Carcinoma. Computational and Mathematical Methods in Medicine 2022;2022:1-17. [DOI: 10.1155/2022/3058342] [Reference Citation Analysis]
|
| 42 |
Blocker SJ, Cook J, Everitt JI, Austin WM, Watts TL, Mowery YM. Automated Nuclear Segmentation in Head and Neck Squamous Cell Carcinoma Pathology Reveals Relationships between Cytometric Features and ESTIMATE Stromal and Immune Scores. The American Journal of Pathology 2022;192:1305-1320. [DOI: 10.1016/j.ajpath.2022.06.003] [Reference Citation Analysis]
|
| 43 |
Centuori SM, Bauman JE. c-Met Signaling as a Therapeutic Target in Head and Neck Cancer. Cancer J 2022;28:346-53. [PMID: 36165722 DOI: 10.1097/PPO.0000000000000619] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 44 |
Zhang X, Lu P, Shen X. Applications of single‐cell multi‐omics sequencing in deep understanding of brain diseases. Clinical and Translational Dis 2022;2. [DOI: 10.1002/ctd2.95] [Reference Citation Analysis]
|
| 45 |
Sharma V, Kumar D, Kumar S, Singh H, Sharma N, Gupta S. Impact of tobacco smoking on oral cancer genetics—A next‐generation sequencing perspective. iMeta 2022;1. [DOI: 10.1002/imt2.44] [Reference Citation Analysis]
|
| 46 |
Kong L, Zhou M, Yang J, Ma T, Feng G, Wang X, Wang L, Ge Y, Gao R, Liu H, Shan L, Chen X. Increased retinoic acid signalling decreases lung metastasis in salivary adenoid cystic carcinoma by inhibiting the noncanonical Notch1 pathway.. [DOI: 10.21203/rs.3.rs-1798275/v1] [Reference Citation Analysis]
|
| 47 |
Xiang J, He Y, Li Y, Wu K, Cheng M, Wang Y, Chen R. A hypoxia-related lncRNA model for prediction of head and neck squamous cell carcinoma prognosis. Cancer Med 2023;12:3773-85. [PMID: 35920349 DOI: 10.1002/cam4.5102] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 48 |
Wu Y, Yu-fong Chang J, Chiang C, Wang Y. Combined evaluation of both WEE1 and phosphorylated cyclin dependent kinase 1 expressions in oral squamous cell carcinomas predicts cancer recurrence and progression. Journal of Dental Sciences 2022. [DOI: 10.1016/j.jds.2022.08.009] [Reference Citation Analysis]
|
| 49 |
Ansary TM, Hossain MR, Komine M, Ohtsuki M. Immunotherapy for the Treatment of Squamous Cell Carcinoma: Potential Benefits and Challenges. IJMS 2022;23:8530. [DOI: 10.3390/ijms23158530] [Reference Citation Analysis]
|
| 50 |
Yang Z, Liao J, Schumaker L, Carter-Cooper B, Lapidus RG, Fan X, Gaykalova DA, Mehra R, Cullen KJ, Dan H. Simultaneously targeting ErbB family kinases and PI3K in HPV-positive head and neck squamous cell carcinoma. Oral Oncol 2022;131:105939. [PMID: 35667295 DOI: 10.1016/j.oraloncology.2022.105939] [Reference Citation Analysis]
|
| 51 |
Ni Y, Low JT, Silke J, O'Reilly LA. Digesting the Role of JAK-STAT and Cytokine Signaling in Oral and Gastric Cancers. Front Immunol 2022;13:835997. [PMID: 35844493 DOI: 10.3389/fimmu.2022.835997] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 52 |
Callahan SC, Kochat V, Liu Z, Raman AT, Divenko M, Schulz J, Terranova CJ, Ghosh AK, Tang M, Johnson FM, Wang J, Skinner HD, Pickering CR, Myers JN, Rai K. High enhancer activity is an epigenetic feature of HPV negative atypical head and neck squamous cell carcinoma. Front Cell Dev Biol 2022;10:936168. [DOI: 10.3389/fcell.2022.936168] [Reference Citation Analysis]
|
| 53 |
Ghosh S, Shah PA, Johnson FM. Novel Systemic Treatment Modalities Including Immunotherapy and Molecular Targeted Therapy for Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma. Int J Mol Sci 2022;23:7889. [PMID: 35887235 DOI: 10.3390/ijms23147889] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 54 |
Parikh AS, Puram SV. RNA sequencing and expression heterogeneity in head and neck cancer. Cancer Cytopathol 2022. [PMID: 35838629 DOI: 10.1002/cncy.22622] [Reference Citation Analysis]
|
| 55 |
Shigemizu D, Asanomi Y, Akiyama S, Higaki S, Sakurai T, Ito K, Niida S, Ozaki K. Network-based meta-analysis and the candidate gene association studies reveal novel ethnicity-specific variants in MFSD3 and MRPL43 associated with dementia with Lewy bodies. Am J Med Genet B Neuropsychiatr Genet 2022;189:139-50. [PMID: 35765761 DOI: 10.1002/ajmg.b.32908] [Reference Citation Analysis]
|
| 56 |
Aulakh SS, Silverman DA, Young K, Dennis SK, Birkeland AC. The Promise of Circulating Tumor DNA in Head and Neck Cancer. Cancers (Basel) 2022;14:2968. [PMID: 35740633 DOI: 10.3390/cancers14122968] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 57 |
Errazquin R, Page A, Suñol A, Segrelles C, Carrasco E, Peral J, Garrido-aranda A, Del Marro S, Ortiz J, Lorz C, Minguillon J, Surralles J, Belendez C, Alvarez M, Balmaña J, Bravo A, Ramirez A, Garcia-escudero R. Development of a mouse model for spontaneous oral squamous cell carcinoma in Fanconi anemia.. [DOI: 10.1101/2022.06.05.494848] [Reference Citation Analysis]
|
| 58 |
Alcazer V, Sujobert P. Panel Informativity Optimizer: An R Package to Improve Cancer Next-Generation Sequencing Panel Informativity. J Mol Diagn 2022;24:697-709. [PMID: 35427780 DOI: 10.1016/j.jmoldx.2022.03.005] [Reference Citation Analysis]
|
| 59 |
Machnicki MM, Rzepakowska A, Janowska J, Pepek M, Krop A, Pruszczyk K, Stawinski P, Rydzanicz M, Grzybowski J, Gornicka B, Wnuk M, Ploski R, Osuch-wojcikiewicz E, Stoklosa T. Analysis of Mutational Profile of Hypopharyngeal and Laryngeal Head and Neck Squamous Cell Carcinomas Identifies KMT2C as a Potential Tumor Suppressor. Front Oncol 2022;12:768954. [DOI: 10.3389/fonc.2022.768954] [Reference Citation Analysis]
|
| 60 |
Michikawa C, Torres-Saavedra PA, Silver NL, Harari PM, Kies MS, Rosenthal DI, Le QT, Jordan RC, Duose DY, Mallampati S, Trivedi S, Luthra R, Wistuba II, Osman AA, Lichtarge O, Foote RL, Parvathaneni U, Hayes DN, Pickering CR, Myers JN. Evolutionary Action Score of TP53 Analysis in Pathologically High-Risk Human Papillomavirus-Negative Head and Neck Cancer From a Phase 2 Clinical Trial: NRG Oncology Radiation Therapy Oncology Group 0234. Adv Radiat Oncol 2022;7:100989. [PMID: 36420184 DOI: 10.1016/j.adro.2022.100989] [Reference Citation Analysis]
|
| 61 |
Ozturk H, Cingoz H, Tufan T, Yang J, Adair SJ, Tummala KS, Kuscu C, Kinali M, Comertpay G, Nagdas S, Goudreau BJ, Luleyap HU, Bingul Y, Ware TB, Hwang WL, Hsu KL, Kashatus DF, Ting DT, Chandel NS, Bardeesy N, Bauer TW, Adli M. ISL2 is a putative tumor suppressor whose epigenetic silencing reprograms the metabolism of pancreatic cancer. Dev Cell 2022:S1534-5807(22)00254-4. [PMID: 35508175 DOI: 10.1016/j.devcel.2022.04.014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 62 |
Jenifer Michael Raj M, Antony Edwin Rodrigues F, Ramasamy S. Mutational Profile of Human Papilloma Virus (HPV) Induced and Non-HPV Induced Head and Neck Squamous Cell Carcinoma. Squamous Cell Carcinoma [Working Title] 2022. [DOI: 10.5772/intechopen.103737] [Reference Citation Analysis]
|
| 63 |
White JR, Ragunath K, Whitton A, Marsh E, Kaye P, Knight G. Study to investigate the prevalence of human papillomavirus in Barrett's oesophagus using a novel screening methodology. BMJ Open Gastroenterol 2022;9:e000840. [PMID: 35379652 DOI: 10.1136/bmjgast-2021-000840] [Reference Citation Analysis]
|
| 64 |
Huang Y, Lan Y, Zhang Z, Xiao X, Huang T. An Update on the Immunotherapy for Oropharyngeal Squamous Cell Carcinoma. Front Oncol 2022;12:800315. [PMID: 35372036 DOI: 10.3389/fonc.2022.800315] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 65 |
Chakraborty B, Basu M, Mukhopadhyay D, Alam N, Ghosh S, Dutta S, Panda CK. Differential promoter usages of PTCH1 and down regulation of HHIP are associated with HNSCC progression. Pathology - Research and Practice 2022;232:153827. [DOI: 10.1016/j.prp.2022.153827] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 66 |
Marques AEM, Borges GA, Viesi do Nascimento Filho CH, Vianna LMS, Ramos DDAR, Castilho RM, Squarize CH, Guerra ENS. Expression profile of the PI3K-AKT-mTOR pathway in head and neck squamous cell carcinoma: Data from Brazilian population. Oral Surg Oral Med Oral Pathol Oral Radiol 2022;133:453-61. [PMID: 35153184 DOI: 10.1016/j.oooo.2021.10.020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 67 |
Zhou B, Lin W, Long Y, Yang Y, Zhang H, Wu K, Chu Q. Notch signaling pathway: architecture, disease, and therapeutics. Signal Transduct Target Ther 2022;7:95. [PMID: 35332121 DOI: 10.1038/s41392-022-00934-y] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 17.0] [Reference Citation Analysis]
|
| 68 |
Wang CP, Chen TC, Hsu WL, Hsiao JR, Chen PR, Chen MK, Hua CH, Tsai MH, Ko JY, Lou PJ, Chiang CJ, Wu CT, Chang YL. Rising incidence of HPV positive oropharyngeal cancer in Taiwan between 1999 and 2014 where betel nut chewing is common. BMC Cancer 2022;22:296. [PMID: 35313837 DOI: 10.1186/s12885-022-09407-5] [Reference Citation Analysis]
|
| 69 |
Rangel R, Pickering CR, Sikora AG, Spiotto MT. Genetic Changes Driving Immunosuppressive Microenvironments in Oral Premalignancy. Front Immunol 2022;13:840923. [PMID: 35154165 DOI: 10.3389/fimmu.2022.840923] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 70 |
Lee SY, Lee M, Yu DS, Lee YB. Identification of genetic mutations of cutaneous squamous cell carcinoma using whole exome sequencing in non-Caucasian population. Journal of Dermatological Science 2022. [DOI: 10.1016/j.jdermsci.2022.03.007] [Reference Citation Analysis]
|
| 71 |
Michmerhuizen NL, Heenan C, Wang J, Leonard E, Bellile E, Loganathan SK, Wong SY, Lei YL, Brenner JC. Combined Pik3ca-H1047R and loss-of-function Notch1 alleles decrease survival time in a 4-nitroquinoline N-oxide-driven head and neck squamous cell carcinoma model. Oral Oncology 2022;126:105770. [DOI: 10.1016/j.oraloncology.2022.105770] [Reference Citation Analysis]
|
| 72 |
Solis RN, Silverman DA, Birkeland AC. Current Trends in Precision Medicine and Next-Generation Sequencing in Head and Neck Cancer. Curr Treat Options Oncol 2022. [PMID: 35195839 DOI: 10.1007/s11864-022-00942-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 73 |
Diez-Fraile A, De Ceulaer J, Derpoorter C, Spaas C, De Backer T, Lamoral P, Abeloos J, Lammens T. Tracking the Molecular Fingerprint of Head and Neck Cancer for Recurrence Detection in Liquid Biopsies. Int J Mol Sci 2022;23:2403. [PMID: 35269544 DOI: 10.3390/ijms23052403] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 74 |
Schmidl B, Siegl M, Boxberg M, Stögbauer F, Jira D, Winter C, Stark L, Pickhard A, Wollenberg B, Wirth M. NOTCH1 Intracellular Domain and the Tumor Microenvironment as Prognostic Markers in HNSCC. Cancers (Basel) 2022;14:1080. [PMID: 35205828 DOI: 10.3390/cancers14041080] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 75 |
Flach S, Howarth K, Hackinger S, Pipinikas C, Ellis P, McLay K, Marsico G, Forshew T, Walz C, Reichel CA, Gires O, Canis M, Baumeister P. Liquid BIOpsy for MiNimal RESidual DiSease Detection in Head and Neck Squamous Cell Carcinoma (LIONESS)-a personalised circulating tumour DNA analysis in head and neck squamous cell carcinoma. Br J Cancer 2022. [PMID: 35132238 DOI: 10.1038/s41416-022-01716-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 76 |
Yabe TE, King K, Russell S, Satgunaseelan L, Gupta R, Chen J, Ashford B. “MYH9 mutation and squamous cell cancer of the tongue in a young adult: a novel case report”. Diagn Pathol 2022;17. [DOI: 10.1186/s13000-022-01210-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 77 |
Tang YF, Wu WJ, Zhang JY, Zhang J. Reconstruction and analysis of the aberrant lncRNA-miRNA-mRNA network based on competitive endogenous RNA in adenoid cystic carcinoma of the salivary gland. Transl Cancer Res 2021;10:5133-49. [PMID: 35116364 DOI: 10.21037/tcr-21-1771] [Reference Citation Analysis]
|
| 78 |
Wondergem NE, Nijenhuis DNLM, Poell JB, Leemans CR, Brakenhoff RH, van de Ven R. At the Crossroads of Molecular Biology and Immunology: Molecular Pathways for Immunological Targeting of Head and Neck Squamous Cell Carcinoma. Front Oral Health 2021;2:647980. [PMID: 35047999 DOI: 10.3389/froh.2021.647980] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 79 |
Heft Neal ME, Brenner JC, Prince MEP, Chinn SB. Advancement in Cancer Stem Cell Biology and Precision Medicine-Review Article Head and Neck Cancer Stem Cell Plasticity and the Tumor Microenvironment. Front Cell Dev Biol 2021;9:660210. [PMID: 35047489 DOI: 10.3389/fcell.2021.660210] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 80 |
Marret G, Bièche I, Dupain C, Borcoman E, du Rusquec P, Ricci F, Hescot S, Sablin MP, Tresca P, Bello D, Dubot C, Loirat D, Frelaut M, Lecerf C, Le Tourneau C, Kamal M. Genomic Alterations in Head and Neck Squamous Cell Carcinoma: Level of Evidence According to ESMO Scale for Clinical Actionability of Molecular Targets (ESCAT). JCO Precis Oncol 2021;5:215-26. [PMID: 34994597 DOI: 10.1200/PO.20.00280] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 81 |
Jatti Patil D, Nagaraju R. Personalised Precision Medicine - A Novel Approach for Oral Cancer Management. Oral Cancer - Current Concepts and Future Perspectives 2022. [DOI: 10.5772/intechopen.99558] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 82 |
Guo H, Xie T, Liu H. Notch in Human Cancers—A Complex Tale. Comprehensive Pharmacology 2022. [DOI: 10.1016/b978-0-12-820472-6.00096-7] [Reference Citation Analysis]
|
| 83 |
Shigemizu D, Asanomi Y, Akiyama S, Mitsumori R, Niida S, Ozaki K. Whole-genome sequencing reveals novel ethnicity-specific rare variants associated with Alzheimer's disease. Mol Psychiatry 2022;27:2554-62. [PMID: 35264725 DOI: 10.1038/s41380-022-01483-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 84 |
den bossche VV, Zaryouh H, Vara-messler M, Vignau J, Machiels J, Wouters A, Schmitz S, Corbet C. Microenvironment-driven intratumoral heterogeneity in head and neck cancers: clinical challenges and opportunities for precision medicine. Drug Resistance Updates 2022. [DOI: 10.1016/j.drup.2022.100806] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 85 |
Bunz F. Common Cancers and Their Genetic Alterations. Principles of Cancer Genetics 2022. [DOI: 10.1007/978-3-030-99387-0_8] [Reference Citation Analysis]
|
| 86 |
Nair R, Nair R, Sonis ST. Introduction to Modern Cancer Diagnosis and Survivorship. Orofacial Supportive Care in Cancer 2022. [DOI: 10.1007/978-3-030-86510-8_1] [Reference Citation Analysis]
|
| 87 |
Panda C, Mukhopadhyay D, Chakraborty B, Sarkar S, Alam N. Human papilloma virus and tobacco-associated modulation of NOTCH1 pathway during development of head and neck squamous cell carcinoma: Clinical importance. J Radiat Cancer Res 2022;0:0. [DOI: 10.4103/jrcr.jrcr_28_22] [Reference Citation Analysis]
|
| 88 |
Gerhard-hartmann E, Maurus K, Bargou R. Molekulare Diagnostik und molekulares Tumorboard. Medikamentöse Tumortherapie von Kopf-Hals-Tumoren 2022. [DOI: 10.1007/978-3-662-62808-9_14] [Reference Citation Analysis]
|
| 89 |
Wai K, Kang H. Epidemiology and Genomics of Head and Neck Squamous Cell Carcinoma. Multidisciplinary Management of Head and Neck Cancer 2022. [DOI: 10.1007/978-3-031-05973-5_8] [Reference Citation Analysis]
|
| 90 |
Lin LH, Chou CH, Cheng HW, Chang KW, Liu CJ. Precise Identification of Recurrent Somatic Mutations in Oral Cancer Through Whole-Exome Sequencing Using Multiple Mutation Calling Pipelines. Front Oncol 2021;11:741626. [PMID: 34912705 DOI: 10.3389/fonc.2021.741626] [Reference Citation Analysis]
|
| 91 |
Mishra V, Singh A, Chen X, Rosenberg AJ, Pearson AT, Zhavoronkov A, Savage PA, Lingen MW, Agrawal N, Izumchenko E. Application of liquid biopsy as multi-functional biomarkers in head and neck cancer. Br J Cancer 2021. [PMID: 34876674 DOI: 10.1038/s41416-021-01626-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 92 |
Ramezani M, Sadeghi M, Zavattaro E, Mozaffari HR. Association between CYP1A1 Ile462Val (m2, A2455G, rs1048943) polymorphism and head and neck cancer susceptibility: A meta-analysis, meta-regression, and trial sequential analysis. Gene Reports 2021;25:101380. [DOI: 10.1016/j.genrep.2021.101380] [Reference Citation Analysis]
|
| 93 |
Anjum S, Sen S, Pushker N, Bajaj MS, Kashyap S, Bakhshi S, Chosdol K, Meel R, Sharma MC. Prognostic impact of Notch1 receptor and clinicopathological High-Risk Predictors in lacrimal gland adenoid cystic carcinoma. Acta Ophthalmol 2021;99:e1467-73. [PMID: 33675181 DOI: 10.1111/aos.14812] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 94 |
Lee JW, Lee HY. Targeting Cancer Stem Cell Markers or Pathways: A Potential Therapeutic Strategy for Oral Cancer Treatment. Int J Stem Cells 2021;14:386-99. [PMID: 34711702 DOI: 10.15283/ijsc21084] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 95 |
Lee S, Kim HR. What's New in Molecular Targeted Therapies for Head and Neck Cancer? Korean J Head Neck Oncol 2021;37:11-17. [DOI: 10.21593/kjhno/2021.37.2.11] [Reference Citation Analysis]
|
| 96 |
McAllister SD, Abood ME, Califano J, Guzmán M. Cannabinoid Cancer Biology and Prevention. J Natl Cancer Inst Monogr 2021;2021:99-106. [PMID: 34850900 DOI: 10.1093/jncimonographs/lgab008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 97 |
Lv Y, Huang Y, Xu X, Wang Z, Yu Y, Ma Y, Wu M. Integrated multi-omics data analysis identifies a novel genetics-risk gene of IRF4 associated with prognosis of oral cavity cancer.. [DOI: 10.1101/2021.11.17.21266500] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 98 |
Raman D, Tay P, Hirpara JL, Liu D, Pervaiz S. TRAIL sensitivity of nasopharyngeal cancer cells involves redox dependent upregulation of TMTC2 and its interaction with membrane caspase-3. Redox Biol 2021;48:102193. [PMID: 34839142 DOI: 10.1016/j.redox.2021.102193] [Reference Citation Analysis]
|
| 99 |
Johansson E, Ueno H. Characterization of normal and cancer stem-like cell populations in murine lingual epithelial organoids using single-cell RNA sequencing. Sci Rep 2021;11:22329. [PMID: 34785704 DOI: 10.1038/s41598-021-01783-5] [Reference Citation Analysis]
|
| 100 |
Vandiver AR, Thomas BJ, Karimzada M, Knowles BC, Botten GA, Spreafico R, Rotman JN, Gharavi NM, Chesnut C, Wesel K, Mangul S, Soriano T, Scumpia PO. Detection of viral gene expression in risk-stratified biopsies reveals no active HPV in cutaneous squamous cell carcinoma. Exp Dermatol 2021;30:1711-6. [PMID: 34036652 DOI: 10.1111/exd.14385] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 101 |
Hudečková M, Koucký V, Rottenberg J, Gál B. Gene Mutations in Circulating Tumour DNA as a Diagnostic and Prognostic Marker in Head and Neck Cancer-A Systematic Review. Biomedicines 2021;9:1548. [PMID: 34829777 DOI: 10.3390/biomedicines9111548] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 102 |
Liao CT, Yang LY, Lee LY, Lin CY, Wang HM, Ng SH, Yen TC, Fan WL, Hsieh JC. Whole-exome sequencing identifies biosignatures that predict adverse survival outcomes in surgically treated patients with oral cavity squamous cell carcinoma. Oral Oncol 2021;122:105547. [PMID: 34700279 DOI: 10.1016/j.oraloncology.2021.105547] [Reference Citation Analysis]
|
| 103 |
Long Q, Huang C, Meng Q, Peng J, Yao F, Du D, Wang X, Zhu W, Shi D, Xu X, Qi X, Deng W, Chen M, Li Y, Yang A. TNF Patterns and Tumor Microenvironment Characterization in Head and Neck Squamous Cell Carcinoma. Front Immunol 2021;12:754818. [PMID: 34691075 DOI: 10.3389/fimmu.2021.754818] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 104 |
Bian W, Tang M, Jiang H, Xu W, Hao W, Sui Y, Hou Y, Nie L, Zhang H, Wang C, Li N, Wang J, Qin J, Wu L, Ma X, Chen J, Wang W, Li X. Low-density-lipoprotein-receptor-related protein 1 mediates Notch pathway activation. Dev Cell 2021;56:2902-2919.e8. [PMID: 34626540 DOI: 10.1016/j.devcel.2021.09.015] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 105 |
Kessler L, Malik S, Leoni M, Burrows F. Potential of Farnesyl Transferase Inhibitors in Combination Regimens in Squamous Cell Carcinomas. Cancers (Basel) 2021;13:5310. [PMID: 34771475 DOI: 10.3390/cancers13215310] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 106 |
Singh CB, Mishra B, Patel R, Kumar A, Ali A. Tripod-shaped Syndactyly in Apert Syndrome with FGFR2 p.P253R Mutation. Indian J Plast Surg 2021;54:370-2. [PMID: 34667527 DOI: 10.1055/s-0041-1733808] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 107 |
Powell SF, Vu L, Spanos WC, Pyeon D. The Key Differences between Human Papillomavirus-Positive and -Negative Head and Neck Cancers: Biological and Clinical Implications. Cancers (Basel) 2021;13:5206. [PMID: 34680354 DOI: 10.3390/cancers13205206] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 108 |
Bai Y, Boath J, White GR, Kariyawasam UGIU, Farah CS, Darido C. The Balance between Differentiation and Terminal Differentiation Maintains Oral Epithelial Homeostasis. Cancers (Basel) 2021;13:5123. [PMID: 34680271 DOI: 10.3390/cancers13205123] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 109 |
Dongre HN, Haave H, Fromreide S, Erland FA, Moe SEE, Dhayalan SM, Riis RK, Sapkota D, Costea DE, Aarstad HJ, Vintermyr OK. Targeted Next-Generation Sequencing of Cancer-Related Genes in a Norwegian Patient Cohort With Head and Neck Squamous Cell Carcinoma Reveals Novel Actionable Mutations and Correlations With Pathological Parameters. Front Oncol 2021;11:734134. [PMID: 34631566 DOI: 10.3389/fonc.2021.734134] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 110 |
Zhdanovskaya N, Firrincieli M, Lazzari S, Pace E, Scribani Rossi P, Felli MP, Talora C, Screpanti I, Palermo R. Targeting Notch to Maximize Chemotherapeutic Benefits: Rationale, Advanced Strategies, and Future Perspectives. Cancers (Basel) 2021;13:5106. [PMID: 34680255 DOI: 10.3390/cancers13205106] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 111 |
Alam MM, Marin Fermin J, Spiller PT, Burnett C, Rong X, Moore-Medlin T, Maxwell CO, Khandelwal AR, Nathan CO. Rapalogs induce non-apoptotic, autophagy-dependent cell death in HPV-negative TP53 mutant head and neck squamous cell carcinoma. Mol Carcinog 2021. [PMID: 34598317 DOI: 10.1002/mc.23357] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 112 |
Bisht SR, Mishra P, Yadav D, Rawal R, Mercado-shekhar KP. Current and emerging techniques for oral cancer screening and diagnosis: a review. Prog Biomed Eng 2021;3:042003. [DOI: 10.1088/2516-1091/ac1f6c] [Reference Citation Analysis]
|
| 113 |
Hamada M, Inaba H, Nishiyama K, Yoshida S, Yura Y, Matsumoto-Nakano M, Uzawa N. Prognostic association of starvation-induced gene expression in head and neck cancer. Sci Rep 2021;11:19130. [PMID: 34580365 DOI: 10.1038/s41598-021-98544-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 114 |
Callahan SC, Kochat V, Liu Z, Raman AT, Schulz J, Terranova C, Divenko M, Ghosh A, Tang M, Pickering C, Myers JN, Rai K. High Enhancer Activity is an Epigenetic Feature of HPV Negative Atypical Head and Neck Squamous Cell Carcinoma.. [DOI: 10.1101/2021.09.21.461310] [Reference Citation Analysis]
|
| 115 |
Osawa Y, Aoyama KI, Hosomichi K, Uchibori M, Tajima A, Kimura M, Ota Y. Somatic mutations in oral squamous cell carcinomas in 98 Japanese patients and their clinical implications. Cancer Treat Res Commun 2021;29:100456. [PMID: 34563788 DOI: 10.1016/j.ctarc.2021.100456] [Reference Citation Analysis]
|
| 116 |
Xu TT, Zeng XW, Wang XH, Yang LX, Luo G, Yu T. Cystatin-B Negatively Regulates the Malignant Characteristics of Oral Squamous Cell Carcinoma Possibly Via the Epithelium Proliferation/Differentiation Program. Front Oncol 2021;11:707066. [PMID: 34504787 DOI: 10.3389/fonc.2021.707066] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 117 |
Jawa Y, Yadav P, Gupta S, Mathan SV, Pandey J, Saxena AK, Kateriya S, Tiku AB, Mondal N, Bhattacharya J, Ahmad S, Chaturvedi R, Tyagi RK, Tandon V, Singh RP. Current Insights and Advancements in Head and Neck Cancer: Emerging Biomarkers and Therapeutics with Cues from Single Cell and 3D Model Omics Profiling. Front Oncol 2021;11:676948. [PMID: 34490084 DOI: 10.3389/fonc.2021.676948] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 118 |
Wang YP, Liu IJ, Chen KC, Wu HC. NOTCH1 signaling promotes protein stability of HER3 through the AKT pathway in squamous cell carcinoma of head and neck. Oncogenesis 2021;10:59. [PMID: 34465724 DOI: 10.1038/s41389-021-00348-5] [Reference Citation Analysis]
|
| 119 |
Machnicki MM, Rzepakowska A, Janowska JI, Pepek M, Krop A, Pruszczyk K, Stawinski P, Rydzanicz M, Grzybowski J, Gornicka B, Wnuk M, Ploski R, Osuch-wojcikiewicz E, Stoklosa T. Analysis of Mutational Profile of Hypopharyngeal and Laryngeal Head and Neck Cancers Identifies KMT2C as a Potential Tumor Suppressor.. [DOI: 10.1101/2021.08.24.21262521] [Reference Citation Analysis]
|
| 120 |
Pecora A, Laprise J, Dahmene M, Laurin M. Skin Cancers and the Contribution of Rho GTPase Signaling Networks to Their Progression. Cancers (Basel) 2021;13:4362. [PMID: 34503171 DOI: 10.3390/cancers13174362] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 121 |
Prasad M, Zorea J, Jagadeeshan S, Shnerb A, Bouaoud J, Michon L, Novoplansky O, Badarni M, Cohen L, Yagodayev K, Tzadok S, Rotblat B, Brezina L, Mock A, Karabajakian A, Fayette J, Cohen I, Cooks T, Allon I, Dimitstei O, Joshua B, Kong D, Voronov E, Scaltriti M, Carmi Y, Hess J, Morris LG, Saintigny P, Elkabets M. MEK1/2 inhibition transiently alters the tumor immune microenvironment to enhance immunotherapy efficacy against head and neck cancer.. [DOI: 10.1101/2021.08.22.457244] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 122 |
Nair SV, Madhulaxmi, Thomas G, Ankathil R. Next-Generation Sequencing in Cancer. J Maxillofac Oral Surg 2021;20:340-4. [PMID: 34408360 DOI: 10.1007/s12663-020-01462-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 123 |
Li X, Liu Z, Zhou W, Liu X, Cao W. Downregulation of CCL22 and mutated NOTCH1 in tongue and mouth floor squamous cell carcinoma results in decreased Th2 cell recruitment and expression, predicting poor clinical outcome. BMC Cancer 2021;21:922. [PMID: 34391381 DOI: 10.1186/s12885-021-08671-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 124 |
Wei H, Ge Q, Zhang LY, Xie J, Gan RH, Lu YG, Zheng DL. EGCG inhibits growth of tumoral lesions on lip and tongue of K-Ras transgenic mice through the Notch pathway. J Nutr Biochem 2021;99:108843. [PMID: 34407449 DOI: 10.1016/j.jnutbio.2021.108843] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 125 |
Li CC, Shen Z, Bavarian R, Yang F, Bhattacharya A. Oral Cancer: Genetics and the Role of Precision Medicine. Surg Oncol Clin N Am 2020;29:127-44. [PMID: 31757309 DOI: 10.1016/j.soc.2019.08.010] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 126 |
Singh P, Rai A, Verma AK, Alsahli MA, Rahmani AH, Almatroodi SA, Alrumaihi F, Dev K, Sinha A, Sankhwar S, Dohare R. Survival-Based Biomarker Module Identification Associated with Oral Squamous Cell Carcinoma (OSCC). Biology (Basel) 2021;10:760. [PMID: 34439992 DOI: 10.3390/biology10080760] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 127 |
Cui Z, Dabas H, Leonard BC, Shiah JV, Grandis JR, Johnson DE. Caspase-8 mutations associated with head and neck cancer differentially retain functional properties related to TRAIL-induced apoptosis and cytokine induction. Cell Death Dis 2021;12:775. [PMID: 34362880 DOI: 10.1038/s41419-021-04066-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 128 |
Yu Y, Fan D, Song X, Zakeri K, Chen L, Kang J, McBride S, Tsai CJ, Dunn L, Sherman E, Katabi N, Dogan S, Cracchiolo J, Cohen M, Boyle JO, Lee M, Valero C, Wang J, Wong R, Morris L, Riaz N, Lee N. TERT Promoter Mutations Are Enriched in Oral Cavity Cancers and Associated With Locoregional Recurrence. JCO Precis Oncol 2021;5:PO. [PMID: 34381934 DOI: 10.1200/PO.20.00515] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 129 |
Bai Y, Zhao Z, Boath J, van Denderen BJ, Darido C. The functional GRHL3-filaggrin axis maintains a tumor differentiation potential and influences drug sensitivity. Mol Ther 2021;29:2571-82. [PMID: 33775911 DOI: 10.1016/j.ymthe.2021.03.016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 130 |
Sathasivam HP, Kist R, Sloan P, Thomson P, Nugent M, Alexander J, Haider S, Robinson M. Predicting the clinical outcome of oral potentially malignant disorders using transcriptomic-based molecular pathology. Br J Cancer 2021;125:413-21. [PMID: 33972745 DOI: 10.1038/s41416-021-01411-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 131 |
Ando M. Genomic characterization of head and neck squamous cell carcinoma. Okayama I Z 2021;133:99-103. [DOI: 10.4044/joma.133.99] [Reference Citation Analysis]
|
| 132 |
Elmusrati A, Wang J, Wang CY. Tumor microenvironment and immune evasion in head and neck squamous cell carcinoma. Int J Oral Sci 2021;13:24. [PMID: 34341329 DOI: 10.1038/s41368-021-00131-7] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 19.5] [Reference Citation Analysis]
|
| 133 |
Smith DH, Raslan S, Samuels MA, Iglesias T, Buitron I, Deo S, Daunert S, Thomas GR, Califano J, Franzmann EJ. Current salivary biomarkers for detection of human papilloma virus-induced oropharyngeal squamous cell carcinoma. Head Neck 2021. [PMID: 34331493 DOI: 10.1002/hed.26830] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 134 |
Lin LH, Cheng HW, Liu CJ. Droplet digital polymerase chain reaction for detection and quantification of cell-free DNA TP53 target somatic mutations in oral cancer. Cancer Biomark 2021. [PMID: 34366328 DOI: 10.3233/CBM-210275] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 135 |
McCarthy C, Fedele S, Ottensmeier C, Shaw RJ. Early-Phase Interventional Trials in Oral Cancer Prevention. Cancers (Basel) 2021;13:3845. [PMID: 34359746 DOI: 10.3390/cancers13153845] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 136 |
Wang F, Xi SY, Hao WW, Yang XH, Deng L, Xu YX, Wu XY, Zeng L, Guo KH, Wang HY. Mutational landscape of primary pulmonary salivary gland-type tumors through targeted next-generation sequencing. Lung Cancer 2021;160:1-7. [PMID: 34364112 DOI: 10.1016/j.lungcan.2021.07.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 137 |
Broner EC, Trujillo JA, Korzinkin M, Subbannayya T, Agrawal N, Ozerov IV, Zhavoronkov A, Rooper L, Kotlov N, Shen L, Pearson AT, Rosenberg AJ, Savage PA, Mishra V, Chatterjee A, Sidransky D, Izumchenko E. Doublecortin-Like Kinase 1 (DCLK1) Is a Novel NOTCH Pathway Signaling Regulator in Head and Neck Squamous Cell Carcinoma. Front Oncol 2021;11:677051. [PMID: 34336664 DOI: 10.3389/fonc.2021.677051] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 138 |
Oprean CM, Segarceanu NA, Stan A, Suciu CS, Grujic D, Rivis IA, Dema ALC, Bredicean AC. Carcinomatous-like mastitis due to axillary lymphadenopathy in a case of nasopharyngeal carcinoma: A case report. Exp Ther Med 2021;22:1026. [PMID: 34373712 DOI: 10.3892/etm.2021.10458] [Reference Citation Analysis]
|
| 139 |
Takemoto A, Tanimoto K, Mori S, Inoue J, Fujiwara N, Noda T, Inazawa J. Integrative genome-wide analyses reveal the transcriptional aberrations in Japanese esophageal squamous cell carcinoma. Cancer Sci 2021. [PMID: 34263978 DOI: 10.1111/cas.15063] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 140 |
Hernandez AL, Karthik R, Sivasubramanian M, Raghavendran A, Lensing S, Lee JY, Abraham P, Mathai D, Palefsky JM. Prevalence of oral human papillomavirus infection among Indian HIV-positive men who have sex with men: a cross-sectional study. BMC Infect Dis 2021;21:675. [PMID: 34247583 DOI: 10.1186/s12879-021-06301-6] [Reference Citation Analysis]
|
| 141 |
Kordbacheh F, Farah CS. Molecular Pathways and Druggable Targets in Head and Neck Squamous Cell Carcinoma. Cancers (Basel) 2021;13:3453. [PMID: 34298667 DOI: 10.3390/cancers13143453] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 142 |
Edwards A, Brennan K. Notch Signalling in Breast Development and Cancer. Front Cell Dev Biol 2021;9:692173. [PMID: 34295896 DOI: 10.3389/fcell.2021.692173] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 143 |
Gao K, Xing W, Liu X, Liu J, Sun H, Hao W, Zheng Y. The Notch1 gene may control cell chemoresistance in esophageal squamous cell cancer. Transl Cancer Res 2021;10:3278-85. [PMID: 35116634 DOI: 10.21037/tcr-21-447] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 144 |
Aggarwal V, Tuli HS, Varol M, Tuorkey M, Sak K, Parashar NC, Barwal TS, Sharma U, Iqubal A, Parashar G, Jain A. NOTCH signaling: Journey of an evolutionarily conserved pathway in driving tumor progression and its modulation as a therapeutic target. Crit Rev Oncol Hematol 2021;164:103403. [PMID: 34214610 DOI: 10.1016/j.critrevonc.2021.103403] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 145 |
Brennan S, Baird AM, O'Regan E, Sheils O. The Role of Human Papilloma Virus in Dictating Outcomes in Head and Neck Squamous Cell Carcinoma. Front Mol Biosci 2021;8:677900. [PMID: 34250016 DOI: 10.3389/fmolb.2021.677900] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 146 |
Burcher KM, Faucheux AT, Lantz JW, Wilson HL, Abreu A, Salafian K, Patel MJ, Song AH, Petro RM, Lycan T Jr, Furdui CM, Topaloglu U, D'Agostino RB, Zhang W, Porosnicu M. Prevalence of DNA Repair Gene Mutations in Blood and Tumor Tissue and Impact on Prognosis and Treatment in HNSCC. Cancers (Basel) 2021;13:3118. [PMID: 34206538 DOI: 10.3390/cancers13133118] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 147 |
Dong H, Shu X, Xu Q, Zhu C, Kaufmann AM, Zheng ZM, Albers AE, Qian X. Current Status of Human Papillomavirus-Related Head and Neck Cancer: From Viral Genome to Patient Care. Virol Sin 2021. [PMID: 34152564 DOI: 10.1007/s12250-021-00413-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 148 |
Ho AL, Brana I, Haddad R, Bauman J, Bible K, Oosting S, Wong DJ, Ahn M, Boni V, Even C, Fayette J, Flor MJ, Harrington K, Hong DS, Kim S, Licitra L, Nixon I, Saba NF, Hackenberg S, Specenier P, Worden F, Balsara B, Leoni M, Martell B, Scholz C, Gualberto A. Tipifarnib in Head and Neck Squamous Cell Carcinoma With HRAS Mutations. JCO 2021;39:1856-64. [DOI: 10.1200/jco.20.02903] [Cited by in Crossref: 36] [Cited by in F6Publishing: 43] [Article Influence: 18.0] [Reference Citation Analysis]
|
| 149 |
Nandi A, Chakrabarti R. The many facets of Notch signaling in breast cancer: toward overcoming therapeutic resistance. Genes Dev 2020;34:1422-38. [PMID: 33872192 DOI: 10.1101/gad.342287.120] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 150 |
Rao VU, Nayar RC, Pandit RV, Ghosh MV, Chatterjee S. Genomics Testing in Head and Neck Cancers: Is there a Benefit? International Journal of Head and Neck Surgery 2021;12:58-64. [DOI: 10.5005/jp-journals-10001-1420] [Reference Citation Analysis]
|
| 151 |
Patel K, Bhat FA, Patil S, Routray S, Mohanty N, Nair B, Sidransky D, Ganesh MS, Ray JG, Gowda H, Chatterjee A. Whole-Exome Sequencing Analysis of Oral Squamous Cell Carcinoma Delineated by Tobacco Usage Habits. Front Oncol 2021;11:660696. [PMID: 34136393 DOI: 10.3389/fonc.2021.660696] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 152 |
Fan WL, Yang LY, Hsieh JC, Lin TC, Lu MJ, Liao CT. Prognostic Genetic Biomarkers Based on Oncogenic Signaling Pathways for Outcome Prediction in Patients with Oral Cavity Squamous Cell Carcinoma. Cancers (Basel) 2021;13:2709. [PMID: 34070941 DOI: 10.3390/cancers13112709] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 153 |
Melis M, Zhang T, Scognamiglio T, Gudas LJ. Mutations in long-lived epithelial stem cells and their clonal progeny in pre-malignant lesions and in oral squamous cell carcinoma. Carcinogenesis 2020;41:1553-64. [PMID: 32115621 DOI: 10.1093/carcin/bgaa019] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 154 |
Chen L, Zeng H, Zhang M, Luo Y, Ma X. Histopathological image and gene expression pattern analysis for predicting molecular features and prognosis of head and neck squamous cell carcinoma. Cancer Med 2021;10:4615-28. [PMID: 33987946 DOI: 10.1002/cam4.3965] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 155 |
Song Z, Liu Y, Cheng G, Chang L, Yu Z, Chen M, Chen G. Distinct mutational backgrounds and clonal architectures implicated prognostic discrepancies in small-cell carcinomas of the esophagus and lung. Cell Death Dis 2021;12:472. [PMID: 33980813 DOI: 10.1038/s41419-021-03754-0] [Reference Citation Analysis]
|
| 156 |
Wu-Chou YH, Hsieh CH, Liao CT, Lin YT, Fan WL, Yang CH. NOTCH1 mutations as prognostic marker in oral squamous cell carcinoma. Pathol Res Pract 2021;223:153474. [PMID: 33993060 DOI: 10.1016/j.prp.2021.153474] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 157 |
Farah CS. Molecular landscape of head and neck cancer and implications for therapy. Ann Transl Med 2021;9:915. [PMID: 34164549 DOI: 10.21037/atm-20-6264] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 158 |
Keam B, Park J, Kim J, Kim G, Yu Y, Cho S, Kim S, Ahn H, Chun S, Kwon J, Yun T, Kim J, Kim J, Ahn M, Kim J, Yun H. Comprehensive Analysis of Mutation-Based and Expressed Genes-Based Pathways in Head and Neck Squamous Cell Carcinoma. Processes 2021;9:792. [DOI: 10.3390/pr9050792] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 159 |
Cao CH, Liu R, Lin XR, Luo JQ, Cao LJ, Zhang QJ, Lin SR, Geng L, Sun ZY, Ye SK, Yu ZY, Shi Y, Xia X. LRP1B mutation is associated with tumor HPV status and promotes poor disease outcomes with a higher mutation count in HPV-related cervical carcinoma and head & neck squamous cell carcinoma. Int J Biol Sci 2021;17:1744-56. [PMID: 33994859 DOI: 10.7150/ijbs.56970] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 160 |
Ferreira A, Aster JC. Notch signaling in cancer: Complexity and challenges on the path to clinical translation. Semin Cancer Biol 2021:S1044-579X(21)00109-7. [PMID: 33862222 DOI: 10.1016/j.semcancer.2021.04.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 161 |
Amin ARMR, Wang D, Nannapaneni S, Lamichhane R, Chen ZG, Shin DM. Combination of resveratrol and green tea epigallocatechin gallate induces synergistic apoptosis and inhibits tumor growth in vivo in head and neck cancer models. Oncol Rep 2021;45:87. [PMID: 33864659 DOI: 10.3892/or.2021.8038] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 162 |
Nakagawa T, Kurokawa T, Mima M, Imamoto S, Mizokami H, Kondo S, Okamoto Y, Misawa K, Hanazawa T, Kaneda A. DNA Methylation and HPV-Associated Head and Neck Cancer. Microorganisms 2021;9:801. [PMID: 33920277 DOI: 10.3390/microorganisms9040801] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 163 |
Raj S, Kumar A, Kumar D. Regulation of Glycolysis in Head and Neck Cancer. Adv Exp Med Biol 2021;1280:219-30. [PMID: 33791985 DOI: 10.1007/978-3-030-51652-9_15] [Reference Citation Analysis]
|
| 164 |
Mutlu M, Mutlu P, Azarkan S, Bayır Ö, Öcal B, Saylam G, Korkmaz MH. Evaluation of Methylation Profiles of An Epidermal Growth Factor Receptor Gene in a Head and Neck Squamous Cell Carcinoma Patient Group. Balkan J Med Genet 2020;23:65-72. [PMID: 33816074 DOI: 10.2478/bjmg-2020-0025] [Reference Citation Analysis]
|
| 165 |
Wang J, Hu Y, Escamilla-Rivera V, Gonzalez CL, Tang L, Wang B, El-Naggar AK, Myers JN, Caulin C. Epithelial Mutant p53 Promotes Resistance to Anti-PD-1-Mediated Oral Cancer Immunoprevention in Carcinogen-Induced Mouse Models. Cancers (Basel) 2021;13:1471. [PMID: 33806894 DOI: 10.3390/cancers13061471] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 166 |
Dlamini Z, Alaouna M, Mbatha S, Bhayat A, Mabongo M, Chatziioannou A, Hull R. Genetic Drivers of Head and Neck Squamous Cell Carcinoma: Aberrant Splicing Events, Mutational Burden, HPV Infection and Future Targets. Genes (Basel) 2021;12:422. [PMID: 33804181 DOI: 10.3390/genes12030422] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 167 |
Koo K, Mouradov D, Angel CM, Iseli TA, Wiesenfeld D, McCullough MJ, Burgess AW, Sieber OM. Genomic Signature of Oral Squamous Cell Carcinomas from Non-Smoking Non-Drinking Patients. Cancers (Basel) 2021;13:1029. [PMID: 33804510 DOI: 10.3390/cancers13051029] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 168 |
Anusewicz D, Orzechowska M, Bednarek AK. Notch Signaling Pathway in Cancer-Review with Bioinformatic Analysis. Cancers (Basel) 2021;13:768. [PMID: 33673145 DOI: 10.3390/cancers13040768] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 169 |
Jensen GL, Axelrud G, Fink D, Hammonds K, Walker K, Volz M, Gowan A, Rao A, Deb N, Jhavar SG. Improved local control in p16 negative oropharyngeal cancers with hypermethylated MGMT. Radiother Oncol 2021;157:234-40. [PMID: 33577867 DOI: 10.1016/j.radonc.2021.01.035] [Reference Citation Analysis]
|
| 170 |
Barua R, Mizuno K, Tashima Y, Ogawa M, Takeuchi H, Taguchi A, Okajima T. Bioinformatics and Functional Analyses Implicate Potential Roles for EOGT and L-fringe in Pancreatic Cancers. Molecules 2021;26:882. [PMID: 33562410 DOI: 10.3390/molecules26040882] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 171 |
Xu C, Zhang Y, Shen Y, Shi Y, Zhang M, Zhou L. Integrated Analysis Reveals ENDOU as a Biomarker in Head and Neck Squamous Cell Carcinoma Progression. Front Oncol 2020;10:522332. [PMID: 33614471 DOI: 10.3389/fonc.2020.522332] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 172 |
Reder H, Wagner S, Wuerdemann N, Langer C, Sandmann S, Braeuninger A, Dugas M, Gattenloehner S, Wittekindt C, Klussmann JP. Mutation patterns in recurrent and/or metastatic oropharyngeal squamous cell carcinomas in relation to human papillomavirus status. Cancer Med 2021;10:1347-56. [PMID: 33527763 DOI: 10.1002/cam4.3741] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 173 |
Riva G, Albano C, Gugliesi F, Pasquero S, Pacheco SFC, Pecorari G, Landolfo S, Biolatti M, Dell'Oste V. HPV Meets APOBEC: New Players in Head and Neck Cancer. Int J Mol Sci 2021;22:1402. [PMID: 33573337 DOI: 10.3390/ijms22031402] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 174 |
Cui J, Wang D, Nie D, Liu W, Sun M, Pei F, Han F. Difference in tumor mutation burden between squamous cell carcinoma in the oral cavity and larynx. Oral Oncol 2021;114:105142. [PMID: 33465682 DOI: 10.1016/j.oraloncology.2020.105142] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 175 |
Economopoulou P, Anastasiou M, Papaxoinis G, Spathas N, Spathis A, Oikonomopoulos N, Kotsantis I, Tsavaris O, Gkotzamanidou M, Gavrielatou N, Vagia E, Kyrodimos E, Gagari E, Giotakis E, Delides A, Psyrri A. Patterns of Response to Immune Checkpoint Inhibitors in Association with Genomic and Clinical Features in Patients with Head and Neck Squamous Cell Carcinoma (HNSCC). Cancers (Basel) 2021;13:286. [PMID: 33466719 DOI: 10.3390/cancers13020286] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 176 |
Riaz N, Sherman E, Pei X, Schöder H, Grkovski M, Paudyal R, Katabi N, Selenica P, Yamaguchi TN, Ma D, Lee SK, Shah R, Kumar R, Kuo F, Ratnakumar A, Aleynick N, Brown D, Zhang Z, Hatzoglou V, Liu LY, Salcedo A, Tsai CJ, McBride S, Morris LGT, Boyle J, Singh B, Higginson DS, Damerla RR, Paula ADC, Price K, Moore EJ, Garcia JJ, Foote R, Ho A, Wong RJ, Chan TA, Powell SN, Boutros PC, Humm JL, Shukla-Dave A, Pfister D, Reis-Filho JS, Lee N. Precision Radiotherapy: Reduction in Radiation for Oropharyngeal Cancer in the 30 ROC Trial. J Natl Cancer Inst 2021;113:742-51. [PMID: 33429428 DOI: 10.1093/jnci/djaa184] [Cited by in Crossref: 48] [Cited by in F6Publishing: 53] [Article Influence: 24.0] [Reference Citation Analysis]
|
| 177 |
Rizzo D, Graziani C, Gallus R, Zannoni GF, Lucchetti D, Parrilla C, Boninsegna A, Galli J, Paludetti G, Bussu F, Sgambato A. Stem cell markers in oral and oropharyngeal squamous cell carcinomas in relation to the site of origin and HPV infection: clinical implications. Acta Otorhinolaryngol Ital 2020;40:90-8. [PMID: 32469002 DOI: 10.14639/0392-100X-2419] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 178 |
Zeng H, Wang Y, Wang Y, Zhang Y. XXYLT1 methylation contributes to the occurrence of lung adenocarcinoma: Methylation and lung adenocarcinoma. Medicine (Baltimore) 2021;100:e24150. [PMID: 33429795 DOI: 10.1097/MD.0000000000024150] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 179 |
Pagliaro L, Marchesini M, Roti G. Targeting oncogenic Notch signaling with SERCA inhibitors. J Hematol Oncol 2021;14:8. [PMID: 33407740 DOI: 10.1186/s13045-020-01015-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 180 |
Cortés-Gutiérrez EI, Garza Molina JG, Dávila-Rodríguez MI, Zapata Benavides P, Faz Eguía JM, Cerda-Flores RM. DBD-FISH, an effective marker for detecting genotoxicity in buccal mucosa exfoliated cells of patients with oral cancer. Toxicol Mech Methods 2021;31:343-8. [PMID: 33297797 DOI: 10.1080/15376516.2020.1862379] [Reference Citation Analysis]
|
| 181 |
Nwachuku K, Johnson DE, Grandis JR. The Mutational Landscape of Head and Neck Squamous Cell Carcinoma: Opportunities for Detection and Monitoring Via Analysis of Circulating Tumor DNA. Early Detection and Treatment of Head & Neck Cancers 2021. [DOI: 10.1007/978-3-030-69852-2_5] [Reference Citation Analysis]
|
| 182 |
Uchibori M, Osawa Y, Ishii Y, Aoki T, Ota Y, Kimura M. Analysis of HRAS mutations in Japanese patients with oral squamous cell carcinoma. Advances in Oral and Maxillofacial Surgery 2021;1:100021. [DOI: 10.1016/j.adoms.2021.100021] [Reference Citation Analysis]
|
| 183 |
Das T, Zhong R, Spiotto MT. Notch Signaling and Human Papillomavirus-Associated Oral Tumorigenesis. Adv Exp Med Biol 2021;1287:105-22. [PMID: 33034029 DOI: 10.1007/978-3-030-55031-8_8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 184 |
Watson GA, Taylor K, Siu LL. Innovation and Advances in Precision Medicine in Head and Neck Cancer. Critical Issues in Head and Neck Oncology 2021. [DOI: 10.1007/978-3-030-63234-2_24] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 185 |
Cao W, Shen Q, Lim MY. Editorial: "Non-Coding RNAs in Head and Neck Squamous Cell Carcinoma". Front Oncol 2021;11:785001. [PMID: 35004307 DOI: 10.3389/fonc.2021.785001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 186 |
Shanmugam A, Hariharan AK, Hasina R, Nair JR, Katragadda S, Irusappan S, Ravichandran A, Veeramachaneni V, Bettadapura R, Bhati M, Ramaswamy V, Rao VUS, Bagadia RK, Manjunath A, Manjunath NML, Solomon MC, Maji S, Bahadur U, Bettegowda C, Papadopoulos N, Lingen MW, Hariharan R, Gupta V, Agrawal N, Izumchenko E. Ultrasensitive detection of tumor-specific mutations in saliva of patients with oral cavity squamous cell carcinoma. Cancer 2021;127:1576-89. [PMID: 33405231 DOI: 10.1002/cncr.33393] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 187 |
Shah PA, Huang C, Li Q, Kazi SA, Byers LA, Wang J, Johnson FM, Frederick MJ. NOTCH1 Signaling in Head and Neck Squamous Cell Carcinoma. Cells 2020;9:E2677. [PMID: 33322834 DOI: 10.3390/cells9122677] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 188 |
Guan Y, Yang YJ, Nagarajan P, Ge Y. Transcriptional and signalling regulation of skin epithelial stem cells in homeostasis, wounds and cancer. Exp Dermatol 2021;30:529-45. [PMID: 33249665 DOI: 10.1111/exd.14247] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 189 |
Fukusumi T, Guo TW, Ren S, Haft S, Liu C, Sakai A, Ando M, Saito Y, Sadat S, Califano JA. Reciprocal activation of HEY1 and NOTCH4 under SOX2 control promotes EMT in head and neck squamous cell carcinoma. Int J Oncol 2021;58:226-37. [PMID: 33491747 DOI: 10.3892/ijo.2020.5156] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 190 |
Enaka M, Nakanishi M, Muragaki Y. The Gain-of-Function Mutation p53R248W Suppresses Cell Proliferation and Invasion of Oral Squamous Cell Carcinoma through the Down-Regulation of Keratin 17. Am J Pathol 2021;191:555-66. [PMID: 33307039 DOI: 10.1016/j.ajpath.2020.11.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 191 |
Uzunparmak B, Gao M, Lindemann A, Erikson K, Wang L, Lin E, Frank SJ, Gleber-Netto FO, Zhao M, Skinner HD, Newton J, Sikora AG, Myers JN, Pickering CR. Caspase-8 loss radiosensitizes head and neck squamous cell carcinoma to SMAC mimetic-induced necroptosis. JCI Insight 2020;5:139837. [PMID: 33108350 DOI: 10.1172/jci.insight.139837] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 192 |
Johnson DE, Burtness B, Leemans CR, Lui VWY, Bauman JE, Grandis JR. Head and neck squamous cell carcinoma. Nat Rev Dis Primers 2020;6:92. [PMID: 33243986 DOI: 10.1038/s41572-020-00224-3] [Cited by in Crossref: 815] [Cited by in F6Publishing: 814] [Article Influence: 271.7] [Reference Citation Analysis]
|
| 193 |
Wilson HL, D'Agostino RB Jr, Meegalla N, Petro R, Commander S, Topaloglu U, Zhang W, Porosnicu M. The Prognostic and Therapeutic Value of the Mutational Profile of Blood and Tumor Tissue in Head and Neck Squamous Cell Carcinoma. Oncologist 2021;26:e279-89. [PMID: 33098199 DOI: 10.1002/onco.13573] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 194 |
Wijetunga NA, Yu Y, Morris LG, Lee N, Riaz N. The head and neck cancer genome in the era of immunotherapy. Oral Oncol 2021;112:105040. [PMID: 33197752 DOI: 10.1016/j.oraloncology.2020.105040] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 195 |
Ludwig S, Sharma P, Wise P, Sposto R, Hollingshead D, Lamb J, Lang S, Fabbri M, Whiteside TL. mRNA and miRNA Profiles of Exosomes from Cultured Tumor Cells Reveal Biomarkers Specific for HPV16-Positive and HPV16-Negative Head and Neck Cancer. Int J Mol Sci 2020;21:E8570. [PMID: 33202950 DOI: 10.3390/ijms21228570] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 196 |
Buenahora MR, Lafaurie GI, Perdomo SJ. Identification of HPV16-p16INK4a mediated methylation in oral potentially malignant disorder. Epigenetics 2021;16:1016-30. [PMID: 33164635 DOI: 10.1080/15592294.2020.1834923] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 197 |
Sequeira I, Rashid M, Tomás IM, Williams MJ, Graham TA, Adams DJ, Vigilante A, Watt FM. Genomic landscape and clonal architecture of mouse oral squamous cell carcinomas dictate tumour ecology. Nat Commun 2020;11:5671. [PMID: 33168804 DOI: 10.1038/s41467-020-19401-9] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 198 |
Wilson GD, Wilson TG, Hanna A, Dabjan M, Buelow K, Torma J, Marples B, Galoforo S. Dacomitinib and gedatolisib in combination with fractionated radiation in head and neck cancer. Clin Transl Radiat Oncol 2021;26:15-23. [PMID: 33251343 DOI: 10.1016/j.ctro.2020.11.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 199 |
Hynes-Smith RW, Wittorf KJ, Buckley SM. Regulation of Normal and Malignant Hematopoiesis by FBOX Ubiquitin E3 Ligases. Trends Immunol 2020;41:1128-40. [PMID: 33160841 DOI: 10.1016/j.it.2020.10.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 200 |
Rodríguez Stewart RM, Raghuram V, Berry JTL, Joshi GN, Mainou BA. Noncanonical Cell Death Induction by Reassortant Reovirus. J Virol 2020;94:e01613-20. [PMID: 32847857 DOI: 10.1128/JVI.01613-20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 201 |
Rajendra S, Pavey D, McKay O, Merrett N, Gautam SD. Human papillomavirus infection in esophageal squamous cell carcinoma and esophageal adenocarcinoma: a concise review. Ann N Y Acad Sci 2020;1482:36-48. [PMID: 33103249 DOI: 10.1111/nyas.14509] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 202 |
Fasoulakis Z, Daskalakis G, Theodora M, Antsaklis P, Sindos M, Diakosavvas M, Angelou K, Loutradis D, Kontomanolis EN. The Relevance of Notch Signaling in Cancer Progression. Adv Exp Med Biol 2021;1287:169-81. [PMID: 33034032 DOI: 10.1007/978-3-030-55031-8_11] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 203 |
Parmigiani E, Taylor V, Giachino C. Oncogenic and Tumor-Suppressive Functions of NOTCH Signaling in Glioma. Cells 2020;9:E2304. [PMID: 33076453 DOI: 10.3390/cells9102304] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 204 |
Monticone G, Miele L. Notch Pathway: A Journey from Notching Phenotypes to Cancer Immunotherapy. Adv Exp Med Biol 2021;1287:201-22. [PMID: 33034034 DOI: 10.1007/978-3-030-55031-8_13] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 205 |
Fernández-Mateos J, Pérez-García J, Seijas-Tamayo R, Mesía R, Rubió-Casadevall J, García-Girón C, Iglesias L, Carral Maseda A, Adansa Klain JC, Taberna M, Vazquez S, Gómez MA, Del Barco E, Ocana A, González-Sarmiento R, Cruz-Hernández JJ. Oncogenic driver mutations predict outcome in a cohort of head and neck squamous cell carcinoma (HNSCC) patients within a clinical trial. Sci Rep 2020;10:16634. [PMID: 33024167 DOI: 10.1038/s41598-020-72927-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 206 |
Kim S, Lee JW, Park YS. The Application of Next-Generation Sequencing to Define Factors Related to Oral Cancer and Discover Novel Biomarkers. Life (Basel) 2020;10:E228. [PMID: 33023080 DOI: 10.3390/life10100228] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 207 |
Pagliaro L, Sorrentino C, Roti G. Targeting Notch Trafficking and Processing in Cancers. Cells 2020;9:E2212. [PMID: 33003595 DOI: 10.3390/cells9102212] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 208 |
Saba NF, Dinasarapu AR, Magliocca KR, Dwivedi B, Seby S, Qin ZS, Patel M, Griffith CC, Wang X, El-Deiry M, Steuer CE, Kowalski J, Shin DM, Zwick ME, Chen ZG. Signatures of somatic mutations and gene expression from p16INK4A positive head and neck squamous cell carcinomas (HNSCC). PLoS One 2020;15:e0238497. [PMID: 32986729 DOI: 10.1371/journal.pone.0238497] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 209 |
Shi MJ, Meng XY, Fontugne J, Chen CL, Radvanyi F, Bernard-Pierrot I. Identification of new driver and passenger mutations within APOBEC-induced hotspot mutations in bladder cancer. Genome Med 2020;12:85. [PMID: 32988402 DOI: 10.1186/s13073-020-00781-y] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 210 |
Chari NS, Ivan C, Le X, Li J, Mijiti A, Patel AA, Osman AA, Peterson CB, Williams MD, Pickering CR, Caulin C, Myers JN, Calin GA, Lai SY. Disruption of TP63-miR-27a* Feedback Loop by Mutant TP53 in Head and Neck Cancer. J Natl Cancer Inst 2020;112:266-77. [PMID: 31124563 DOI: 10.1093/jnci/djz097] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 211 |
Pan L, Lemieux ME, Thomas T, Rogers JM, Lipper CH, Lee W, Johnson C, Sholl LM, South AP, Marto JA, Adelmant GO, Blacklow SC, Aster JC. IER5, a DNA damage response gene, is required for Notch-mediated induction of squamous cell differentiation. Elife 2020;9:e58081. [PMID: 32936072 DOI: 10.7554/eLife.58081] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 212 |
Dudek AZ, Baxstrom K, Bharadwaj S, Blaes A, Kulkarni A, Lou E, Nehru V, Rabinovich E, Shergill A, Viner M. Genomic Strategies for Personalized Cancer Therapy. Precision Medicine in Oncology 2020. [DOI: 10.1002/9781119432487.ch1] [Reference Citation Analysis]
|
| 213 |
Grilli G, Hermida-Prado F, Álvarez-Fernández M, Allonca E, Álvarez-González M, Astudillo A, Moreno-Bueno G, Cano A, García-Pedrero JM, Rodrigo JP. Impact of notch signaling on the prognosis of patients with head and neck squamous cell carcinoma. Oral Oncol 2020;110:105003. [PMID: 32932170 DOI: 10.1016/j.oraloncology.2020.105003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 214 |
Babiker AY, Almatroodi SA, Almatroudi A, Alrumaihi F, Abdalaziz MS, Alsahli MA, Husain Rahmani A. Clinicopathological significance of VEGF and pAkt expressions in oral squamous cell carcinoma. All Life 2020;13:507-15. [DOI: 10.1080/26895293.2020.1815595] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 215 |
Sathasivam HP, Casement J, Bates T, Sloan P, Thomson P, Robinson M, Kist R. Gene expression changes associated with malignant transformation of oral potentially malignant disorders. J Oral Pathol Med 2021;50:60-7. [PMID: 32740996 DOI: 10.1111/jop.13090] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 216 |
González-Moles MÁ, Ayén Á, González-Ruiz I, de Porras-Carrique T, González-Ruiz L, Ruiz-Ávila I, Ramos-García P. Prognostic and Clinicopathological Significance of FADD Upregulation in Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis. Cancers (Basel) 2020;12:E2393. [PMID: 32847023 DOI: 10.3390/cancers12092393] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 217 |
Deliu Z, Shergill A, Meier A, Myint PT, Khan S, Khosla P, Feldman L. Prognostic Implications of EGFR, p53, p16, Cyclin D1, and Bcl‐2 in Head and Neck Squamous Cell Carcinoma (HNSCC). In: Aydogan B, Radosevich JA, editors. Precision Medicine in Oncology. Wiley; 2020. pp. 99-131. [DOI: 10.1002/9781119432487.ch4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 218 |
Chandel V, Raj S, Kumar P, Gupta S, Dhasmana A, Kesari KK, Ruokolainen J, Mehra P, Das BC, Kamal MA, Kumar D. Metabolic regulation in HPV associated head and neck squamous cell carcinoma. Life Sci 2020;258:118236. [PMID: 32795537 DOI: 10.1016/j.lfs.2020.118236] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 219 |
Wang S, Yu Y, Fang Y, Huang H, Wu D, Fang H, Bai Y, Sun C, Yu A, Fan Q, Yu Z, Zhang C, Wang C, Tai Z, Huang Y, Li N. Whole-exome sequencing reveals genetic underpinnings of salivary adenoid cystic carcinoma in the Chinese population. J Genet Genomics 2020;47:397-401. [PMID: 33077413 DOI: 10.1016/j.jgg.2020.07.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 220 |
Chen TC, Wu CT, Wang CP, Lou PJ, Ko JY, Chang YL. The differences of immunologic and TP53 mutant phenotypes between synchronous and metachronous head and neck cancer and esophageal cancer. Oral Oncol 2020;111:104945. [PMID: 32769036 DOI: 10.1016/j.oraloncology.2020.104945] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 221 |
Lin D, Lin B, Bhanot H, Riou R, Abt NB, Rajagopal J, Saladi SV. RUVBL1 is an amplified epigenetic factor promoting proliferation and inhibiting differentiation program in head and neck squamous cancers. Oral Oncol 2020;111:104930. [PMID: 32745900 DOI: 10.1016/j.oraloncology.2020.104930] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 222 |
Yura Y, Masui A, Hamada M. Inhibitors of Ceramide- and Sphingosine-Metabolizing Enzymes as Sensitizers in Radiotherapy and Chemotherapy for Head and Neck Squamous Cell Carcinoma. Cancers (Basel) 2020;12:E2062. [PMID: 32722626 DOI: 10.3390/cancers12082062] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 223 |
Okoturo E, Osasuyi A, Opaleye T. Genetic Polymorphism of Head and Neck Cancers in African Populations: A Systematic Review. OTO Open 2020;4:2473974X20942202. [PMID: 32743234 DOI: 10.1177/2473974X20942202] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 224 |
Stepan KO, Li MM, Kang SY, Puram SV. Molecular margins in head and neck cancer: Current techniques and future directions. Oral Oncol 2020;110:104893. [PMID: 32702629 DOI: 10.1016/j.oraloncology.2020.104893] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 225 |
Zhang H, Song Y, Du Z, Li X, Zhang J, Chen S, Chen F, Li T, Zhan Q. Exome sequencing identifies new somatic alterations and mutation patterns of tongue squamous cell carcinoma in a Chinese population. J Pathol 2020;251:353-64. [PMID: 32432340 DOI: 10.1002/path.5467] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 226 |
Facompre ND, Rajagopalan P, Sahu V, Pearson AT, Montone KT, James CD, Gleber-Netto FO, Weinstein GS, Jalaly J, Lin A, Rustgi AK, Nakagawa H, Califano JA, Pickering CR, White EA, Windle BE, Morgan IM, Cohen RB, Gimotty PA, Basu D. Identifying predictors of HPV-related head and neck squamous cell carcinoma progression and survival through patient-derived models. Int J Cancer 2020;147:3236-49. [PMID: 32478869 DOI: 10.1002/ijc.33125] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 227 |
Madhura MG, Rao RS, Patil S, Fageeh HN, Alhazmi A, Awan KH. Advanced diagnostic aids for oral cancer. Dis Mon 2020;66:101034. [PMID: 32594996 DOI: 10.1016/j.disamonth.2020.101034] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 228 |
Enver N, Şahin A, Sönmez S, Demokan S. Most Cited Articles in Head and Neck Oncology. Ear Nose Throat J 2020;:145561320934920. [PMID: 32579405 DOI: 10.1177/0145561320934920] [Reference Citation Analysis]
|
| 229 |
Moore G, Annett S, McClements L, Robson T. Top Notch Targeting Strategies in Cancer: A Detailed Overview of Recent Insights and Current Perspectives. Cells 2020;9:E1503. [PMID: 32575680 DOI: 10.3390/cells9061503] [Cited by in Crossref: 61] [Cited by in F6Publishing: 67] [Article Influence: 20.3] [Reference Citation Analysis]
|
| 230 |
de Carvalho AC, Perdomo S, Dos Santos W, Fernandes GC, de Jesus LM, Carvalho RS, Scapulatempo-Neto C, de Almeida GC, Sorroche BP, Arantes LMRB, Melendez ME, De Marchi P, Hayes N, Reis RM, Carvalho AL. Impact of genetic variants in clinical outcome of a cohort of patients with oropharyngeal squamous cell carcinoma. Sci Rep 2020;10:9970. [PMID: 32561788 DOI: 10.1038/s41598-020-66741-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 231 |
Yang WF, Qin N, Song X, Jiang C, Li T, Ji P, Li Y, Ding D, Wang C, Dai J, Jin G, Chen TW, Chang YS, Ouyang DQ, Liao GQ, Hu Z, Chang KP, Su YX, Ma H. Genomic Signature of Mismatch Repair Deficiency in Areca Nut-Related Oral Cancer. J Dent Res 2020;99:1252-61. [PMID: 32527169 DOI: 10.1177/0022034520930641] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 232 |
Tan MT, Wu JG, Callejas-Valera JL, Schwarz RA, Gillenwater AM, Richards-Kortum RR, Vigneswaran N. A PIK3CA transgenic mouse model with chemical carcinogen exposure mimics human oral tongue tumorigenesis. Int J Exp Pathol 2020;101:45-54. [PMID: 32436348 DOI: 10.1111/iep.12347] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 233 |
Stewart RMR, Raghuram V, Berry JT, Mainou BA. Non-canonical cell death by reassortant reovirus.. [DOI: 10.1101/2020.05.20.107706] [Reference Citation Analysis]
|
| 234 |
Harsha C, Banik K, Ang HL, Girisa S, Vikkurthi R, Parama D, Rana V, Shabnam B, Khatoon E, Kumar AP, Kunnumakkara AB. Targeting AKT/mTOR in Oral Cancer: Mechanisms and Advances in Clinical Trials. Int J Mol Sci 2020;21:E3285. [PMID: 32384682 DOI: 10.3390/ijms21093285] [Cited by in Crossref: 69] [Cited by in F6Publishing: 77] [Article Influence: 23.0] [Reference Citation Analysis]
|
| 235 |
Malgundkar SH, Burney I, Al Moundhri M, Al Kalbani M, Lakhtakia R, Okamoto A, Tamimi Y. FAT4 silencing promotes epithelial-to-mesenchymal transition and invasion via regulation of YAP and β-catenin activity in ovarian cancer. BMC Cancer 2020;20:374. [PMID: 32366234 DOI: 10.1186/s12885-020-06900-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 236 |
Jiang N, Dai Q, Su X, Fu J, Feng X, Peng J. Role of PI3K/AKT pathway in cancer: the framework of malignant behavior. Mol Biol Rep 2020;47:4587-629. [PMID: 32333246 DOI: 10.1007/s11033-020-05435-1] [Cited by in Crossref: 166] [Cited by in F6Publishing: 192] [Article Influence: 55.3] [Reference Citation Analysis]
|
| 237 |
Pan L, Lemieux ME, Thomas T, Rogers JM, Lee W, Johnson C, Sholl L, South AP, Marto JA, Adelmant GO, Blacklow SC, Aster JC. IER5, a DNA-damage response gene, is required for Notch-mediated induction of squamous cell differentiation.. [DOI: 10.1101/2020.04.21.051730] [Reference Citation Analysis]
|
| 238 |
Wang YP, Liu IJ, Chung MJ, Wu HC. Novel anti-EGFR scFv human antibody-conjugated immunoliposomes enhance chemotherapeutic efficacy in squamous cell carcinoma of head and neck. Oral Oncol 2020;106:104689. [PMID: 32330686 DOI: 10.1016/j.oraloncology.2020.104689] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 239 |
Ngan HL, Poon PHY, Su YX, Chan JYK, Lo KW, Yeung CK, Liu Y, Wong E, Li H, Lau CW, Piao W, Lui VWY. Erlotinib sensitivity of MAPK1p.D321N mutation in head and neck squamous cell carcinoma. NPJ Genom Med 2020;5:17. [PMID: 32351709 DOI: 10.1038/s41525-020-0124-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 240 |
Uzunparmak B, Gao M, Lindemann A, Erikson K, Wang L, Lin E, Frank SJ, Gleber-netto FO, Zhao M, Skinner HD, Newton J, Sikora AG, Myers JN, Pickering CR. Loss of Caspase-8 function in combination with SMAC mimetic treatment sensitizes Head and Neck Squamous Carcinoma to radiation through induction of necroptosis.. [DOI: 10.1101/2020.04.17.039040] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 241 |
Bommireddy R, Munoz LE, Kumari A, Huang L, Fan Y, Monterroza L, Pack CD, Ramachandiran S, Reddy SJC, Kim J, Chen ZG, Saba NF, Shin DM, Selvaraj P. Tumor Membrane Vesicle Vaccine Augments the Efficacy of Anti-PD1 Antibody in Immune Checkpoint Inhibitor-Resistant Squamous Cell Carcinoma Models of Head and Neck Cancer. Vaccines (Basel) 2020;8:E182. [PMID: 32295135 DOI: 10.3390/vaccines8020182] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 242 |
Chai AWY, Lim KP, Cheong SC. Translational genomics and recent advances in oral squamous cell carcinoma. Seminars in Cancer Biology 2020;61:71-83. [DOI: 10.1016/j.semcancer.2019.09.011] [Cited by in Crossref: 72] [Cited by in F6Publishing: 83] [Article Influence: 24.0] [Reference Citation Analysis]
|
| 243 |
Essers PBM, van der Heijden M, Vossen D, de Roest RH, Leemans CR, Brakenhoff RH, van den Brekel MWM, Bartelink H, Verheij M, Vens C. Ovarian cancer-derived copy number alterations signatures are prognostic in chemoradiotherapy-treated head and neck squamous cell carcinoma. Int J Cancer 2020;147:1732-9. [PMID: 32167160 DOI: 10.1002/ijc.32962] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 244 |
Alzahrani R, Alrehaili AA, Gharib AF, Anjum F, Ismail KA, Elsawy WH. Cancerous Inhibitor of Protein Phosphatase 2A as a Molecular Marker for Aggressiveness and Survival in Oral Squamous Cell Carcinoma. J Cancer Prev 2020;25:21-6. [PMID: 32266176 DOI: 10.15430/JCP.2020.25.1.21] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 245 |
Wang H, Xue W, Ouyang W, Jiang X, Jiang X. miR-23a-3p/SIX1 regulates glucose uptake and proliferation through GLUT3 in head and neck squamous cell carcinomas. J Cancer 2020;11:2529-39. [PMID: 32201523 DOI: 10.7150/jca.30995] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 246 |
Saada-Bouzid E, Peyrade F, Guigay J. Molecular genetics of head and neck squamous cell carcinoma. Curr Opin Oncol 2019;31:131-7. [PMID: 30893149 DOI: 10.1097/CCO.0000000000000536] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 247 |
Chandler KB, Alamoud KA, Stahl VL, Nguyen BC, Kartha VK, Bais MV, Nomoto K, Owa T, Monti S, Kukuruzinska MA, Costello CE. β-Catenin/CBP inhibition alters epidermal growth factor receptor fucosylation status in oral squamous cell carcinoma. Mol Omics 2020;16:195-209. [PMID: 32203567 DOI: 10.1039/d0mo00009d] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 248 |
Guo T, Zambo KDA, Zamuner FT, Ou T, Hopkins C, Kelley DZ, Wulf HA, Winkler E, Erbe R, Danilova L, Considine M, Sidransky D, Favorov A, Florea L, Fertig EJ, Gaykalova DA. Chromatin structure regulates cancer-specific alternative splicing events in primary HPV-related oropharyngeal squamous cell carcinoma. Epigenetics 2020;15:959-71. [PMID: 32164487 DOI: 10.1080/15592294.2020.1741757] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 249 |
Yang J, Chen Y, Luo H, Cai H. The Landscape of Somatic Copy Number Alterations in Head and Neck Squamous Cell Carcinoma. Front Oncol 2020;10:321. [PMID: 32226775 DOI: 10.3389/fonc.2020.00321] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 250 |
Chaudhary S, Ganguly K, Muniyan S, Pothuraju R, Sayed Z, Jones DT, Batra SK, Macha MA. Immunometabolic Alterations by HPV Infection: New Dimensions to Head and Neck Cancer Disparity. J Natl Cancer Inst 2019;111:233-44. [PMID: 30615137 DOI: 10.1093/jnci/djy207] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 251 |
Galot R, van Marcke C, Helaers R, Mendola A, Goebbels RM, Caignet X, Ambroise J, Wittouck K, Vikkula M, Limaye N, Machiels JH. Liquid biopsy for mutational profiling of locoregional recurrent and/or metastatic head and neck squamous cell carcinoma. Oral Oncol 2020;104:104631. [PMID: 32169746 DOI: 10.1016/j.oraloncology.2020.104631] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 252 |
García-Carracedo D, Cai Y, Qiu W, Saeki K, Friedman RA, Lee A, Li Y, Goldberg EM, Stratikopoulos EE, Parsons R, Lu C, Efstratiadis A, Philipone EM, Yoon AJ, Su GH. PIK3CA and p53 Mutations Promote 4NQO-Initated Head and Neck Tumor Progression and Metastasis in Mice. Mol Cancer Res 2020;18:822-34. [PMID: 32152233 DOI: 10.1158/1541-7786.MCR-19-0549] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 253 |
Mandal R, Barrón JC, Kostova I, Becker S, Strebhardt K. Caspase-8: The double-edged sword. Biochim Biophys Acta Rev Cancer 2020;1873:188357. [PMID: 32147543 DOI: 10.1016/j.bbcan.2020.188357] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 12.3] [Reference Citation Analysis]
|
| 254 |
Wai KC, Strohl MP, van Zante A, Ha PK. Molecular Diagnostics in Human Papillomavirus-Related Head and Neck Squamous Cell Carcinoma. Cells 2020;9:E500. [PMID: 32098320 DOI: 10.3390/cells9020500] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 255 |
Nakagawa T, Matsusaka K, Misawa K, Ota S, Fukuyo M, Rahmutulla B, Kunii N, Sakurai D, Hanazawa T, Matsubara H, Okamoto Y, Kaneda A. Stratification of HPV-associated and HPV-negative oropharyngeal squamous cell carcinomas based on DNA methylation epigenotypes. Int J Cancer 2020;146:2460-74. [PMID: 31997344 DOI: 10.1002/ijc.32890] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 256 |
Budania S, Sur D, Nangal J, Pilli S, Mukherjee K, Biswas M, Prasad R, Saxena S, Mandal PK. LINE-1 retrotransposon encoded ORF1p expression and promoter methylation in oral squamous cell carcinoma: a pilot study. Cancer Genet 2020;244:21-9. [PMID: 32088612 DOI: 10.1016/j.cancergen.2020.01.050] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 257 |
Ramesh PS, Devegowda D, Singh A, Thimmulappa RK. NRF2, p53, and p16: Predictive biomarkers to stratify human papillomavirus associated head and neck cancer patients for de-escalation of cancer therapy. Crit Rev Oncol Hematol 2020;148:102885. [PMID: 32062315 DOI: 10.1016/j.critrevonc.2020.102885] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 258 |
Devaraja K, Aggarwal S, Verma SS, Gupta SC. Clinico-pathological peculiarities of human papilloma virus driven head and neck squamous cell carcinoma: A comprehensive update. Life Sci 2020;245:117383. [PMID: 32007572 DOI: 10.1016/j.lfs.2020.117383] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 259 |
Chen TC, Wu CT, Ko JY, Yang TL, Lou PJ, Wang CP, Chang YL. Clinical characteristics and treatment outcome of oropharyngeal squamous cell carcinoma in an endemic betel quid region. Sci Rep 2020;10:526. [PMID: 31949181 DOI: 10.1038/s41598-019-57177-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 260 |
Yamamoto S. Making sense out of missense mutations: Mechanistic dissection of Notch receptors through structure-function studies in Drosophila. Dev Growth Differ 2020;62:15-34. [PMID: 31943162 DOI: 10.1111/dgd.12640] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 261 |
van der Heijden M, Essers PBM, de Jong MC, de Roest RH, Sanduleanu S, Verhagen CVM, Hamming-Vrieze O, Hoebers F, Lambin P, Bartelink H, Leemans CR, Verheij M, Brakenhoff RH, van den Brekel MWM, Vens C. Biological Determinants of Chemo-Radiotherapy Response in HPV-Negative Head and Neck Cancer: A Multicentric External Validation. Front Oncol 2019;9:1470. [PMID: 31998639 DOI: 10.3389/fonc.2019.01470] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 262 |
Hsu PJ, Yan K, Shi H, Izumchenko E, Agrawal N. Molecular biology of oral cavity squamous cell carcinoma. Oral Oncol 2020;102:104552. [PMID: 31918173 DOI: 10.1016/j.oraloncology.2019.104552] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 263 |
Ow TJ, Thomas C, Fulcher CD, Chen J, López A, Reyna DE, Prystowsky MB, Smith RV, Schiff BA, Rosenblatt G, Belbin TJ, Harris TM, Childs GC, Kawachi N, Schlecht NF, Gavathiotis E. Apoptosis signaling molecules as treatment targets in head and neck squamous cell carcinoma. Laryngoscope 2020;130:2643-9. [PMID: 31894587 DOI: 10.1002/lary.28441] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 264 |
Wang Z, Liu T, Li G, Cao Z. The exploration of new therapeutic targets for HPV-negative head and neck squamous cell cancer through the construction of a ceRNA network and immune microenvironment analysis. J Cell Biochem 2020;121:3426-37. [PMID: 31898341 DOI: 10.1002/jcb.29615] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 265 |
Bhatia S, Karam SD. Eph/ephrin family proteins and therapeutic resistance. Improving the Therapeutic Ratio in Head and Neck Cancer 2020. [DOI: 10.1016/b978-0-12-817868-3.00009-3] [Reference Citation Analysis]
|
| 266 |
Khuda-bukhsh AR, Samadder A, Saha SK. Introduction to Cancer Stem Cells. Cancer Stem Cells: New Horizons in Cancer Therapies 2020. [DOI: 10.1007/978-981-15-5120-8_1] [Reference Citation Analysis]
|
| 267 |
Zhang C, Cao W, Wang J, Liu J, Liu J, Wu H, Li S, Zhang C. A prognostic long non-coding RNA-associated competing endogenous RNA network in head and neck squamous cell carcinoma. PeerJ 2020;8:e9701. [PMID: 32983633 DOI: 10.7717/peerj.9701] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 268 |
Osman AA, Lindemann A, Wang L, Frank SJ, Myers JN. Targeting TP53 to augment therapeutic response in head and neck cancer. Improving the Therapeutic Ratio in Head and Neck Cancer 2020. [DOI: 10.1016/b978-0-12-817868-3.00004-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 269 |
Sandulache VC, Myers JN. Treatment resistance and a glimmer of hope, the promise of new agents. Novel Therapies in Head and Neck Cancer: Beyond the Horizon 2020. [DOI: 10.1016/b978-0-12-820679-9.00006-2] [Reference Citation Analysis]
|
| 270 |
Li PC, Margalit DN. Overview of head and neck cancer management. Improving the Therapeutic Ratio in Head and Neck Cancer 2020. [DOI: 10.1016/b978-0-12-817868-3.00001-9] [Reference Citation Analysis]
|
| 271 |
Del-Río-Ibisate N, Granda-Díaz R, Rodrigo JP, Menéndez ST, García-Pedrero JM. Ion Channel Dysregulation in Head and Neck Cancers: Perspectives for Clinical Application. Rev Physiol Biochem Pharmacol 2021;181:375-427. [PMID: 32789787 DOI: 10.1007/112_2020_38] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 272 |
Monteiro L, Warnakulasuriya S. Molecular and Signaling Pathways During Oral Carcinogenesis. Textbook of Oral Cancer 2020. [DOI: 10.1007/978-3-030-32316-5_14] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 273 |
Westbrook TC, Hagemann IS, Ley J, Chen K, Palka K, Liu J, Chen L, Oppelt P, Adkins D. Prospective assessment of the clinical benefit of a tailored cancer gene set built on a next-generation sequencing platform in patients with recurrent or metastatic head and neck cancer. Med Oncol 2019;37:12. [PMID: 31865465 DOI: 10.1007/s12032-019-1336-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 274 |
Riva G, Biolatti M, Pecorari G, Dell'Oste V, Landolfo S. PYHIN Proteins and HPV: Role in the Pathogenesis of Head and Neck Squamous Cell Carcinoma. Microorganisms 2019;8:E14. [PMID: 31861809 DOI: 10.3390/microorganisms8010014] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 275 |
Anekpuritanang T, Pongsapich W, Watcharadilokkul T, Ngaotepprutaram P, Pithuksurachai P, Bunbanjerdsuk S. Notch Intracellular Domain (NICD) Expression and Clinical Manifestations of Second Primary Tumor at Esophagus in Patients with Head and Neck Squamous Cell Carcinoma. Onco Targets Ther 2019;12:11175-81. [PMID: 31908484 DOI: 10.2147/OTT.S227745] [Reference Citation Analysis]
|
| 276 |
Guan Y, Wang G, Fails D, Nagarajan P, Ge Y. Unraveling cancer lineage drivers in squamous cell carcinomas. Pharmacol Ther. 2020;206:107448. [PMID: 31836455 DOI: 10.1016/j.pharmthera.2019.107448] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 277 |
Lin LH, Chang KW, Cheng HW, Liu CJ. SMAD4 Somatic Mutations in Head and Neck Carcinoma Are Associated With Tumor Progression. Front Oncol. 2019;9:1379. [PMID: 31867281 DOI: 10.3389/fonc.2019.01379] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 278 |
Katoh M, Katoh M. Precision medicine for human cancers with Notch signaling dysregulation (Review). Int J Mol Med. 2020;45:279-297. [PMID: 31894255 DOI: 10.3892/ijmm.2019.4418] [Cited by in Crossref: 41] [Cited by in F6Publishing: 53] [Article Influence: 10.3] [Reference Citation Analysis]
|
| 279 |
Santos-de-Frutos K, Segrelles C, Lorz C. Hippo Pathway and YAP Signaling Alterations in Squamous Cancer of the Head and Neck. J Clin Med 2019;8:E2131. [PMID: 31817001 DOI: 10.3390/jcm8122131] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 280 |
Denninghoff V, Muino A, Diaz M, Harada L, Lence A, Turon P, Labbrozzi M, Aguas S, Peñaloza P, Avagnina A, Adler I. Mutational status of PIK3ca oncogene in oral cancer-In the new age of PI3K inhibitors. Pathol Res Pract 2020;216:152777. [PMID: 31831300 DOI: 10.1016/j.prp.2019.152777] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 281 |
Cata JP, Owusu-agyemang P, Kapoor R, Lonnqvist P. Impact of Anesthetics, Analgesics, and Perioperative Blood Transfusion in Pediatric Cancer Patients: A Comprehensive Review of the Literature. Anesthesia & Analgesia 2019;129:1653-65. [DOI: 10.1213/ane.0000000000004314] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 282 |
Batta N, Pandey M. Mutational spectrum of tobacco associated oral squamous carcinoma and its therapeutic significance. World J Surg Oncol 2019;17:198. [PMID: 31775759 DOI: 10.1186/s12957-019-1741-2] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 283 |
Salameti V, Bhosale PG, Ames-Draycott A, Sipilä K, Watt FM. NOTCH1 signaling in oral squamous cell carcinoma via a TEL2/SERPINE1 axis. Oncotarget 2019;10:6791-804. [PMID: 31827722 DOI: 10.18632/oncotarget.27306] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 284 |
Huang Y, Zhao J, Mao G, Lee GS, Zhang J, Bi L, Gu L, Chang Z, Valentino J, Li GM. Identification of novel genetic variants predisposing to familial oral squamous cell carcinomas. Cell Discov 2019;5:57. [PMID: 31798960 DOI: 10.1038/s41421-019-0126-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 285 |
Al Feghali KA, Ghanem AI, Burmeister C, Chang SS, Ghanem T, Keller C, Siddiqui F. Impact of smoking on pathological features in oral cavity squamous cell carcinoma. J Cancer Res Ther 2019;15:582-8. [PMID: 31169224 DOI: 10.4103/jcrt.JCRT_641_16] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 286 |
Galot R, Le Tourneau C, Guigay J, Licitra L, Tinhofer I, Kong A, Caballero C, Fortpied C, Bogaerts J, Govaerts AS, Staelens D, Raveloarivahy T, Rodegher L, Laes JF, Saada-Bouzid E, Machiels JP. Personalized biomarker-based treatment strategy for patients with squamous cell carcinoma of the head and neck: EORTC position and approach. Ann Oncol 2018;29:2313-27. [PMID: 30307465 DOI: 10.1093/annonc/mdy452] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 287 |
Ghias K, Rehmani SS, Razzak SA, Madhani S, Azim MK, Ahmed R, Khan MJ. Mutational landscape of head and neck squamous cell carcinomas in a South Asian population. Genet Mol Biol 2019;4242:526-42. [PMID: 31188922 DOI: 10.1590/1678-4685-GMB-2018-0005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 288 |
Taghizadeh E, Mirzaei F, Jalilian N, Ghayour Mobarhan M, Ferns GA, Pasdar A. A novel mutation in USF1 gene is associated with familial combined hyperlipidemia. IUBMB Life 2019;72:616-23. [DOI: 10.1002/iub.2186] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 289 |
Roldan CS, Chen JJ, Fareed MM, Hameed MY, Churilla TM, Lango MN, Galloway TJ. Impact of primary tumor-specific growth rate on treatment failure for nonoropharyngeal head and neck cancers. Laryngoscope 2020;130:2378-84. [PMID: 31714626 DOI: 10.1002/lary.28393] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 290 |
Tomita H. Comment from the Editor on the Special Issue "Head and Neck Critical Illness: Basic and Clinical Research Implications". J Clin Med 2019;8:E1905. [PMID: 31703323 DOI: 10.3390/jcm8111905] [Reference Citation Analysis]
|
| 291 |
Su S, Chang L, Lin C, Chen M, Yu C, Chung W, Yang S. Mutational signatures and mutagenic impacts associated with betel quid chewing in oral squamous cell carcinoma. Hum Genet 2019;138:1379-89. [DOI: 10.1007/s00439-019-02083-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 292 |
Zhou Y, Zheng S, Luo Q, Huang X, Zhou Y, Li Z. Hypermethylation of DcR1, DcR2, DR4, DR5 gene promoters and clinical significance in tongue carcinoma. Am J Otolaryngol 2019;40:102258. [PMID: 31399243 DOI: 10.1016/j.amjoto.2019.07.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 293 |
Wilson TG, Hanna A, Recknagel J, Pruetz BL, Baschnagel AM, Wilson GD. Prognostic significance of MTOR expression in HPV positive and negative head and neck cancers treated by chemoradiation. Head Neck 2020;42:153-62. [PMID: 31657099 DOI: 10.1002/hed.25983] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 294 |
Shaikh I, Ansari A, Ayachit G, Gandhi M, Sharma P, Bhairappanavar S, Joshi CG, Das J. Differential gene expression analysis of HNSCC tumors deciphered tobacco dependent and independent molecular signatures. Oncotarget 2019;10:6168-83. [PMID: 31692905 DOI: 10.18632/oncotarget.27249] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 295 |
Tanimoto K, Muramatsu T, Inazawa J. Massive computational identification of somatic variants in exonic splicing enhancers using The Cancer Genome Atlas. Cancer Med 2019;8:7372-84. [PMID: 31631560 DOI: 10.1002/cam4.2619] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 296 |
Flam EL, Danilova L, Kelley DZ, Stavrovskaya E, Guo T, Considine M, Qian J, Califano JA, Favorov A, Fertig EJ, Gaykalova DA. Differentially Methylated Super-Enhancers Regulate Target Gene Expression in Human Cancer. Sci Rep 2019;9:15034. [PMID: 31636280 DOI: 10.1038/s41598-019-51018-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 297 |
Sandulache VC, Wilde DC, Sturgis EM, Chiao EY, Sikora AG. A Hidden Epidemic of "Intermediate Risk" Oropharynx Cancer. Laryngoscope Investig Otolaryngol 2019;4:617-23. [PMID: 31890879 DOI: 10.1002/lio2.316] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 298 |
Wood DE, White JR, Georgiadis A, Van Emburgh B, Parpart-Li S, Mitchell J, Anagnostou V, Niknafs N, Karchin R, Papp E, McCord C, LoVerso P, Riley D, Diaz LA Jr, Jones S, Sausen M, Velculescu VE, Angiuoli SV. A machine learning approach for somatic mutation discovery. Sci Transl Med 2018;10:eaar7939. [PMID: 30185652 DOI: 10.1126/scitranslmed.aar7939] [Cited by in Crossref: 56] [Cited by in F6Publishing: 55] [Article Influence: 14.0] [Reference Citation Analysis]
|
| 299 |
Wei T, Choi S, Buehler D, Anderson RA, Lambert PF. A PI3K/AKT Scaffolding Protein, IQ Motif-Containing GTPase Associating Protein 1 (IQGAP1), Promotes Head and Neck Carcinogenesis. Clin Cancer Res 2020;26:301-11. [PMID: 31597661 DOI: 10.1158/1078-0432.CCR-19-1063] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 300 |
De Blasio C, Zonfrilli A, Franchitto M, Mariano G, Cialfi S, Verma N, Checquolo S, Bellavia D, Palermo R, Benelli D, Screpanti I, Talora C. PLK1 targets NOTCH1 during DNA damage and mitotic progression. J Biol Chem 2019;294:17941-50. [PMID: 31597699 DOI: 10.1074/jbc.RA119.009881] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 301 |
Panwar A, Rieke K, Burke WJ, Sayles H, Lydiatt WM; Prevention of Depression in Patients Being Treated for Head and Neck Cancer Trial (PROTECT) study group. Identification of Baseline Characteristics Associated With Development of Depression Among Patients With Head and Neck Cancer: A Secondary Analysis of a Randomized Clinical Trial. JAMA Otolaryngol Head Neck Surg 2018;144:1004-10. [PMID: 30286230 DOI: 10.1001/jamaoto.2018.2228] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 302 |
Chen D, Wang CY. Targeting cancer stem cells in squamous cell carcinoma. Precis Clin Med 2019;2:152-65. [PMID: 31598386 DOI: 10.1093/pcmedi/pbz016] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 9.5] [Reference Citation Analysis]
|
| 303 |
Lee YS. Current Development and Research Trend of Chemotherapeutic Agents for Head and Neck Squamous Cell Carcinoma. Korean J Otorhinolaryngol-Head Neck Surg 2019;62:487-498. [DOI: 10.3342/kjorl-hns.2019.00479] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 304 |
Economopoulou P, de Bree R, Kotsantis I, Psyrri A. Diagnostic Tumor Markers in Head and Neck Squamous Cell Carcinoma (HNSCC) in the Clinical Setting. Front Oncol 2019;9:827. [PMID: 31555588 DOI: 10.3389/fonc.2019.00827] [Cited by in Crossref: 68] [Cited by in F6Publishing: 78] [Article Influence: 17.0] [Reference Citation Analysis]
|
| 305 |
Ruicci KM, Plantinga P, Pinto N, Khan MI, Stecho W, Dhaliwal SS, Yoo J, Fung K, MacNeil D, Mymryk JS, Barrett JW, Howlett CJ, Nichols AC. Disruption of the RICTOR/mTORC2 complex enhances the response of head and neck squamous cell carcinoma cells to PI3K inhibition. Mol Oncol 2019;13:2160-77. [PMID: 31393061 DOI: 10.1002/1878-0261.12558] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 306 |
Veeramachaneni R, Walker T, Revil T, Weck A, Badescu D, O'Sullivan J, Higgins C, Elliott L, Liloglou T, Risk JM, Shaw R, Hampson L, Hampson I, Dearden S, Woodwards R, Prime S, Hunter K, Parkinson EK, Ragoussis J, Thakker N. Analysis of head and neck carcinoma progression reveals novel and relevant stage-specific changes associated with immortalisation and malignancy. Sci Rep 2019;9:11992. [PMID: 31427592 DOI: 10.1038/s41598-019-48229-7] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 307 |
Ladányi A, Tímár J. Immunologic and immunogenomic aspects of tumor progression. Semin Cancer Biol 2020;60:249-61. [PMID: 31419526 DOI: 10.1016/j.semcancer.2019.08.011] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 308 |
Cruz-Gregorio A, Aranda-Rivera AK, Aparicio-Trejo OE, Coronado-Martínez I, Pedraza-Chaverri J, Lizano M. E6 Oncoproteins from High-Risk Human Papillomavirus Induce Mitochondrial Metabolism in a Head and Neck Squamous Cell Carcinoma Model. Biomolecules 2019;9:E351. [PMID: 31398842 DOI: 10.3390/biom9080351] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 309 |
Chu LP, Franck D, Parachoniak CA, Gregg JP, Moore MG, Farwell DG, Rao S, Heilmann AM, Erlich RL, Ross JS, Miller VA, Ali S, Riess JW. MET Genomic Alterations in Head and Neck Squamous Cell Carcinoma (HNSCC): Rapid Response to Crizotinib in a Patient with HNSCC with a Novel MET R1004G Mutation. Oncologist 2019;24:1305-8. [PMID: 31391294 DOI: 10.1634/theoncologist.2019-0230] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 310 |
Allgayer H, Leupold JH, Patil N. Defining the "Metastasome": Perspectives from the genome and molecular landscape in colorectal cancer for metastasis evolution and clinical consequences. Semin Cancer Biol 2020;60:1-13. [PMID: 31362074 DOI: 10.1016/j.semcancer.2019.07.018] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 311 |
Shahoumi LA, Yeudall WA. Targeted therapies for non-HPV-related head and neck cancer: challenges and opportunities in the context of predictive, preventive, and personalized medicine. EPMA J 2019;10:291-305. [PMID: 31462945 DOI: 10.1007/s13167-019-00177-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 312 |
Alsahafi E, Begg K, Amelio I, Raulf N, Lucarelli P, Sauter T, Tavassoli M. Clinical update on head and neck cancer: molecular biology and ongoing challenges. Cell Death Dis 2019;10:540. [PMID: 31308358 DOI: 10.1038/s41419-019-1769-9] [Cited by in Crossref: 198] [Cited by in F6Publishing: 208] [Article Influence: 49.5] [Reference Citation Analysis]
|
| 313 |
Ghani WMN, Ramanathan A, Prime SS, Yang Y, Razak IA, Abdul Rahman ZA, Abraham MT, Mustafa WMW, Tay KK, Kallarakkal TG, Doss JG, Cheong SC, Bustam AZ, Zain RB. Survival of Oral Cancer Patients in Different Ethnicities. Cancer Investigation 2019;37:275-87. [DOI: 10.1080/07357907.2019.1635614] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 314 |
Lindemann A, Patel AA, Silver NL, Tang L, Liu Z, Wang L, Tanaka N, Rao X, Takahashi H, Maduka NK, Zhao M, Chen TC, Liu W, Gao M, Wang J, Frank SJ, Hittelman WN, Mills GB, Myers JN, Osman AA. COTI-2, A Novel Thiosemicarbazone Derivative, Exhibits Antitumor Activity in HNSCC through p53-dependent and -independent Mechanisms. Clin Cancer Res 2019;25:5650-62. [PMID: 31308060 DOI: 10.1158/1078-0432.CCR-19-0096] [Cited by in Crossref: 27] [Cited by in F6Publishing: 38] [Article Influence: 6.8] [Reference Citation Analysis]
|
| 315 |
Gluck C, Glathar A, Tsompana M, Nowak N, Garrett-Sinha LA, Buck MJ, Sinha S. Molecular dissection of the oncogenic role of ETS1 in the mesenchymal subtypes of head and neck squamous cell carcinoma. PLoS Genet 2019;15:e1008250. [PMID: 31306413 DOI: 10.1371/journal.pgen.1008250] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 316 |
Tee WV, Guarnera E, Berezovsky IN. On the Allosteric Effect of nsSNPs and the Emerging Importance of Allosteric Polymorphism. J Mol Biol 2019;431:3933-42. [PMID: 31306666 DOI: 10.1016/j.jmb.2019.07.012] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 7.8] [Reference Citation Analysis]
|
| 317 |
Tanese K, Nakamura Y, Hirai I, Funakoshi T. Updates on the Systemic Treatment of Advanced Non-melanoma Skin Cancer. Front Med (Lausanne) 2019;6:160. [PMID: 31355203 DOI: 10.3389/fmed.2019.00160] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 318 |
Farah CS, Jessri M, Bennett NC, Dalley AJ, Shearston KD, Fox SA. Exome sequencing of oral leukoplakia and oral squamous cell carcinoma implicates DNA damage repair gene defects in malignant transformation. Oral Oncol 2019;96:42-50. [PMID: 31422212 DOI: 10.1016/j.oraloncology.2019.07.005] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 319 |
Oliva J, Larque A, Marti C, Bodalo‐torruella M, Nonell L, Nadal A, Castillo P, Sieira R, Ferrer A, Garcia‐diez E, Alos L. Oral premalignant lesions of smokers and non‐smokers show similar carcinogenic pathways and outcomes. A clinicopathological and molecular comparative analysis. J Oral Pathol Med 2021;50:280-6. [DOI: 10.1111/jop.12864] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 320 |
Webber LP, Yujra VQ, Vargas PA, Martins MD, Squarize CH, Castilho RM. Interference with the bromodomain epigenome readers drives p21 expression and tumor senescence. Cancer Lett 2019;461:10-20. [PMID: 31265875 DOI: 10.1016/j.canlet.2019.06.019] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 321 |
Schmitt K, Molfenter B, Laureano NK, Tawk B, Bieg M, Hostench XP, Weichenhan D, Ullrich ND, Shang V, Richter D, Stögbauer F, Schroeder L, de Bem Prunes B, Visioli F, Rados PV, Jou A, Plath M, Federspil PA, Thierauf J, Döscher J, Weissinger SE, Hoffmann TK, Wagner S, Wittekindt C, Ishaque N, Eils R, Klussmann JP, Holzinger D, Plass C, Abdollahi A, Freier K, Weichert W, Zaoui K, Hess J. Somatic mutations and promotor methylation of the ryanodine receptor 2 is a common event in the pathogenesis of head and neck cancer. Int J Cancer 2019;145:3299-310. [PMID: 31135957 DOI: 10.1002/ijc.32481] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 322 |
Lin SC, Lin LH, Yu SY, Kao SY, Chang KW, Cheng HW, Liu CJ. FAT1 somatic mutations in head and neck carcinoma are associated with tumor progression and survival. Carcinogenesis 2018;39:1320-30. [PMID: 30102337 DOI: 10.1093/carcin/bgy107] [Cited by in Crossref: 24] [Cited by in F6Publishing: 34] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 323 |
Cramer JD, Burtness B, Le QT, Ferris RL. The changing therapeutic landscape of head and neck cancer. Nat Rev Clin Oncol 2019;16:669-83. [PMID: 31189965 DOI: 10.1038/s41571-019-0227-z] [Cited by in Crossref: 242] [Cited by in F6Publishing: 256] [Article Influence: 60.5] [Reference Citation Analysis]
|
| 324 |
Bi H, Liu Y, Tian T, Xia T, Pu R, Zhang Y, Hu F, Zhao Y. A Propensity Score-adjusted Analysis of the Effects of Ubiquitin E3 Ligase Copy Number Variation in Peripheral Blood Leukocytes on Colorectal Cancer Risk. J Cancer 2019;10:3291-302. [PMID: 31289601 DOI: 10.7150/jca.29872] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 325 |
Rahman S, Kraljević Pavelić S, Markova-Car E. Circadian (De)regulation in Head and Neck Squamous Cell Carcinoma. Int J Mol Sci 2019;20:E2662. [PMID: 31151182 DOI: 10.3390/ijms20112662] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 326 |
Facompre N, Rajagopalan P, Sahu V, Pearson A, Montone K, James C, Gleber-netto F, Weinstein G, Jalaly J, Lin A, Rustgi A, Nakagawa H, Califano J, Pickering C, White E, Windle B, Morgan I, Cohen R, Gimotty P, Basu D. Identifying predictors of HPV-related head and neck squamous cell carcinoma progression and survival through patient-derived models.. [DOI: 10.1101/652537] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 327 |
Dogan S, Xu B, Middha S, Vanderbilt CM, Bowman AS, Migliacci J, Morris LGT, Seshan VE, Ganly I. Identification of prognostic molecular biomarkers in 157 HPV-positive and HPV-negative squamous cell carcinomas of the oropharynx. Int J Cancer 2019;145:3152-62. [PMID: 31093971 DOI: 10.1002/ijc.32412] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 328 |
Li Z, Jiang C, Yuan Y. TCGA based integrated genomic analyses of ceRNA network and novel subtypes revealing potential biomarkers for the prognosis and target therapy of tongue squamous cell carcinoma. PLoS One 2019;14:e0216834. [PMID: 31141819 DOI: 10.1371/journal.pone.0216834] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 329 |
Hernandez AL, Young CD, Wang JH, Wang XJ. Lessons learned from SMAD4 loss in squamous cell carcinomas. Mol Carcinog 2019;58:1648-55. [PMID: 31140647 DOI: 10.1002/mc.23049] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 330 |
Mitsiadis TA. Emerging Trends and Promises in Orofacial Cancers. Front Physiol 2019;10:679. [PMID: 31191362 DOI: 10.3389/fphys.2019.00679] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 331 |
Shoffel-Havakuk H, O'Dell K, Johns MM 3rd, Reder L, Popova M, Halperin D, Feldberg E, Lahav Y. The rising rate of nonsmokers among laryngeal carcinoma patients: Are we facing a new disease? Laryngoscope 2020;130:E108-15. [PMID: 31090946 DOI: 10.1002/lary.28067] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 332 |
Noguchi K, Moridera K, Sotsuka Y, Yamanegi K, Takaoka K, Kishimoto H. Oral squamous cell carcinoma occurring secondary to oral lichen planus around the dental implant: A case report. Oral Science International 2019;16:110-3. [DOI: 10.1002/osi2.1008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 333 |
Polverini PJ, Lingen MW. A History of Innovations in the Diagnosis and Treatment of Oral and Head and Neck Cancer. J Dent Res 2019;98:489-97. [PMID: 31008698 DOI: 10.1177/0022034519833645] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 334 |
White EA. Manipulation of Epithelial Differentiation by HPV Oncoproteins. Viruses 2019;11:E369. [PMID: 31013597 DOI: 10.3390/v11040369] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 335 |
Goodman AM, Kato S, Chattopadhyay R, Okamura R, Saunders IM, Montesion M, Frampton GM, Miller VA, Daniels GA, Kurzrock R. Phenotypic and Genomic Determinants of Immunotherapy Response Associated with Squamousness. Cancer Immunol Res 2019;7:866-73. [PMID: 31003990 DOI: 10.1158/2326-6066.CIR-18-0716] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 336 |
Adeola HA, Papagerakis S, Papagerakis P. Systems Biology Approaches and Precision Oral Health: A Circadian Clock Perspective. Front Physiol 2019;10:399. [PMID: 31040792 DOI: 10.3389/fphys.2019.00399] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 337 |
Riva G, Pecorari G, Biolatti M, Pautasso S, Lo Cigno I, Garzaro M, Dell'Oste V, Landolfo S. PYHIN genes as potential biomarkers for prognosis of human papillomavirus-positive or -negative head and neck squamous cell carcinomas. Mol Biol Rep 2019;46:3333-47. [PMID: 30980272 DOI: 10.1007/s11033-019-04795-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 338 |
Németh CG, Röcken C, Siebert R, Wiltfang J, Ammerpohl O, Gassling V. Recurrent chromosomal and epigenetic alterations in oral squamous cell carcinoma and its putative premalignant condition oral lichen planus. PLoS One 2019;14:e0215055. [PMID: 30964915 DOI: 10.1371/journal.pone.0215055] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 339 |
Tan FH, Bai Y, Saintigny P, Darido C. mTOR Signalling in Head and Neck Cancer: Heads Up. Cells 2019;8:E333. [PMID: 30970654 DOI: 10.3390/cells8040333] [Cited by in Crossref: 29] [Cited by in F6Publishing: 34] [Article Influence: 7.3] [Reference Citation Analysis]
|
| 340 |
Haft S, Ren S, Xu G, Mark A, Fisch K, Guo TW, Khan Z, Pang J, Ando M, Liu C, Sakai A, Fukusumi T, Califano JA. Mutation of chromatin regulators and focal hotspot alterations characterize human papillomavirus-positive oropharyngeal squamous cell carcinoma. Cancer 2019;125:2423-34. [PMID: 30933315 DOI: 10.1002/cncr.32068] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 341 |
Thierauf J, Ramamurthy N, Jo VY, Robinson H, Frazier RP, Gonzalez J, Pacula M, Dominguez Meneses E, Nose V, Nardi V, Dias-Santagata D, Le LP, Lin DT, Faquin WC, Wirth LJ, Hess J, Iafrate AJ, Lennerz JK. Clinically Integrated Molecular Diagnostics in Adenoid Cystic Carcinoma. Oncologist 2019;24:1356-67. [PMID: 30926674 DOI: 10.1634/theoncologist.2018-0515] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 342 |
Porcheri C, Meisel CT, Mitsiadis T. Multifactorial Contribution of Notch Signaling in Head and Neck Squamous Cell Carcinoma. Int J Mol Sci 2019;20:E1520. [PMID: 30917608 DOI: 10.3390/ijms20061520] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 6.8] [Reference Citation Analysis]
|
| 343 |
Gatti V, Fierro C, Annicchiarico-Petruzzelli M, Melino G, Peschiaroli A. ΔNp63 in squamous cell carcinoma: defining the oncogenic routes affecting epigenetic landscape and tumour microenvironment. Mol Oncol 2019;13:981-1001. [PMID: 30845357 DOI: 10.1002/1878-0261.12473] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 8.8] [Reference Citation Analysis]
|
| 344 |
Kobayashi K, Yoshimoto S, Matsumoto F, Ando M, Murakami N, Omura G, Fukasawa M, Matsumoto Y, Matsumura S, Akamatsu M, Hiraoka N, Eigitsu R, Mori T. All-Exon TP53 Sequencing and Protein Phenotype Analysis Accurately Predict Clinical Outcome after Surgical Treatment of Head and Neck Squamous Cell Carcinoma. Ann Surg Oncol 2019;26:2294-303. [DOI: 10.1245/s10434-019-07287-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 345 |
Wang Z, Feng X, Molinolo AA, Martin D, Vitale-Cross L, Nohata N, Ando M, Wahba A, Amornphimoltham P, Wu X, Gilardi M, Allevato M, Wu V, Steffen DJ, Tofilon P, Sonenberg N, Califano J, Chen Q, Lippman SM, Gutkind JS. 4E-BP1 Is a Tumor Suppressor Protein Reactivated by mTOR Inhibition in Head and Neck Cancer. Cancer Res 2019;79:1438-50. [PMID: 30894372 DOI: 10.1158/0008-5472.CAN-18-1220] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 10.3] [Reference Citation Analysis]
|
| 346 |
Zandberg DP, Tallon LJ, Nagaraj S, Sadzewicz LK, Zhang Y, Strome MB, Zhao XE, Vavikolanu K, Zhang X, Papadimitriou JC, Hubbard FA, Bentzen SM, Strome SE, Fraser CM. Intratumor genetic heterogeneity in squamous cell carcinoma of the oral cavity. Head Neck 2019;41:2514-24. [PMID: 30869813 DOI: 10.1002/hed.25719] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 347 |
Rossa C Jr, D'Silva NJ. Non-murine models to investigate tumor-immune interactions in head and neck cancer. Oncogene 2019;38:4902-14. [PMID: 30872793 DOI: 10.1038/s41388-019-0776-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 348 |
Wang DY, Hong Y, Chen YG, Dong PZ, Liu SY, Gao YR, Lu D, Li HM, Li T, Guo JC, He F, Ren XQ, Sun SY, Wu DD, Duan SF, Ji XY. PEST-containing nuclear protein regulates cell proliferation, migration, and invasion in lung adenocarcinoma. Oncogenesis 2019;8:22. [PMID: 30872582 DOI: 10.1038/s41389-019-0132-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 349 |
Eze N, Lee JW, Yang DH, Zhu F, Neumeister V, Sandoval-Schaefer T, Mehra R, Ridge JA, Forastiere A, Chung CH, Burtness B. PTEN loss is associated with resistance to cetuximab in patients with head and neck squamous cell carcinoma. Oral Oncol 2019;91:69-78. [PMID: 30926065 DOI: 10.1016/j.oraloncology.2019.02.026] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 350 |
Saintigny P, William WN Jr, Foy JP, Papadimitrakopoulou V, Lang W, Zhang L, Fan YH, Feng L, Kim ES, El-Naggar AK, Lee JJ, Mao L, Hong WK, Lingen MW, Lippman SM. Met Receptor Tyrosine Kinase and Chemoprevention of Oral Cancer. J Natl Cancer Inst 2018;110. [PMID: 29617836 DOI: 10.1093/jnci/djx186] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 351 |
Pandey A, Li-Kroeger D, Sethi MK, Lee TV, Buettner FF, Bakker H, Jafar-Nejad H. Sensitized genetic backgrounds reveal differential roles for EGF repeat xylosyltransferases in Drosophila Notch signaling. Glycobiology 2018;28:849-59. [PMID: 30169771 DOI: 10.1093/glycob/cwy080] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 352 |
Sambandam V, Frederick MJ, Shen L, Tong P, Rao X, Peng S, Singh R, Mazumdar T, Huang C, Li Q, Pickering CR, Myers JN, Wang J, Johnson FM. PDK1 Mediates NOTCH1-Mutated Head and Neck Squamous Carcinoma Vulnerability to Therapeutic PI3K/mTOR Inhibition. Clin Cancer Res 2019;25:3329-40. [PMID: 30770351 DOI: 10.1158/1078-0432.CCR-18-3276] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 353 |
Saada-Bouzid E, Le Tourneau C. Beyond EGFR Targeting in SCCHN: Angiogenesis, PI3K, and Other Molecular Targets. Front Oncol 2019;9:74. [PMID: 30815390 DOI: 10.3389/fonc.2019.00074] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 354 |
Ghanekar Y, Sadasivam S. In silico analysis reveals a shared immune signature in CASP8-mutated carcinomas with varying correlations to prognosis. PeerJ 2019;7:e6402. [PMID: 30775178 DOI: 10.7717/peerj.6402] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 355 |
Jiang X, Ye J, Dong Z, Hu S, Xiao M. Novel genetic alterations and their impact on target therapy response in head and neck squamous cell carcinoma. Cancer Manag Res 2019;11:1321-36. [PMID: 30799957 DOI: 10.2147/CMAR.S187780] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 356 |
Cruz-Gregorio A, Martínez-Ramírez I, Pedraza-Chaverri J, Lizano M. Reprogramming of Energy Metabolism in Response to Radiotherapy in Head and Neck Squamous Cell Carcinoma. Cancers (Basel) 2019;11:E182. [PMID: 30764513 DOI: 10.3390/cancers11020182] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 7.3] [Reference Citation Analysis]
|
| 357 |
Dogan S, Frosina D, Fayad M, de Oliveira TB, Alemar B, Rosenblum M, Tang LH, Hameed M, Xu B, Ghossein RA, Chute DJ, Weigelt B, Jungbluth AA. The role of a monoclonal antibody 11C8B1 as a diagnostic marker of IDH2-mutated sinonasal undifferentiated carcinoma. Mod Pathol 2019;32:205-15. [PMID: 30206411 DOI: 10.1038/s41379-018-0126-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 358 |
Aoki K, Nakamura H, Suzuki H, Matsuo K, Kataoka K, Shimamura T, Motomura K, Ohka F, Shiina S, Yamamoto T, Nagata Y, Yoshizato T, Mizoguchi M, Abe T, Momii Y, Muragaki Y, Watanabe R, Ito I, Sanada M, Yajima H, Morita N, Takeuchi I, Miyano S, Wakabayashi T, Ogawa S, Natsume A. Prognostic relevance of genetic alterations in diffuse lower-grade gliomas. Neuro Oncol 2018;20:66-77. [PMID: 29016839 DOI: 10.1093/neuonc/nox132] [Cited by in Crossref: 155] [Cited by in F6Publishing: 161] [Article Influence: 38.8] [Reference Citation Analysis]
|
| 359 |
Krishnan NM, I M, Hariharan J, Panda B. CAFE MOCHA: An Integrated Platform for Discovering Clinically Relevant Molecular Changes in Cancer-An Example of Distant Metastasis- and Recurrence-Linked Classifiers in Head and Neck Squamous Cell Carcinoma. JCO Clin Cancer Inform 2018;2:1-11. [PMID: 30652568 DOI: 10.1200/CCI.17.00045] [Reference Citation Analysis]
|
| 360 |
Fleming JC, Woo J, Moutasim K, Mellone M, Frampton SJ, Mead A, Ahmed W, Wood O, Robinson H, Ward M, Woelk CH, Ottensmeier CH, King E, Kim D, Blaydes JP, Thomas GJ. HPV, tumour metabolism and novel target identification in head and neck squamous cell carcinoma. Br J Cancer 2019;120:356-67. [PMID: 30655616 DOI: 10.1038/s41416-018-0364-7] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 8.3] [Reference Citation Analysis]
|
| 361 |
Byeon HK, Ku M, Yang J. Beyond EGFR inhibition: multilateral combat strategies to stop the progression of head and neck cancer. Exp Mol Med 2019;51:1-14. [PMID: 30700700 DOI: 10.1038/s12276-018-0202-2] [Cited by in Crossref: 56] [Cited by in F6Publishing: 62] [Article Influence: 14.0] [Reference Citation Analysis]
|
| 362 |
Hernandez AL, Wang Y, Somerset HL, Keysar SB, Aisner DL, Marshall C, Bowles DW, Karam SD, Raben D, Jimeno A, Varella-Garcia M, Wang XJ. Inter- and intra-tumor heterogeneity of SMAD4 loss in head and neck squamous cell carcinomas. Mol Carcinog 2019;58:666-73. [PMID: 30575147 DOI: 10.1002/mc.22958] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 363 |
Cannataro VL, Gaffney SG, Sasaki T, Issaeva N, Grewal NKS, Grandis JR, Yarbrough WG, Burtness B, Anderson KS, Townsend JP. APOBEC-induced mutations and their cancer effect size in head and neck squamous cell carcinoma. Oncogene 2019;38:3475-87. [PMID: 30647454 DOI: 10.1038/s41388-018-0657-6] [Cited by in Crossref: 52] [Cited by in F6Publishing: 56] [Article Influence: 13.0] [Reference Citation Analysis]
|
| 364 |
Chan JW, Yeh I, El‐sayed IH, Algazi AP, Glastonbury CM, Ha PK, Yom SS, Zante A. Ultraviolet light‐related DNA damage mutation signature distinguishes cutaneous from mucosal or other origin for head and neck squamous cell carcinoma of unknown primary site. Head & Neck 2019;41:E82-5. [DOI: 10.1002/hed.25613] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 365 |
Kuo TM, Nithiyanantham S, Lee CP, Hsu HT, Luo SY, Lin YZ, Yeh KT, Ko YC. Arecoline N-oxide regulates oral squamous cell carcinoma development through NOTCH1 and FAT1 expressions. J Cell Physiol 2019;234:13984-93. [PMID: 30624777 DOI: 10.1002/jcp.28084] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 366 |
Husain N, Neyaz A. Molecular Diagnostics in Head and Neck Squamous Cell Carcinoma. Molecular Diagnostics in Cancer Patients 2019. [DOI: 10.1007/978-981-13-5877-7_11] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 367 |
Bellairs JA, Yesensky J, Ku JA, Agrawal N. Genomic Applications in Head and Neck Cancers. Genomic Applications in Pathology 2019. [DOI: 10.1007/978-3-319-96830-8_23] [Reference Citation Analysis]
|
| 368 |
Farah CS, Kujan O, Prime S, Zain RB. Oral Mucosal Malignancies. Contemporary Oral Medicine 2019. [DOI: 10.1007/978-3-319-72303-7_21] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 369 |
Seront E, Machiels J, Schmitz S. Squamous Cell Carcinoma of the Head and Neck. International Manual of Oncology Practice 2019. [DOI: 10.1007/978-3-030-16245-0_31] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 370 |
Theurer JA. Human Papillomavirus-Related Head and Neck Cancer. Clinical Care and Rehabilitation in Head and Neck Cancer 2019. [DOI: 10.1007/978-3-030-04702-3_4] [Reference Citation Analysis]
|
| 371 |
Kuriakose MA, Chakrabarti S, Cheong SC, Kowalski LP, Novaes Pinheiro T, Farah CS. Head and Neck Tumors. Contemporary Oral Medicine 2019. [DOI: 10.1007/978-3-319-72303-7_20] [Reference Citation Analysis]
|
| 372 |
Lee HM, Okuda KS, González FE, Patel V. Current Perspectives on Nasopharyngeal Carcinoma. Adv Exp Med Biol 2019;1164:11-34. [PMID: 31576537 DOI: 10.1007/978-3-030-22254-3_2] [Cited by in Crossref: 73] [Cited by in F6Publishing: 74] [Article Influence: 18.3] [Reference Citation Analysis]
|
| 373 |
Sano D, Oridate N. The advantages and limitations of animal models of head and neck cancers. Toukeibu Gan 2019;45:366-368. [DOI: 10.5981/jjhnc.45.366] [Reference Citation Analysis]
|
| 374 |
Muñoz-cordero MG, López F, García-inclán C, López-hernández A, Potes-ares S, Fernández-vañes L, Llorente JL, Hermsen M. Predictive Value of EGFR-PI3K-pAKT-mTOR-pS6 Pathway in Sinonasal Squamous Cell Carcinomas. Acta Otorrinolaringologica (English Edition) 2019;70:16-24. [DOI: 10.1016/j.otoeng.2017.10.011] [Reference Citation Analysis]
|
| 375 |
Ramakodi MP, Eaaswarkhanth M. Genomic Revolution-Driven Cancer Research. Essentials of Bioinformatics, Volume II 2019. [DOI: 10.1007/978-3-030-18375-2_4] [Reference Citation Analysis]
|
| 376 |
Jessri M, Mawardi H, Farah CS, Woo S. White and Red Lesions of the Oral Mucosa. Contemporary Oral Medicine 2019. [DOI: 10.1007/978-3-319-72303-7_16] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 377 |
Peng H, Wang S, Pang L, Yang L, Chen Y, Cui X. Comprehensive bioinformation analysis of methylated and differentially expressed genes in esophageal squamous cell carcinoma. Mol Omics 2019;15:88-100. [DOI: 10.1039/c8mo00218e] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 378 |
Pan C, Issaeva N, Yarbrough WG. HPV-driven oropharyngeal cancer: current knowledge of molecular biology and mechanisms of carcinogenesis. Cancers Head Neck 2018;3:12. [PMID: 31093365 DOI: 10.1186/s41199-018-0039-3] [Cited by in Crossref: 58] [Cited by in F6Publishing: 62] [Article Influence: 11.6] [Reference Citation Analysis]
|
| 379 |
Gillison ML, Akagi K, Xiao W, Jiang B, Pickard RKL, Li J, Swanson BJ, Agrawal AD, Zucker M, Stache-Crain B, Emde AK, Geiger HM, Robine N, Coombes KR, Symer DE. Human papillomavirus and the landscape of secondary genetic alterations in oral cancers. Genome Res 2019;29:1-17. [PMID: 30563911 DOI: 10.1101/gr.241141.118] [Cited by in Crossref: 114] [Cited by in F6Publishing: 116] [Article Influence: 22.8] [Reference Citation Analysis]
|
| 380 |
Ruicci KM, Meens J, Sun RX, Rizzo G, Pinto N, Yoo J, Fung K, MacNeil D, Mymryk JS, Barrett JW, Boutros PC, Ailles L, Nichols AC. A controlled trial of HNSCC patient-derived xenografts reveals broad efficacy of PI3Kα inhibition in controlling tumor growth. Int J Cancer 2019;145:2100-6. [PMID: 30468243 DOI: 10.1002/ijc.32009] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 381 |
Suárez-Canto J, Suárez-Sánchez FJ, Domínguez-Iglesias F, Hernández-Vallejo G, García-Pedrero JM, de Vicente JC. Distinct Expression and Clinical Significance of Zinc Finger AN-1-Type Containing 4 in Oral Squamous Cell Carcinomas. J Clin Med 2018;7:E534. [PMID: 30544692 DOI: 10.3390/jcm7120534] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 382 |
Zheng Y, Wang Z, Xiong X, Zhong Y, Zhang W, Dong Y, Li J, Zhu Z, Zhang W, Wu H, Gu W, Wu Y, Wang X, Song X. Membrane-tethered Notch1 exhibits oncogenic property via activation of EGFR-PI3K-AKT pathway in oral squamous cell carcinoma. J Cell Physiol 2019;234:5940-52. [PMID: 30515785 DOI: 10.1002/jcp.27022] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 383 |
Li B, Zhu J, Meng L. High expression of ACTL8 is poor prognosis and accelerates cell progression in head and neck squamous cell carcinoma. Mol Med Rep 2019;19:877-84. [PMID: 30535476 DOI: 10.3892/mmr.2018.9716] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 384 |
Lee YS, Johnson DE, Grandis JR. An update: emerging drugs to treat squamous cell carcinomas of the head and neck. Expert Opin Emerg Drugs 2018;23:283-99. [PMID: 30376740 DOI: 10.1080/14728214.2018.1543400] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 385 |
da Costa AABA, Costa FD, Araújo DV, Camandaroba MPG, de Jesus VHF, Oliveira A, Alves ACF, Stecca C, Machado L, de Oliveira ACF, de Oliveira TB, Nicolau UR, de Lima VCC. The roles of PTEN, cMET, and p16 in resistance to cetuximab in head and neck squamous cell carcinoma. Med Oncol 2019;36. [DOI: 10.1007/s12032-018-1234-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 386 |
Sapna G, Gokul S. Next generation sequencing in oral disease diagnostics. World J Stomatol 2018; 6(2): 6-10 [DOI: 10.5321/wjs.v6.i2.6] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 387 |
de Morais EF, Santos HBP, Cavalcante IL, Rabenhorst SHB, Dos Santos JN, Galvão HC, Freitas RA. Twist and E-cadherin deregulation might predict poor prognosis in lower lip squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol 2019;127:318-29. [PMID: 30598410 DOI: 10.1016/j.oooo.2018.11.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 388 |
Ludwig ML, Kulkarni A, Birkeland AC, Michmerhuizen NL, Foltin SK, Mann JE, Hoesli RC, Devenport SN, Jewell BM, Shuman AG, Spector ME, Carey TE, Jiang H, Brenner JC. The genomic landscape of UM-SCC oral cavity squamous cell carcinoma cell lines. Oral Oncol 2018;87:144-51. [PMID: 30527230 DOI: 10.1016/j.oraloncology.2018.10.031] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 389 |
Halani SH, Yousefi S, Velazquez Vega J, Rossi MR, Zhao Z, Amrollahi F, Holder CA, Baxter-Stoltzfus A, Eschbacher J, Griffith B, Olson JJ, Jiang T, Yates JR, Eberhart CG, Poisson LM, Cooper LAD, Brat DJ. Multi-faceted computational assessment of risk and progression in oligodendroglioma implicates NOTCH and PI3K pathways. NPJ Precis Oncol 2018;2:24. [PMID: 30417117 DOI: 10.1038/s41698-018-0067-9] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 5.2] [Reference Citation Analysis]
|
| 390 |
Tian J, Liu X, Liu X, Jing P, Sa N, Wang H, Xu W. Notch1 serves as a prognostic factor and regulates metastasis via regulating EGFR expression in hypopharyngeal squamous cell carcinoma. Onco Targets Ther 2018;11:7395-405. [PMID: 30425527 DOI: 10.2147/OTT.S175423] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 391 |
Shalom B, Farago M, Pikarsky E, Katzav S. Vav1 mutations identified in human cancers give rise to different oncogenic phenotypes. Oncogenesis 2018;7:80. [PMID: 30297765 DOI: 10.1038/s41389-018-0091-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 392 |
Sawangarun W, Mandasari M, Aida J, Morita KI, Kayamori K, Ikeda T, Sakamoto K. Loss of Notch1 predisposes oro-esophageal epithelium to tumorigenesis. Exp Cell Res 2018;372:129-40. [PMID: 30266659 DOI: 10.1016/j.yexcr.2018.09.019] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 393 |
Baron M. Combining genetic and biophysical approaches to probe the structure and function relationships of the notch receptor. Mol Membr Biol 2017;34:33-49. [PMID: 30246579 DOI: 10.1080/09687688.2018.1503742] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 394 |
Zhu S, Jin J, Gokhale S, Lu AM, Shan H, Feng J, Xie P. Genetic Alterations of TRAF Proteins in Human Cancers. Front Immunol 2018;9:2111. [PMID: 30294322 DOI: 10.3389/fimmu.2018.02111] [Cited by in Crossref: 46] [Cited by in F6Publishing: 50] [Article Influence: 9.2] [Reference Citation Analysis]
|
| 395 |
Kudo Y. Predicting cancer outcome: Artificial intelligence vs. pathologists. Oral Dis 2019;25:643-5. [PMID: 30095205 DOI: 10.1111/odi.12954] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 396 |
Sánchez-Danés A, Blanpain C. Deciphering the cells of origin of squamous cell carcinomas. Nat Rev Cancer 2018;18:549-61. [PMID: 29849070 DOI: 10.1038/s41568-018-0024-5] [Cited by in Crossref: 121] [Cited by in F6Publishing: 124] [Article Influence: 24.2] [Reference Citation Analysis]
|
| 397 |
Read ML, Modasia B, Fletcher A, Thompson RJ, Brookes K, Rae PC, Nieto HR, Poole VL, Roberts S, Campbell MJ, Boelaert K, Turnell AS, Smith VE, Mehanna H, McCabe CJ. PTTG and PBF Functionally Interact with p53 and Predict Overall Survival in Head and Neck Cancer. Cancer Res 2018;78:5863-76. [PMID: 30154144 DOI: 10.1158/0008-5472.CAN-18-0855] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 398 |
Jamieson SM, Tsai P, Kondratyev MK, Budhani P, Liu A, Senzer NN, Chiorean EG, Jalal SI, Nemunaitis JJ, Kee D, Shome A, Wong WW, Li D, Poonawala-Lohani N, Kakadia PM, Knowlton NS, Lynch CR, Hong CR, Lee TW, Grénman RA, Caporiccio L, McKee TD, Zaidi M, Butt S, Macann AM, McIvor NP, Chaplin JM, Hicks KO, Bohlander SK, Wouters BG, Hart CP, Print CG, Wilson WR, Curran MA, Hunter FW. Evofosfamide for the treatment of human papillomavirus-negative head and neck squamous cell carcinoma. JCI Insight 2018;3:122204. [PMID: 30135316 DOI: 10.1172/jci.insight.122204] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 7.4] [Reference Citation Analysis]
|
| 399 |
Pang X, Tang YL, Liang XH. Transforming growth factor-β signaling in head and neck squamous cell carcinoma: Insights into cellular responses. Oncol Lett 2018;16:4799-806. [PMID: 30250544 DOI: 10.3892/ol.2018.9319] [Cited by in Crossref: 23] [Cited by in F6Publishing: 29] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 400 |
Salazar‐garcía L, Pérez‐sayáns M, García‐garcía A, Carracedo Á, Cruz R, Lozano A, Sobrino B, Barros F. Whole exome sequencing approach to analysis of the origin of cancer stem cells in patients with head and neck squamous cell carcinoma. J Oral Pathol Med 2018;47:938-44. [DOI: 10.1111/jop.12771] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 401 |
de Carvalho AC, Melendez ME, da Silva Sabato C, Palmero EI, Arantes LMRB, Neto CS, Carvalho AL. Clinical and Molecular Characterization of Surgically Treated Oropharynx Squamous Cell Carcinoma Samples. Pathol Oncol Res 2019;25:1047-58. [PMID: 30099696 DOI: 10.1007/s12253-018-0462-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 402 |
Ainouze M, Rochefort P, Parroche P, Roblot G, Tout I, Briat F, Zannetti C, Marotel M, Goutagny N, Auron P, Traverse-Glehen A, Lunel-Potencier A, Golfier F, Masson M, Robitaille A, Tommasino M, Carreira C, Walzer T, Henry T, Zanier K, Trave G, Hasan UA. Human papillomavirus type 16 antagonizes IRF6 regulation of IL-1β. PLoS Pathog 2018;14:e1007158. [PMID: 30089163 DOI: 10.1371/journal.ppat.1007158] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 403 |
Nyman PE, Buehler D, Lambert PF. Loss of Function of Canonical Notch Signaling Drives Head and Neck Carcinogenesis. Clin Cancer Res 2018;24:6308-18. [PMID: 30087145 DOI: 10.1158/1078-0432.CCR-17-3535] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 6.2] [Reference Citation Analysis]
|
| 404 |
Li CC, Shen Z, Bavarian R, Yang F, Bhattacharya A. Oral Cancer: Genetics and the Role of Precision Medicine. Dent Clin North Am 2018;62:29-46. [PMID: 29126492 DOI: 10.1016/j.cden.2017.08.002] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 405 |
Chan JYK, Zhen G, Agrawal N. The role of tumor DNA as a diagnostic tool for head and neck squamous cell carcinoma. Semin Cancer Biol 2019;55:1-7. [PMID: 30082187 DOI: 10.1016/j.semcancer.2018.07.008] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 406 |
Degboe A, Knight SL, Halling K, Trigg A, Al-Zubeidi T, Aldhouse N, Kitchen H, Wirth L, Rogers SN. Patients' experience of recurrent/metastatic head and neck squamous cell carcinoma and their perspective on the EORTC QLQ-C30 and QLQ-H&N35 questionnaires: a qualitative study. J Patient Rep Outcomes 2017;2:33. [PMID: 30148250 DOI: 10.1186/s41687-018-0060-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 407 |
Keam B, Kim HR, Yun HJ. TRIUMPH Trial: One Small Step Could Become One Giant Leap for Precision Oncology in Head and Neck Cancer. Cancer Res Treat 2019;51:413-4. [PMID: 30064199 DOI: 10.4143/crt.2018.335] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 408 |
Qin T, Zhang Y, Zarins KR, Jones TR, Virani S, Peterson LA, McHugh JB, Chepeha D, Wolf GT, Rozek LS, Sartor MA. Expressed HNSCC variants by HPV-status in a well-characterized Michigan cohort. Sci Rep 2018;8:11458. [PMID: 30061624 DOI: 10.1038/s41598-018-29599-w] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 409 |
Ruicci KM, Pinto N, Khan MI, Yoo J, Fung K, MacNeil D, Mymryk JS, Barrett JW, Nichols AC. ERK-TSC2 signalling in constitutively-active HRAS mutant HNSCC cells promotes resistance to PI3K inhibition. Oral Oncol 2018;84:95-103. [PMID: 30115483 DOI: 10.1016/j.oraloncology.2018.07.010] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 410 |
Harbison RA, Kubik M, Konnick EQ, Zhang Q, Lee SG, Park H, Zhang J, Carlson CS, Chen C, Schwartz SM, Rodriguez CP, Duvvuri U, Méndez E. The mutational landscape of recurrent versus nonrecurrent human papillomavirus-related oropharyngeal cancer. JCI Insight 2018;3:99327. [PMID: 30046007 DOI: 10.1172/jci.insight.99327] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 4.4] [Reference Citation Analysis]
|
| 411 |
Ma J, Fu Y, Tu YY, Liu Y, Tan YR, Ju WT, Pickering CR, Myers JN, Zhang ZY, Zhong LP. Mutation allele frequency threshold does not affect prognostic analysis using next-generation sequencing in oral squamous cell carcinoma. BMC Cancer 2018;18:758. [PMID: 30041611 DOI: 10.1186/s12885-018-4481-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 412 |
Adkins D, Mehan P, Ley J, Siegel MJ, Siegel BA, Dehdashti F, Jiang X, Salama NN, Trinkaus K, Oppelt P. Pazopanib plus cetuximab in recurrent or metastatic head and neck squamous cell carcinoma: an open-label, phase 1b and expansion study. Lancet Oncol 2018;19:1082-93. [PMID: 30001987 DOI: 10.1016/S1470-2045(18)30350-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 413 |
Veeramachaneni R, Walker T, De Weck A, Revil T, Badescu D, O’sullivan J, Higgins C, Elliott L, Liloglou T, Risk JM, Shaw R, Hampson L, Hampson I, Dearden S, Woodwards R, Prime S, Hunter K, Parkinson EK, Ragoussis I, Thakker N. Analysis of head and neck carcinoma progression reveals novel and relevant stage-specific changes associated with immortalisation and malignancy.. [DOI: 10.1101/365205] [Reference Citation Analysis]
|
| 414 |
Lim YH, Moscato Z, Choate KA. Mosaicism in Cutaneous Disorders. Annu Rev Genet 2017;51:123-41. [PMID: 29178821 DOI: 10.1146/annurev-genet-121415-121955] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 415 |
Harbuzariu A, Oprea-Ilies GM, Gonzalez-Perez RR. The Role of Notch Signaling and Leptin-Notch Crosstalk in Pancreatic Cancer. Medicines (Basel) 2018;5. [PMID: 30004402 DOI: 10.3390/medicines5030068] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 416 |
Saada-Bouzid E, Milano G, Thariat J. [Genomic characterization of head and neck squamous cell carcinoma: Impact and challenges for therapeutic management]. Bull Cancer 2018;105:820-9. [PMID: 29937334 DOI: 10.1016/j.bulcan.2018.05.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 417 |
Giuliani M, Troiano G, Cordaro M, Corsalini M, Gioco G, Lo Muzio L, Pignatelli P, Lajolo C. Rate of malignant transformation of oral lichen planus: A systematic review. Oral Dis 2019;25:693-709. [PMID: 29738106 DOI: 10.1111/odi.12885] [Cited by in Crossref: 102] [Cited by in F6Publishing: 114] [Article Influence: 20.4] [Reference Citation Analysis]
|
| 418 |
Ngan HL, Wang L, Lo KW, Lui VWY. Genomic Landscapes of EBV-Associated Nasopharyngeal Carcinoma vs. HPV-Associated Head and Neck Cancer. Cancers (Basel) 2018;10:E210. [PMID: 29933636 DOI: 10.3390/cancers10070210] [Cited by in Crossref: 28] [Cited by in F6Publishing: 33] [Article Influence: 5.6] [Reference Citation Analysis]
|
| 419 |
Mishra A, Sriram H, Chandarana P, Tanavde V, Kumar RV, Gopinath A, Govindarajan R, Ramaswamy S, Sadasivam S. Decreased expression of cell adhesion genes in cancer stem-like cells isolated from primary oral squamous cell carcinomas. Tumour Biol 2018;40:1010428318780859. [PMID: 29888653 DOI: 10.1177/1010428318780859] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 420 |
Grønhøj C, Jensen DH, Agander T, Kiss K, Høgdall E, Specht L, Bagger FO, Nielsen FC, von Buchwald C. Deep sequencing of human papillomavirus positive loco-regionally advanced oropharyngeal squamous cell carcinomas reveals novel mutational signature. BMC Cancer 2018;18:640. [PMID: 29879932 DOI: 10.1186/s12885-018-4567-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 421 |
Le X, Hanna EY. Optimal regimen of cisplatin in squamous cell carcinoma of head and neck yet to be determined. Ann Transl Med 2018;6:229. [PMID: 30023392 DOI: 10.21037/atm.2018.05.10] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 422 |
Rettig EM, Bishop JA, Agrawal N, Chung CH, Sharma R, Zamuner F, Li RJ, Koch WM, Califano JA, Guo T, Gaykalova DA, Fakhry C. HEY1 is expressed independent of NOTCH1 and is associated with poor prognosis in head and neck squamous cell carcinoma. Oral Oncol 2018;82:168-75. [PMID: 29909892 DOI: 10.1016/j.oraloncology.2018.05.017] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 423 |
Cho J, Johnson DE, Grandis JR. Therapeutic Implications of the Genetic Landscape of Head and Neck Cancer. Semin Radiat Oncol 2018;28:2-11. [PMID: 29173752 DOI: 10.1016/j.semradonc.2017.08.005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 424 |
Wichmann G, Lehmann C, Herchenhahn C, Kolb M, Hofer M, Wiegand S, Dietz A. Development of a Human Leukocyte Antigen Score to Predict Progression-Free Survival in Head and Neck Squamous Cell Carcinoma Patients. Front Oncol 2018;8:168. [PMID: 29868484 DOI: 10.3389/fonc.2018.00168] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 425 |
Nör J, Gutkind J. Head and Neck Cancer in the New Era of Precision Medicine. J Dent Res 2018;97:601-2. [DOI: 10.1177/0022034518772278] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 4.2] [Reference Citation Analysis]
|
| 426 |
Untch BR, Dos Anjos V, Garcia-Rendueles MER, Knauf JA, Krishnamoorthy GP, Saqcena M, Bhanot UK, Socci ND, Ho AL, Ghossein R, Fagin JA. Tipifarnib Inhibits HRAS-Driven Dedifferentiated Thyroid Cancers. Cancer Res 2018;78:4642-57. [PMID: 29760048 DOI: 10.1158/0008-5472.CAN-17-1925] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 6.6] [Reference Citation Analysis]
|
| 427 |
Ma S, Paiboonrungruan C, Yan T, Williams KP, Major MB, Chen XL. Targeted therapy of esophageal squamous cell carcinoma: the NRF2 signaling pathway as target. Ann N Y Acad Sci 2018;1434:164-72. [PMID: 29752726 DOI: 10.1111/nyas.13681] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 5.2] [Reference Citation Analysis]
|
| 428 |
Alcolea MP. Oesophageal Stem Cells and Cancer. Adv Exp Med Biol 2017;1041:187-206. [PMID: 29204834 DOI: 10.1007/978-3-319-69194-7_10] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 429 |
Li Y, McGrail DJ, Latysheva N, Yi S, Babu MM, Sahni N. Pathway perturbations in signaling networks: Linking genotype to phenotype. Semin Cell Dev Biol 2020;99:3-11. [PMID: 29738884 DOI: 10.1016/j.semcdb.2018.05.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 430 |
Lim SM, Cho SH, Hwang IG, Choi JW, Chang H, Ahn MJ, Park KU, Kim JW, Ko YH, Ahn HK, Cho BC, Nam BH, Chun SH, Hong JH, Kwon JH, Choi JG, Kang EJ, Yun T, Lee KW, Kim JH, Kim JS, Lee HW, Kim MK, Jung D, Kim JE, Keam B, Yun HJ, Kim S, Kim HR. Investigating the Feasibility of Targeted Next-Generation Sequencing to Guide the Treatment of Head and Neck Squamous Cell Carcinoma. Cancer Res Treat 2019;51:300-12. [PMID: 29747488 DOI: 10.4143/crt.2018.012] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 431 |
Wu DD, Gao YR, Li T, Wang DY, Lu D, Liu SY, Hong Y, Ning HB, Liu JP, Shang J, Shi JF, Wei JS, Ji XY. PEST-containing nuclear protein mediates the proliferation, migration, and invasion of human neuroblastoma cells through MAPK and PI3K/AKT/mTOR signaling pathways. BMC Cancer 2018;18:499. [PMID: 29716528 DOI: 10.1186/s12885-018-4391-9] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 4.2] [Reference Citation Analysis]
|
| 432 |
Leemans CR, Snijders PJF, Brakenhoff RH. The molecular landscape of head and neck cancer. Nat Rev Cancer 2018;18:269-82. [PMID: 29497144 DOI: 10.1038/nrc.2018.11] [Cited by in Crossref: 650] [Cited by in F6Publishing: 658] [Article Influence: 130.0] [Reference Citation Analysis]
|
| 433 |
Gan GN, Kimple RJ. Genomics Reloaded: Rise of the Expression Profiles. Int J Radiat Oncol Biol Phys 2018;101:1-3. [PMID: 29619961 DOI: 10.1016/j.ijrobp.2017.10.023] [Reference Citation Analysis]
|
| 434 |
Mirghani H, Lacroix L, Rossoni C, Sun R, Aupérin A, Casiraghi O, Villepelet A, Lacave R, Faucher G, Marty V, Ferté C, Soria JC, Even C. Does smoking alter the mutation profile of human papillomavirus–driven head and neck cancers? European Journal of Cancer 2018;94:61-9. [DOI: 10.1016/j.ejca.2018.02.013] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 4.2] [Reference Citation Analysis]
|
| 435 |
Manterola L, Aguirre P, Larrea E, Arestín M, Gaafar A, Elorriaga K, Goicoechea I, Armesto M, Fernández-Mercado M, Zabalza I, López-Duque JC, Larruskain E, Sistiaga JA, Landa M, Zabala A, Santaolalla F, Municio JA, Ispizua Á, García-Pedrero JM, Rodrigo JP, Lawrie CH. Mutational profiling can identify laryngeal dysplasia at risk of progression to invasive carcinoma. Sci Rep 2018;8:6613. [PMID: 29700339 DOI: 10.1038/s41598-018-24780-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 436 |
Chan JYK, Poon PHY, Zhang Y, Ng CWK, Piao WY, Ma M, Yip KY, Chan ABW, Lui VWY. Case Report: Exome sequencing reveals recurrent RETSAT mutations and a loss-of-function POLDIP2 mutation in a rare undifferentiated tongue sarcoma. F1000Res 2018;7:499. [PMID: 29862022 DOI: 10.12688/f1000research.14383.1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 437 |
Ghanekar Y, Sadasivam S. In Silico Analysis Reveals a Shared Immune Signature in CASP8-Mutated Carcinomas with Varying Correlations to Prognosis.. [DOI: 10.1101/305755] [Reference Citation Analysis]
|
| 438 |
Rhee JK, Kim TM. Population-based statistical inference for temporal sequence of somatic mutations in cancer genomes. BMC Med Genomics 2018;11:29. [PMID: 29697365 DOI: 10.1186/s12920-018-0352-z] [Reference Citation Analysis]
|
| 439 |
Resteghini C, Perrone F, Miceli R, Bergamini C, Alfieri S, Orlandi E, Guzzo M, Granata R, Galbiati D, Cavalieri S, Locati L, Licitra L, Bossi P. Prognostic role of PIK3CA and TP53 in human papillomavirus-negative oropharyngeal cancers. Tumori 2018;104:213-20. [PMID: 29714670 DOI: 10.1177/0300891618765558] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 440 |
Annunziata C, Pezzuto F, Greggi S, Ionna F, Losito S, Botti G, Buonaguro L, Buonaguro FM, Tornesello ML. Distinct profiles of TERT promoter mutations and telomerase expression in head and neck cancer and cervical carcinoma: TERT promoter mutations in head and neck cancer and cervical carcinoma. Int J Cancer 2018;143:1153-61. [DOI: 10.1002/ijc.31412] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 441 |
Chakraborty R, Hampton OA, Abhyankar H, Zinn DJ, Grimes A, Skull B, Eckstein O, Mahmood N, Wheeler DA, Lopez-Terrada D, Peters TL, Hicks JM, Elghetany T, Krance R, Poulikakos PI, Merad M, McClain KL, Allen CE, Parsons DW. Activating MAPK1 (ERK2) mutation in an aggressive case of disseminated juvenile xanthogranuloma. Oncotarget 2017;8:46065-70. [PMID: 28512266 DOI: 10.18632/oncotarget.17521] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 4.2] [Reference Citation Analysis]
|
| 442 |
Vossen DM, Verhagen CVM, Verheij M, Wessels LFA, Vens C, van den Brekel MWM. Comparative genomic analysis of oral versus laryngeal and pharyngeal cancer. Oral Oncol 2018;81:35-44. [PMID: 29884412 DOI: 10.1016/j.oraloncology.2018.04.006] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 443 |
Polverini PJ, D'Silva NJ, Lei YL. Precision Therapy of Head and Neck Squamous Cell Carcinoma. J Dent Res 2018;97:614-21. [PMID: 29649374 DOI: 10.1177/0022034518769645] [Cited by in Crossref: 26] [Cited by in F6Publishing: 31] [Article Influence: 5.2] [Reference Citation Analysis]
|
| 444 |
Goriki A, Seiler R, Wyatt AW, Contreras-sanz A, Bhat A, Matsubara A, Hayashi T, Black PC. Unravelling disparate roles of NOTCH in bladder cancer. Nat Rev Urol 2018;15:345-57. [DOI: 10.1038/s41585-018-0005-1] [Cited by in Crossref: 28] [Cited by in F6Publishing: 33] [Article Influence: 5.6] [Reference Citation Analysis]
|
| 445 |
Ma X, Sheng S, Wu J, Jiang Y, Gao X, Cen X, Wu J, Wang S, Tang Y, Tang Y, Liang X. LncRNAs as an intermediate in HPV16 promoting myeloid-derived suppressor cell recruitment of head and neck squamous cell carcinoma. Oncotarget 2017;8:42061-75. [PMID: 28159935 DOI: 10.18632/oncotarget.14939] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 7.6] [Reference Citation Analysis]
|
| 446 |
Bellairs JA, Hasina R, Agrawal N. Tumor DNA: an emerging biomarker in head and neck cancer. Cancer Metastasis Rev 2017;36:515-23. [PMID: 28801876 DOI: 10.1007/s10555-017-9685-x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 6.8] [Reference Citation Analysis]
|
| 447 |
Xu MJ, Johnson DE, Grandis JR. EGFR-targeted therapies in the post-genomic era. Cancer Metastasis Rev 2017;36:463-73. [PMID: 28866730 DOI: 10.1007/s10555-017-9687-8] [Cited by in Crossref: 109] [Cited by in F6Publishing: 94] [Article Influence: 21.8] [Reference Citation Analysis]
|
| 448 |
Wang Z, Valera JC, Zhao X, Chen Q, Gutkind JS. mTOR co-targeting strategies for head and neck cancer therapy. Cancer Metastasis Rev 2017;36:491-502. [PMID: 28822012 DOI: 10.1007/s10555-017-9688-7] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 7.8] [Reference Citation Analysis]
|
| 449 |
Bergamo A, Dyson PJ, Sava G. The mechanism of tumour cell death by metal-based anticancer drugs is not only a matter of DNA interactions. Coordination Chemistry Reviews 2018;360:17-33. [DOI: 10.1016/j.ccr.2018.01.009] [Cited by in Crossref: 79] [Cited by in F6Publishing: 82] [Article Influence: 15.8] [Reference Citation Analysis]
|
| 450 |
Padmanabhan A, Candelaria N, Wong KK, Nikolai BC, Lonard DM, O'Malley BW, Richards JS. USP15-dependent lysosomal pathway controls p53-R175H turnover in ovarian cancer cells. Nat Commun 2018;9:1270. [PMID: 29593334 DOI: 10.1038/s41467-018-03599-w] [Cited by in Crossref: 37] [Cited by in F6Publishing: 42] [Article Influence: 7.4] [Reference Citation Analysis]
|
| 451 |
Ding X, Zheng Y, Wang Z, Zhang W, Dong Y, Chen W, Li J, Chu W, Zhang W, Zhong Y, Mao L, Song X, Wu Y. Expression and oncogenic properties of membranous Notch1 in oral leukoplakia and oral squamous cell carcinoma. Oncol Rep 2018;39:2584-94. [PMID: 29620248 DOI: 10.3892/or.2018.6335] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 452 |
Tanaka T, Watanabe M, Yamashita K. Potential therapeutic targets of TP53 gene in the context of its classically canonical functions and its latest non-canonical functions in human cancer. Oncotarget 2018;9:16234-47. [PMID: 29662640 DOI: 10.18632/oncotarget.24611] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 453 |
Muñoz-Cordero MG, López F, García-Inclán C, López-Hernández A, Potes-Ares S, Fernández-Vañes L, Llorente JL, Hermsen M. Predictive value of EGFR-PI3K-pAKT-mTOR-pS6 pathway in sinonasal squamous cell carcinomas. Acta Otorrinolaringol Esp (Engl Ed) 2019;70:16-24. [PMID: 29573781 DOI: 10.1016/j.otorri.2017.10.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 454 |
Melchardt T, Magnes T, Hufnagl C, Thorner AR, Ducar M, Neureiter D, Tränkenschuh W, Klieser E, Gaggl A, Rösch S, Rasp G, Hartmann TN, Pleyer L, Rinnerthaler G, Weiss L, Greil R, Egle A. Clonal evolution and heterogeneity in metastatic head and neck cancer-An analysis of the Austrian Study Group of Medical Tumour Therapy study group. Eur J Cancer 2018;93:69-78. [PMID: 29477794 DOI: 10.1016/j.ejca.2018.01.064] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 455 |
Kozakiewicz P, Grzybowska-Szatkowska L. Application of molecular targeted therapies in the treatment of head and neck squamous cell carcinoma. Oncol Lett 2018;15:7497-505. [PMID: 29725456 DOI: 10.3892/ol.2018.8300] [Cited by in Crossref: 21] [Cited by in F6Publishing: 32] [Article Influence: 4.2] [Reference Citation Analysis]
|
| 456 |
Méndez E, Rodriguez CP, Kao MC, Raju S, Diab A, Harbison RA, Konnick EQ, Mugundu GM, Santana-Davila R, Martins R, Futran ND, Chow LQM. A Phase I Clinical Trial of AZD1775 in Combination with Neoadjuvant Weekly Docetaxel and Cisplatin before Definitive Therapy in Head and Neck Squamous Cell Carcinoma. Clin Cancer Res 2018;24:2740-8. [PMID: 29535125 DOI: 10.1158/1078-0432.CCR-17-3796] [Cited by in Crossref: 54] [Cited by in F6Publishing: 58] [Article Influence: 10.8] [Reference Citation Analysis]
|
| 457 |
Wirth M, Jira D, Ott A, Piontek G, Pickhard A. High NOTCH1 mRNA Expression Is Associated with Better Survival in HNSCC. Int J Mol Sci 2018;19:E830. [PMID: 29533972 DOI: 10.3390/ijms19030830] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 458 |
Zhang X, Zhang M, Hou Y, Xu L, Li W, Zou Z, Liu C, Xu A, Wu S. Single-cell analyses of transcriptional heterogeneity in squamous cell carcinoma of urinary bladder. Oncotarget. 2016;7:66069-66076. [PMID: 27602771 DOI: 10.18632/oncotarget.11803] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 4.4] [Reference Citation Analysis]
|
| 459 |
Yu W, Chen Y, Dubrulle J, Stossi F, Putluri V, Sreekumar A, Putluri N, Baluya D, Lai SY, Sandulache VC. Cisplatin generates oxidative stress which is accompanied by rapid shifts in central carbon metabolism. Sci Rep 2018;8:4306. [PMID: 29523854 DOI: 10.1038/s41598-018-22640-y] [Cited by in Crossref: 47] [Cited by in F6Publishing: 50] [Article Influence: 9.4] [Reference Citation Analysis]
|
| 460 |
Meyers JM, Grace M, Uberoi A, Lambert PF, Munger K. Inhibition of TGF-β and NOTCH Signaling by Cutaneous Papillomaviruses. Front Microbiol 2018;9:389. [PMID: 29568286 DOI: 10.3389/fmicb.2018.00389] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 461 |
García-Escudero R, Segrelles C, Dueñas M, Pombo M, Ballestín C, Alonso-Riaño M, Nenclares P, Álvarez-Rodríguez R, Sánchez-Aniceto G, Ruíz-Alonso A, López-Cedrún JL, Paramio JM, Lorz C. Overexpression of PIK3CA in head and neck squamous cell carcinoma is associated with poor outcome and activation of the YAP pathway. Oral Oncol 2018;79:55-63. [PMID: 29598951 DOI: 10.1016/j.oraloncology.2018.02.014] [Cited by in Crossref: 37] [Cited by in F6Publishing: 41] [Article Influence: 7.4] [Reference Citation Analysis]
|
| 462 |
Signoretti S, Aster JC. Metastatic penile carcinoma associated with convergent gain-of-function mutations in NOTCH1. Human Pathology: Case Reports 2018;11:19-20. [DOI: 10.1016/j.ehpc.2017.09.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 463 |
Griewank KG, Wiesner T, Murali R, Pischler C, Müller H, Koelsche C, Möller I, Franklin C, Cosgarea I, Sucker A, Schadendorf D, Schaller J, Horn S, Brenn T, Mentzel T. Atypical fibroxanthoma and pleomorphic dermal sarcoma harbor frequent NOTCH1/2 and FAT1 mutations and similar DNA copy number alteration profiles. Mod Pathol 2018;31:418-28. [PMID: 29099504 DOI: 10.1038/modpathol.2017.146] [Cited by in Crossref: 49] [Cited by in F6Publishing: 51] [Article Influence: 9.8] [Reference Citation Analysis]
|
| 464 |
Fukusumi T, Califano JA. The NOTCH Pathway in Head and Neck Squamous Cell Carcinoma. J Dent Res 2018;97:645-53. [PMID: 29489439 DOI: 10.1177/0022034518760297] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 9.2] [Reference Citation Analysis]
|
| 465 |
Lindemann A, Takahashi H, Patel AA, Osman AA, Myers JN. Targeting the DNA Damage Response in OSCC with TP53 Mutations. J Dent Res 2018;97:635-44. [PMID: 29489434 DOI: 10.1177/0022034518759068] [Cited by in Crossref: 44] [Cited by in F6Publishing: 53] [Article Influence: 8.8] [Reference Citation Analysis]
|
| 466 |
Shang W, Zhang Q, Huang Y, Shanti R, Alawi F, Le A, Jiang C. Cellular Plasticity-Targeted Therapy in Head and Neck Cancers. J Dent Res 2018;97:654-64. [PMID: 29486673 DOI: 10.1177/0022034518756351] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 467 |
Rector J, Kapil S, Treude KJ, Kumm P, Glanzer JG, Byrne BM, Liu S, Smith LM, DiMaio DJ, Giannini P, Smith RB, Oakley GG. S4S8-RPA phosphorylation as an indicator of cancer progression in oral squamous cell carcinomas. Oncotarget 2017;8:9243-50. [PMID: 27999209 DOI: 10.18632/oncotarget.14001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 468 |
Gong W, Xiao Y, Wei Z, Yuan Y, Qiu M, Sun C, Zeng X, Liang X, Feng M, Chen Q. Toward the use of precision medicine for the treatment of head and neck squamous cell carcinoma. Oncotarget 2017;8:2141-52. [PMID: 27924064 DOI: 10.18632/oncotarget.13798] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 469 |
Tuna M, Amos CI. Next generation sequencing and its applications in HPV-associated cancers. Oncotarget 2017;8:8877-89. [PMID: 27784002 DOI: 10.18632/oncotarget.12830] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 470 |
Liu X, Gao XL, Liang XH, Tang YL. The etiologic spectrum of head and neck squamous cell carcinoma in young patients. Oncotarget 2016;7:66226-38. [PMID: 27528225 DOI: 10.18632/oncotarget.11265] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 471 |
Kemmer JD, Johnson DE, Grandis JR. Leveraging Genomics for Head and Neck Cancer Treatment. J Dent Res 2018;97:603-13. [PMID: 29420101 DOI: 10.1177/0022034518756352] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 472 |
Sablin MP, Dubot C, Klijanienko J, Vacher S, Ouafi L, Chemlali W, Caly M, Sastre-Garau X, Lappartient E, Mariani O, Rodriguez J, Jouffroy T, Girod A, Calugaru V, Hoffmann C, Lidereau R, Berger F, Kamal M, Bieche I, Le Tourneau C. Identification of new candidate therapeutic target genes in head and neck squamous cell carcinomas. Oncotarget 2016;7:47418-30. [PMID: 27329726 DOI: 10.18632/oncotarget.10163] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 473 |
Chen C, Chen Y, Yang T. Application of three-dimensional collagen scaffolds to recapitulate and monitor the dynamics of epithelial-mesenchymal transition during tumor satellite formation of head and neck cancer. Biomaterials 2018;154:134-46. [DOI: 10.1016/j.biomaterials.2017.08.011] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 474 |
Solomon B, Young RJ, Rischin D. Head and neck squamous cell carcinoma: Genomics and emerging biomarkers for immunomodulatory cancer treatments. Semin Cancer Biol. 2018;52:228-240. [PMID: 29355614 DOI: 10.1016/j.semcancer.2018.01.008] [Cited by in Crossref: 171] [Cited by in F6Publishing: 187] [Article Influence: 34.2] [Reference Citation Analysis]
|
| 475 |
van Ginkel JH, de Leng WW, de Bree R, van Es RJ, Willems SM. Targeted sequencing reveals TP53 as a potential diagnostic biomarker in the post-treatment surveillance of head and neck cancer. Oncotarget. 2016;7:61575-61586. [PMID: 27528217 DOI: 10.18632/oncotarget.11196] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 4.4] [Reference Citation Analysis]
|
| 476 |
Perdomo S, Anantharaman D, Foll M, Abedi-Ardekani B, Durand G, Reis Rosa LA, Holmila R, Le Calvez-Kelm F, Tajara EH, Wünsch-Filho V, Levi JE, Vilensky M, Polesel J, Holcatova I, Simonato L, Canova C, Lagiou P, McKay JD, Brennan P. Genomic analysis of head and neck cancer cases from two high incidence regions. PLoS One 2018;13:e0191701. [PMID: 29377909 DOI: 10.1371/journal.pone.0191701] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 477 |
Chung JH, Jung HR, Jung AR, Lee YC, Kong M, Lee JS, Eun YG. SOX2 activation predicts prognosis in patients with head and neck squamous cell carcinoma. Sci Rep 2018;8:1677. [PMID: 29374236 DOI: 10.1038/s41598-018-20086-w] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 478 |
Wei T, Choi S, Buehler D, Rapraeger AC, Anderson RA, Lambert PF. Role of IQGAP1 in Head and Neck Carcinogenesis.. [DOI: 10.1101/253484] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 479 |
Matsumoto CS, Almeida LO, Guimarães DM, Martins MD, Papagerakis P, Papagerakis S, Leopoldino AM, Castilho RM, Squarize CH. PI3K-PTEN dysregulation leads to mTOR-driven upregulation of the core clock gene BMAL1 in normal and malignant epithelial cells. Oncotarget 2016;7:42393-407. [PMID: 27285754 DOI: 10.18632/oncotarget.9877] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 480 |
Tsigelny IF, Kouznetsova VL, Lian N, Kesari S. Molecular mechanisms of OLIG2 transcription factor in brain cancer. Oncotarget 2016;7:53074-101. [PMID: 27447975 DOI: 10.18632/oncotarget.10628] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 481 |
Hang W, Yin ZX, Liu G, Zeng Q, Shen XF, Sun QH, Li DD, Jian YP, Zhang YH, Wang YS, Quan CS, Zhao RX, Li YL, Xu ZX. Piperlongumine and p53-reactivator APR-246 selectively induce cell death in HNSCC by targeting GSTP1. Oncogene 2018;37:3384-98. [PMID: 29348462 DOI: 10.1038/s41388-017-0110-2] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 7.6] [Reference Citation Analysis]
|
| 482 |
Sandulache VC, Michikawa C, Kataria P, Gleber-Netto FO, Bell D, Trivedi S, Rao X, Wang J, Zhao M, Jasser S, Myers JN, Pickering CR. High-Risk TP53 Mutations Are Associated with Extranodal Extension in Oral Cavity Squamous Cell Carcinoma. Clin Cancer Res 2018;24:1727-33. [PMID: 29330202 DOI: 10.1158/1078-0432.CCR-17-0721] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 483 |
García-Carracedo D, Villaronga MÁ, Álvarez-Teijeiro S, Hermida-Prado F, Santamaría I, Allonca E, Suárez-Fernández L, Gonzalez MV, Balbín M, Astudillo A, Martínez-Camblor P, Su GH, Rodrigo JP, García-Pedrero JM. Impact of PI3K/AKT/mTOR pathway activation on the prognosis of patients with head and neck squamous cell carcinomas. Oncotarget 2016;7:29780-93. [PMID: 27119232 DOI: 10.18632/oncotarget.8957] [Cited by in Crossref: 49] [Cited by in F6Publishing: 50] [Article Influence: 9.8] [Reference Citation Analysis]
|
| 484 |
Jouhi L, Hagström J, Atula T, Mäkitie A. Is p16 an adequate surrogate for human papillomavirus status determination? Curr Opin Otolaryngol Head Neck Surg 2017;25:108-12. [PMID: 28141601 DOI: 10.1097/MOO.0000000000000341] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 485 |
Milewska M, Cremona M, Morgan C, O'Shea J, Carr A, Vellanki SH, Hopkins AM, Toomey S, Madden SF, Hennessy BT, Eustace AJ. Development of a personalized therapeutic strategy for ERBB-gene-mutated cancers. Ther Adv Med Oncol 2018;10:1758834017746040. [PMID: 29383036 DOI: 10.1177/1758834017746040] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 486 |
Polo V, Pasello G, Frega S, Favaretto A, Koussis H, Conte P, Bonanno L. Squamous cell carcinomas of the lung and of the head and neck: new insights on molecular characterization. Oncotarget 2016;7:25050-63. [PMID: 26933818 DOI: 10.18632/oncotarget.7732] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 487 |
Zheng Y, Wang Z, Ding X, Zhang W, Li G, Liu L, Wu H, Gu W, Wu Y, Song X. A novel Notch1 missense mutation (C1133Y) in the Abruptex domain exhibits enhanced proliferation and invasion in oral squamous cell carcinoma. Cancer Cell Int 2018;18:6. [PMID: 29321718 DOI: 10.1186/s12935-017-0496-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 488 |
Redlich N, Robinson AM, Nickel KP, Stein AP, Wheeler DL, Adkins DR, Uppaluri R, Kimple RJ, Van Tine BA, Michel LS. Anti-Trop2 blockade enhances the therapeutic efficacy of ErbB3 inhibition in head and neck squamous cell carcinoma. Cell Death Dis 2018;9:5. [PMID: 29305574 DOI: 10.1038/s41419-017-0029-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 489 |
Zhang X, Wu J, Luo S, Lechler T, Zhang JY. FRA1 promotes squamous cell carcinoma growth and metastasis through distinct AKT and c-Jun dependent mechanisms. Oncotarget 2016;7:34371-83. [PMID: 27144339 DOI: 10.18632/oncotarget.9110] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 6.4] [Reference Citation Analysis]
|
| 490 |
Sinicropi-yao SL, Koenig MJ, Carbone DP. Notch in Lung Cancer. Targeting Notch in Cancer 2018. [DOI: 10.1007/978-1-4939-8859-4_10] [Reference Citation Analysis]
|
| 491 |
White JH, Salehi-tabar R, Dimitrov V, Bouttier M. Diverse Mechanisms of Transcriptional Regulation by the Vitamin D Receptor. Vitamin D 2018. [DOI: 10.1016/b978-0-12-809965-0.00010-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 492 |
Hoare M, Narita M. Notch and Senescence. Adv Exp Med Biol 2018;1066:299-318. [PMID: 30030833 DOI: 10.1007/978-3-319-89512-3_15] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 493 |
Kuriakose MA, Chakrabarti S, Cheong SC, Kowalski LP, Novaes Pinheiro T, Farah CS. Head and Neck Tumors. Contemporary Oral Medicine 2018. [DOI: 10.1007/978-3-319-28100-1_20-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 494 |
Faraji F, Schubert AD, Kagohara LT, Tan M, Xu Y, Zaidi M, Fortin J, Fakhry C, Izumchenko E, Gaykalova DA, Fertig EJ. The Genome-Wide Molecular Landscape of HPV-Driven and HPV-Negative Head and Neck Squamous Cell Carcinoma. Molecular Determinants of Head and Neck Cancer 2018. [DOI: 10.1007/978-3-319-78762-6_11] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 495 |
Clayburgh DR, Grandis JR. Molecular Biology. Oral, Head and Neck Oncology and Reconstructive Surgery. Elsevier; 2018. pp. 79-89. [DOI: 10.1016/b978-0-323-26568-3.00003-8] [Cited by in Crossref: 3] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 496 |
Tinhofer I. Targeted Next-Generation Sequencing in Head and Neck Cancer. Critical Issues in Head and Neck Oncology 2018. [DOI: 10.1007/978-3-319-98854-2_4] [Reference Citation Analysis]
|
| 497 |
Peri S, Andrews AJ, Bhatia A, Mehra R. Epigenetic Changes and Epigenetic Targets in Head and Neck Cancer. Molecular Determinants of Head and Neck Cancer 2018. [DOI: 10.1007/978-3-319-78762-6_12] [Reference Citation Analysis]
|
| 498 |
Wu F, Weigel KJ, Zhou H, Wang XJ. Paradoxical roles of TGF-β signaling in suppressing and promoting squamous cell carcinoma. Acta Biochim Biophys Sin (Shanghai) 2018;50:98-105. [PMID: 29206939 DOI: 10.1093/abbs/gmx127] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 6.4] [Reference Citation Analysis]
|
| 499 |
Kenneth Parkinson E. Oral Cancer: Recent Developments and Future Challenges. Oral Mucosa in Health and Disease 2018. [DOI: 10.1007/978-3-319-56065-6_8] [Reference Citation Analysis]
|
| 500 |
Schubert AD, Zamuner FT, London NR, Zhavoronkov A, Mehra R, Hoque MO, Bedi A, Ravi R, Fertig EJ, Sidransky D, Gaykalova DA, Izumchenko E. Role of the NOTCH Signaling Pathway in Head and Neck Cancer. Molecular Determinants of Head and Neck Cancer 2018. [DOI: 10.1007/978-3-319-78762-6_8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 501 |
Farah CS, Kujan O, Prime S, Zain R. Oral Mucosal Malignancies. Contemporary Oral Medicine 2018. [DOI: 10.1007/978-3-319-28100-1_21-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 502 |
Kiseleva A, Beck TN, Serebriiskii IG, Liu H, Burtness B, Golemis EA. Targeting the ErbB Family in Head and Neck Cancer. Molecular Determinants of Head and Neck Cancer 2018. [DOI: 10.1007/978-3-319-78762-6_2] [Reference Citation Analysis]
|
| 503 |
Koch U, Radtke F. Dual Function of Notch Signaling in Cancer: Oncogene and Tumor Suppressor. Targeting Notch in Cancer 2018. [DOI: 10.1007/978-1-4939-8859-4_3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 504 |
Deneka AY, Howard JD, Chung CH. The PI3K Signaling Pathway in Head and Neck Squamous Cell Carcinoma. Molecular Determinants of Head and Neck Cancer 2018. [DOI: 10.1007/978-3-319-78762-6_5] [Reference Citation Analysis]
|
| 505 |
Alamoud K, Kukuruzinska MA. Diversity of Wnt/β-Catenin Signaling in Head and Neck Cancer: Cancer Stem Cells, Epithelial-to-Mesenchymal Transition, and Tumor Microenvironment. Molecular Determinants of Head and Neck Cancer 2018. [DOI: 10.1007/978-3-319-78762-6_18] [Reference Citation Analysis]
|
| 506 |
Seung SK, Cheng A, Patel AA, Dierks EJ, Hyers MJ, Watters AL, Leidner R, Bryan Bell R. Advanced HPV-Unrelated Pharynx Cancer. Oral, Head and Neck Oncology and Reconstructive Surgery 2018. [DOI: 10.1016/b978-0-323-26568-3.00035-x] [Reference Citation Analysis]
|
| 507 |
Demidova EV, Iqbal W, Arora S. Molecular Regulation of Cell Cycle and Cell Cycle-Targeted Therapies in Head and Neck Squamous Cell Carcinoma (HNSCC). Molecular Determinants of Head and Neck Cancer 2018. [DOI: 10.1007/978-3-319-78762-6_7] [Reference Citation Analysis]
|
| 508 |
Burtness B, Golemis EA. Overview: The Pathobiology of Head and Neck Cancer. Molecular Determinants of Head and Neck Cancer 2018. [DOI: 10.1007/978-3-319-78762-6_1] [Reference Citation Analysis]
|
| 509 |
El Hallani S, Udager AM, Bell D, Fonseca I, Thompson LDR, Assaad A, Agaimy A, Luvison AM, Miller C, Seethala RR, Chiosea S. Epithelial-Myoepithelial Carcinoma: Frequent Morphologic and Molecular Evidence of Preexisting Pleomorphic Adenoma, Common HRAS Mutations in PLAG1-intact and HMGA2-intact Cases, and Occasional TP53, FBXW7, and SMARCB1 Alterations in High-grade Cases. Am J Surg Pathol 2018;42:18-27. [PMID: 29135520 DOI: 10.1097/PAS.0000000000000933] [Cited by in Crossref: 49] [Cited by in F6Publishing: 50] [Article Influence: 8.2] [Reference Citation Analysis]
|
| 510 |
Brimer N, Drews CM, Vande Pol SB. Association of papillomavirus E6 proteins with either MAML1 or E6AP clusters E6 proteins by structure, function, and evolutionary relatedness. PLoS Pathog 2017;13:e1006781. [PMID: 29281732 DOI: 10.1371/journal.ppat.1006781] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 511 |
von Mässenhausen A, Sanders C, Thewes B, Deng M, Queisser A, Vogel W, Kristiansen G, Duensing S, Schröck A, Bootz F, Brossart P, Kirfel J, Heasley L, Brägelmann J, Perner S. MERTK as a novel therapeutic target in head and neck cancer. Oncotarget 2016;7:32678-94. [PMID: 27081701 DOI: 10.18632/oncotarget.8724] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 512 |
Stangl S, Tontcheva N, Sievert W, Shevtsov M, Niu M, Schmid TE, Pigorsch S, Combs SE, Haller B, Balermpas P, Rödel F, Rödel C, Fokas E, Krause M, Linge A, Lohaus F, Baumann M, Tinhofer I, Budach V, Stuschke M, Grosu AL, Abdollahi A, Debus J, Belka C, Maihöfer C, Mönnich D, Zips D, Multhoff G. Heat shock protein 70 and tumor-infiltrating NK cells as prognostic indicators for patients with squamous cell carcinoma of the head and neck after radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG). Int J Cancer 2018;142:1911-25. [PMID: 29235112 DOI: 10.1002/ijc.31213] [Cited by in Crossref: 34] [Cited by in F6Publishing: 38] [Article Influence: 5.7] [Reference Citation Analysis]
|
| 513 |
Tanaka N, Zhao M, Tang L, Patel AA, Xi Q, Van HT, Takahashi H, Osman AA, Zhang J, Wang J, Myers JN, Zhou G. Gain-of-function mutant p53 promotes the oncogenic potential of head and neck squamous cell carcinoma cells by targeting the transcription factors FOXO3a and FOXM1. Oncogene 2018;37:1279-92. [PMID: 29269868 DOI: 10.1038/s41388-017-0032-z] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 5.7] [Reference Citation Analysis]
|
| 514 |
Gan RH, Wei H, Xie J, Zheng DP, Luo EL, Huang XY, Xie J, Zhao Y, Ding LC, Su BH, Lin LS, Zheng DL, Lu YG. Notch1 regulates tongue cancer cells proliferation, apoptosis and invasion. Cell Cycle 2018;17:216-24. [PMID: 29117785 DOI: 10.1080/15384101.2017.1395534] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 515 |
Verduci L, Ferraiuolo M, Sacconi A, Ganci F, Vitale J, Colombo T, Paci P, Strano S, Macino G, Rajewsky N, Blandino G. The oncogenic role of circPVT1 in head and neck squamous cell carcinoma is mediated through the mutant p53/YAP/TEAD transcription-competent complex. Genome Biol 2017;18:237. [PMID: 29262850 DOI: 10.1186/s13059-017-1368-y] [Cited by in Crossref: 127] [Cited by in F6Publishing: 144] [Article Influence: 21.2] [Reference Citation Analysis]
|
| 516 |
Ledgerwood LG, Kumar D, Eterovic AK, Wick J, Chen K, Zhao H, Tazi L, Manna P, Kerley S, Joshi R, Wang L, Chiosea SI, Garnett JD, Tsue TT, Chien J, Mills GB, Grandis JR, Thomas SM. The degree of intratumor mutational heterogeneity varies by primary tumor sub-site. Oncotarget 2016;7:27185-98. [PMID: 27034009 DOI: 10.18632/oncotarget.8448] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 517 |
Fadlullah MZ, Chiang IK, Dionne KR, Yee PS, Gan CP, Sam KK, Tiong KH, Ng AK, Martin D, Lim KP, Kallarakkal TG, Mustafa WM, Lau SH, Abraham MT, Zain RB, Rahman ZA, Molinolo A, Patel V, Gutkind JS, Tan AC, Cheong SC. Genetically-defined novel oral squamous cell carcinoma cell lines for the development of molecular therapies. Oncotarget 2016;7:27802-18. [PMID: 27050151 DOI: 10.18632/oncotarget.8533] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 5.7] [Reference Citation Analysis]
|
| 518 |
Albers AE, Qian X, Kaufmann AM, Coordes A. Meta analysis: HPV and p16 pattern determines survival in patients with HNSCC and identifies potential new biologic subtype. Sci Rep 2017;7:16715. [PMID: 29196639 DOI: 10.1038/s41598-017-16918-w] [Cited by in Crossref: 74] [Cited by in F6Publishing: 76] [Article Influence: 12.3] [Reference Citation Analysis]
|
| 519 |
Puram SV, Tirosh I, Parikh AS, Patel AP, Yizhak K, Gillespie S, Rodman C, Luo CL, Mroz EA, Emerick KS, Deschler DG, Varvares MA, Mylvaganam R, Rozenblatt-Rosen O, Rocco JW, Faquin WC, Lin DT, Regev A, Bernstein BE. Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Head and Neck Cancer. Cell 2017;171:1611-1624.e24. [PMID: 29198524 DOI: 10.1016/j.cell.2017.10.044] [Cited by in Crossref: 1072] [Cited by in F6Publishing: 1119] [Article Influence: 178.7] [Reference Citation Analysis]
|
| 520 |
Peri S, Izumchenko E, Schubert AD, Slifker MJ, Ruth K, Serebriiskii IG, Guo T, Burtness BA, Mehra R, Ross EA, Sidransky D, Golemis EA. NSD1- and NSD2-damaging mutations define a subset of laryngeal tumors with favorable prognosis. Nat Commun 2017;8:1772. [PMID: 29176703 DOI: 10.1038/s41467-017-01877-7] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 521 |
Natsuizaka M, Whelan KA, Kagawa S, Tanaka K, Giroux V, Chandramouleeswaran PM, Long A, Sahu V, Darling DS, Que J, Yang Y, Katz JP, Wileyto EP, Basu D, Kita Y, Natsugoe S, Naganuma S, Klein-Szanto AJ, Diehl JA, Bass AJ, Wong KK, Rustgi AK, Nakagawa H. Interplay between Notch1 and Notch3 promotes EMT and tumor initiation in squamous cell carcinoma. Nat Commun 2017;8:1758. [PMID: 29170450 DOI: 10.1038/s41467-017-01500-9] [Cited by in Crossref: 101] [Cited by in F6Publishing: 114] [Article Influence: 16.8] [Reference Citation Analysis]
|
| 522 |
Compagnone M, Gatti V, Presutti D, Ruberti G, Fierro C, Markert EK, Vousden KH, Zhou H, Mauriello A, Anemone L, Bongiorno-Borbone L, Melino G, Peschiaroli A. ΔNp63-mediated regulation of hyaluronic acid metabolism and signaling supports HNSCC tumorigenesis. Proc Natl Acad Sci U S A 2017;114:13254-9. [PMID: 29162693 DOI: 10.1073/pnas.1711777114] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 5.2] [Reference Citation Analysis]
|
| 523 |
Fukusumi T, Guo TW, Sakai A, Ando M, Ren S, Haft S, Liu C, Amornphimoltham P, Gutkind JS, Califano JA. The NOTCH4-HEY1 Pathway Induces Epithelial-Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma. Clin Cancer Res 2018;24:619-33. [PMID: 29146722 DOI: 10.1158/1078-0432.CCR-17-1366] [Cited by in Crossref: 43] [Cited by in F6Publishing: 51] [Article Influence: 7.2] [Reference Citation Analysis]
|
| 524 |
Dong Y, Ochsenreither S, Cai C, Kaufmann AM, Albers AE, Qian X. Aldehyde dehydrogenase 1 isoenzyme expression as a marker of cancer stem cells correlates to histopathological features in head and neck cancer: A meta-analysis. PLoS One 2017;12:e0187615. [PMID: 29112953 DOI: 10.1371/journal.pone.0187615] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 525 |
Arita H, Nagata M, Yoshida R, Matsuoka Y, Hirosue A, Kawahara K, Sakata J, Nakashima H, Kojima T, Toya R, Murakami R, Hiraki A, Shinohara M, Nakayama H. FBXW7 expression affects the response to chemoradiotherapy and overall survival among patients with oral squamous cell carcinoma: A single-center retrospective study. Tumour Biol 2017;39:1010428317731771. [PMID: 29072128 DOI: 10.1177/1010428317731771] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 526 |
Mao L, Zhao ZL, Yu GT, Wu L, Deng WW, Li YC, Liu JF, Bu LL, Liu B, Kulkarni AB, Zhang WF, Zhang L, Sun ZJ. γ-Secretase inhibitor reduces immunosuppressive cells and enhances tumour immunity in head and neck squamous cell carcinoma. Int J Cancer 2018;142:999-1009. [PMID: 29047105 DOI: 10.1002/ijc.31115] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 6.7] [Reference Citation Analysis]
|
| 527 |
Ichimura N, Yamamoto N, Nishikawa M, Furue H, Kondo Y, Hibi H. Notch3 is frequently downregulated in oral cancer. Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology 2017;29:504-10. [DOI: 10.1016/j.ajoms.2017.06.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 528 |
Kanwal S, Lonie A, Sinnott RO. Digital reproducibility requirements of computational genomic workflows. 2017 IEEE International Conference on Bioinformatics and Biomedicine (BIBM) 2017. [DOI: 10.1109/bibm.2017.8217887] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 529 |
von Mässenhausen A, Deng M, Billig H, Queisser A, Vogel W, Kristiansen G, Schröck A, Bootz F, Göke F, Franzen A, Heasley L, Kirfel J, Brägelmann J, Perner S. Evaluation of FGFR3 as a Therapeutic Target in Head and Neck Squamous Cell Carcinoma. Target Oncol 2016;11:631-42. [PMID: 27053219 DOI: 10.1007/s11523-016-0431-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 530 |
Lynch MD, Lynch CNS, Craythorne E, Liakath-Ali K, Mallipeddi R, Barker JN, Watt FM. Spatial constraints govern competition of mutant clones in human epidermis. Nat Commun 2017;8:1119. [PMID: 29066762 DOI: 10.1038/s41467-017-00993-8] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 531 |
Gleber-Netto FO, Zhao M, Trivedi S, Wang J, Jasser S, McDowell C, Kadara H, Zhang J, Wang J, William WN Jr, Lee JJ, Nguyen ML, Pai SI, Walline HM, Shin DM, Ferris RL, Carey TE, Myers JN, Pickering CR; Head and Neck Cancer Specialized Program of Research Excellence (SPORE) Human Immunodeficiency Virus (HIV) Supplement Consortium. Distinct pattern of TP53 mutations in human immunodeficiency virus-related head and neck squamous cell carcinoma. Cancer 2018;124:84-94. [PMID: 29053175 DOI: 10.1002/cncr.31063] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 532 |
Guo W, Chen X, Zhu L, Wang Q. A six-mRNA signature model for the prognosis of head and neck squamous cell carcinoma. Oncotarget 2017;8:94528-38. [PMID: 29212247 DOI: 10.18632/oncotarget.21786] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 533 |
Chung C, Lee C, Chen M, Tsai M, Ko Y. Interaction Between Rare Variants in NOTCH1 and Betel Quid Chewing in Oral Squamous Cell Carcinoma. Genetic Testing and Molecular Biomarkers 2017;21:608-12. [DOI: 10.1089/gtmb.2017.0013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 534 |
Upadhyay P, Gardi N, Desai S, Chandrani P, Joshi A, Dharavath B, Arora P, Bal M, Nair S, Dutt A. Genomic characterization of tobacco/nut chewing HPV-negative early stage tongue tumors identify MMP10 asa candidate to predict metastases. Oral Oncol 2017;73:56-64. [PMID: 28939077 DOI: 10.1016/j.oraloncology.2017.08.003] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 4.2] [Reference Citation Analysis]
|
| 535 |
Coaxum SD, Tiedeken J, Garrett-Mayer E, Myers J, Rosenzweig SA, Neskey DM. The tumor suppressor capability of p53 is dependent on non-muscle myosin IIA function in head and neck cancer. Oncotarget 2017;8:22991-3007. [PMID: 28160562 DOI: 10.18632/oncotarget.14967] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 536 |
Siebel C, Lendahl U. Notch Signaling in Development, Tissue Homeostasis, and Disease. Physiol Rev. 2017;97:1235-1294. [PMID: 28794168 DOI: 10.1152/physrev.00005.2017] [Cited by in Crossref: 451] [Cited by in F6Publishing: 473] [Article Influence: 75.2] [Reference Citation Analysis]
|
| 537 |
Yin ZX, Hang W, Liu G, Wang YS, Shen XF, Sun QH, Li DD, Jian YP, Zhang YH, Quan CS, Zeng Q, Li YL, Zhao RX, Ding Q, Xu ZX. PARP-1 inhibitors sensitize HNSCC cells to APR-246 by inactivation of thioredoxin reductase 1 (TrxR1) and promotion of ROS accumulation. Oncotarget 2018;9:1885-97. [PMID: 29416738 DOI: 10.18632/oncotarget.21277] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 538 |
Horn D, Freudlsperger C, Holzinger D, Kunzmann K, Plinkert P, Dyckhoff G, Hoffmann J, Freier K, Hess J. Upregulation of pAKT(Ser473) expression in progression of HPV-positive oropharyngeal squamous cell carcinoma. Head & Neck 2017;39:2397-405. [DOI: 10.1002/hed.24910] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 539 |
Gaponova AV, Deneka AY, Beck TN, Liu H, Andrianov G, Nikonova AS, Nicolas E, Einarson MB, Golemis EA, Serebriiskii IG. Identification of evolutionarily conserved DNA damage response genes that alter sensitivity to cisplatin. Oncotarget 2017;8:19156-71. [PMID: 27863405 DOI: 10.18632/oncotarget.13353] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 540 |
Sandulache VC, Chen Y, Feng L, William WN, Skinner HD, Myers JN, Meyn RE, Li J, Mijiti A, Bankson JA, Fuller CD, Konopleva MY, Lai SY. Metabolic interrogation as a tool to optimize chemotherapeutic regimens. Oncotarget 2017;8:18154-65. [PMID: 28184025 DOI: 10.18632/oncotarget.15186] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 541 |
Smith EA, Kumar B, Komurov K, Smith SM, Brown NV, Zhao S, Kumar P, Teknos TN, Wells SI. DEK associates with tumor stage and outcome in HPV16 positive oropharyngeal squamous cell carcinoma. Oncotarget 2017;8:23414-26. [PMID: 28423581 DOI: 10.18632/oncotarget.15582] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 542 |
El Baroudi M, Machiels JP, Schmitz S. Expression of SESN1, UHRF1BP1, and miR-377-3p as prognostic markers in mutated TP53 squamous cell carcinoma of the head and neck. Cancer Biol Ther 2017;18:775-82. [PMID: 28886272 DOI: 10.1080/15384047.2017.1373212] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 543 |
Guerrero-Preston R, White JR, Godoy-Vitorino F, Rodríguez-Hilario A, Navarro K, González H, Michailidi C, Jedlicka A, Canapp S, Bondy J, Dziedzic A, Mora-Lagos B, Rivera-Alvarez G, Ili-Gangas C, Brebi-Mieville P, Westra W, Koch W, Kang H, Marchionni L, Kim Y, Sidransky D. High-resolution microbiome profiling uncovers Fusobacterium nucleatum, Lactobacillus gasseri/johnsonii, and Lactobacillus vaginalis associated to oral and oropharyngeal cancer in saliva from HPV positive and HPV negative patients treated with surgery and chemo-radiation. Oncotarget 2017;8:110931-48. [PMID: 29340028 DOI: 10.18632/oncotarget.20677] [Cited by in Crossref: 54] [Cited by in F6Publishing: 58] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 544 |
Chen TW, Lee CC, Liu H, Wu CS, Pickering CR, Huang PJ, Wang J, Chang IY, Yeh YM, Chen CD, Li HP, Luo JD, Tan BC, Chan TEH, Hsueh C, Chu LJ, Chen YT, Zhang B, Yang CY, Wu CC, Hsu CW, See LC, Tang P, Yu JS, Liao WC, Chiang WF, Rodriguez H, Myers JN, Chang KP, Chang YS. APOBEC3A is an oral cancer prognostic biomarker in Taiwanese carriers of an APOBEC deletion polymorphism. Nat Commun 2017;8:465. [PMID: 28878238 DOI: 10.1038/s41467-017-00493-9] [Cited by in Crossref: 68] [Cited by in F6Publishing: 76] [Article Influence: 11.3] [Reference Citation Analysis]
|
| 545 |
Husain N, Neyaz A. Human papillomavirus associated head and neck squamous cell carcinoma: Controversies and new concepts. J Oral Biol Craniofac Res 2017;7:198-205. [PMID: 29124000 DOI: 10.1016/j.jobcr.2017.08.003] [Cited by in Crossref: 45] [Cited by in F6Publishing: 38] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 546 |
Bhatia A, Burtness B. Novel Molecular Targets for Chemoprevention in Malignancies of the Head and Neck. Cancers (Basel) 2017;9:E113. [PMID: 28858212 DOI: 10.3390/cancers9090113] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 547 |
Eze N, Lo YC, Burtness B. Biomarker driven treatment of head and neck squamous cell cancer. Cancers Head Neck 2017;2:6. [PMID: 31093353 DOI: 10.1186/s41199-017-0025-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 548 |
Gaykalova DA, Zizkova V, Guo T, Tiscareno I, Wei Y, Vatapalli R, Hennessey PT, Ahn J, Danilova L, Khan Z, Bishop JA, Gutkind JS, Koch WM, Westra WH, Fertig EJ, Ochs MF, Califano JA. Integrative computational analysis of transcriptional and epigenetic alterations implicates DTX1 as a putative tumor suppressor gene in HNSCC. Oncotarget 2017;8:15349-63. [PMID: 28146432 DOI: 10.18632/oncotarget.14856] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 549 |
Vanderdys V, Allak A, Guessous F, Benamar M, Read PW, Jameson MJ, Abbas T. The Neddylation Inhibitor Pevonedistat (MLN4924) Suppresses and Radiosensitizes Head and Neck Squamous Carcinoma Cells and Tumors. Mol Cancer Ther 2018;17:368-80. [PMID: 28838998 DOI: 10.1158/1535-7163.MCT-17-0083] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 550 |
Tabatabaeifar S, Thomassen M, Larsen MJ, Larsen SR, Kruse TA, Sørensen JA. The subclonal structure and genomic evolution of oral squamous cell carcinoma revealed by ultra-deep sequencing. Oncotarget 2017;8:16571-80. [PMID: 28157713 DOI: 10.18632/oncotarget.15014] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 551 |
Van Waes C, Musbahi O. Genomics and advances towards precision medicine for head and neck squamous cell carcinoma. Laryngoscope Investig Otolaryngol 2017;2:310-9. [PMID: 29094075 DOI: 10.1002/lio2.86] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 552 |
Nakagawa T, Matsusaka K, Misawa K, Ota S, Takane K, Fukuyo M, Rahmutulla B, Shinohara KI, Kunii N, Sakurai D, Hanazawa T, Matsubara H, Nakatani Y, Okamoto Y, Kaneda A. Frequent promoter hypermethylation associated with human papillomavirus infection in pharyngeal cancer. Cancer Lett 2017;407:21-31. [PMID: 28823962 DOI: 10.1016/j.canlet.2017.08.008] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 553 |
Ilmarinen T, Munne P, Hagström J, Haglund C, Auvinen E, Virtanen EI, Haesevoets A, Speel EJM, Aaltonen LM. Prevalence of high-risk human papillomavirus infection and cancer gene mutations in nonmalignant tonsils. Oral Oncol 2017;73:77-82. [PMID: 28939080 DOI: 10.1016/j.oraloncology.2017.08.010] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 554 |
Deng G, Zheng X, Jiang P, Chen K, Wang X, Jiang K, Zhang W, Tu L, Yan D, Ma L, Ma S. Notch1 suppresses prostate cancer cell invasion via the metastasis-associated 1-KiSS-1 metastasis-suppressor pathway. Oncol Lett 2017;14:4477-82. [PMID: 29085444 DOI: 10.3892/ol.2017.6761] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 555 |
Ito Y, Hoare M, Narita M. Spatial and Temporal Control of Senescence. Trends Cell Biol. 2017;27:820-832. [PMID: 28822679 DOI: 10.1016/j.tcb.2017.07.004] [Cited by in Crossref: 91] [Cited by in F6Publishing: 95] [Article Influence: 15.2] [Reference Citation Analysis]
|
| 556 |
Tonlaar N, Galoforo S, Thibodeau BJ, Ahmed S, Wilson TG, Yumpo Cardenas P, Marples B, Wilson GD. Antitumor activity of the dual PI3K/MTOR inhibitor, PF-04691502, in combination with radiation in head and neck cancer. Radiother Oncol 2017;124:504-12. [PMID: 28823407 DOI: 10.1016/j.radonc.2017.08.001] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 557 |
Kakushadze Z, Yu W. Mutation Clusters from Cancer Exome. Genes (Basel) 2017;8:E201. [PMID: 28809811 DOI: 10.3390/genes8080201] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 558 |
Kudo I, Esumi M, Kusumi Y, Furusaka T, Oshima T. Particular gene upregulation and p53 heterogeneous expression in TP53-mutated maxillary carcinoma. Oncol Lett 2017;14:4633-40. [PMID: 29085461 DOI: 10.3892/ol.2017.6751] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 559 |
De Paz D, Kao HK, Huang Y, Chang KP. Prognostic Stratification of Patients With Advanced Oral Cavity Squamous Cell Carcinoma. Curr Oncol Rep 2017;19:65. [PMID: 28799122 DOI: 10.1007/s11912-017-0624-3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 560 |
Tanaka N, Patel AA, Tang L, Silver NL, Lindemann A, Takahashi H, Jaksik R, Rao X, Kalu NN, Chen TC, Wang J, Frederick MJ, Johnson F, Gleber-Netto FO, Fu S, Kimmel M, Wang J, Hittelman WN, Pickering CR, Myers JN, Osman AA. Replication Stress Leading to Apoptosis within the S-phase Contributes to Synergism between Vorinostat and AZD1775 in HNSCC Harboring High-Risk TP53 Mutation. Clin Cancer Res 2017;23:6541-54. [PMID: 28790110 DOI: 10.1158/1078-0432.CCR-17-0947] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 561 |
Rajendra S, Yang T, Xuan W, Sharma P, Pavey D, Lee CS, Le S, Collins J, Wang B. Active human papillomavirus involvement in Barrett's dysplasia and oesophageal adenocarcinoma is characterized by wild-type p53 and aberrations of the retinoblastoma protein pathway. Int J Cancer 2017;141:2037-49. [PMID: 28722212 DOI: 10.1002/ijc.30896] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 562 |
Litwin TR, Clarke MA, Dean M, Wentzensen N. Somatic Host Cell Alterations in HPV Carcinogenesis. Viruses 2017;9:E206. [PMID: 28771191 DOI: 10.3390/v9080206] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 6.8] [Reference Citation Analysis]
|
| 563 |
O'Donnell E, Markt SC, Miller R, Bernard B, Albiges L, Beard C, Sweeney C. Smoking and Disease Outcomes in Patients With Malignant Germ Cell Tumors. Clin Genitourin Cancer 2017:S1558-7673(17)30234-3. [PMID: 28851592 DOI: 10.1016/j.clgc.2017.07.024] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 564 |
Saha SK, Maiti GP, Roychoudhury S, Panda CK. Molecular progression of head and neck squamous cell carcinoma. Nucleus 2017;60:111-119. [DOI: 10.1007/s13237-017-0212-9] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 565 |
Wu P, Wu H, Tang Y, Luo S, Fang X, Xie C, He J, Zhao S, Wang X, Xu J, Chen X, Li D, Yang H, Wang J. Whole-exome sequencing reveals novel mutations and epigenetic regulation in hypopharyngeal carcinoma. Oncotarget 2017;8:85326-40. [PMID: 29156722 DOI: 10.18632/oncotarget.19674] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 566 |
Guo T, Sakai A, Afsari B, Considine M, Danilova L, Favorov AV, Yegnasubramanian S, Kelley DZ, Flam E, Ha PK, Khan Z, Wheelan SJ, Gutkind JS, Fertig EJ, Gaykalova DA, Califano J. A Novel Functional Splice Variant of AKT3 Defined by Analysis of Alternative Splice Expression in HPV-Positive Oropharyngeal Cancers. Cancer Res 2017;77:5248-58. [PMID: 28733453 DOI: 10.1158/0008-5472.CAN-16-3106] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 567 |
Nakagaki T, Tamura M, Kobashi K, Koyama R, Fukushima H, Ohashi T, Idogawa M, Ogi K, Hiratsuka H, Tokino T, Sasaki Y. Profiling cancer-related gene mutations in oral squamous cell carcinoma from Japanese patients by targeted amplicon sequencing. Oncotarget 2017;8:59113-22. [PMID: 28938622 DOI: 10.18632/oncotarget.19262] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 568 |
Kiwerska K, Szaumkessel M, Paczkowska J, Bodnar M, Byzia E, Kowal E, Kostrzewska-Poczekaj M, Janiszewska J, Bednarek K, Jarmuż-Szymczak M, Kalinowicz E, Wierzbicka M, Grenman R, Szyfter K, Marszałek A, Giefing M. Combined deletion and DNA methylation result in silencing of FAM107A gene in laryngeal tumors. Sci Rep 2017;7:5386. [PMID: 28710449 DOI: 10.1038/s41598-017-05857-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 569 |
Wichmann G, Dietz A. [Preclinical models to establish innovative therapy strategies : Ex‑vivo assessment of head and neck tumor chemo- and immune responses]. HNO 2016;64:460-9. [PMID: 27259639 DOI: 10.1007/s00106-016-0160-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 570 |
Birkeland AC, Yanik M, Tillman BN, Scott MV, Foltin SK, Mann JE, Michmerhuizen NL, Ludwig ML, Sandelski MM, Komarck CM, Carey TE, Prince ME, Bradford CR, McHugh JB, Spector ME, Brenner JC. Identification of Targetable ERBB2 Aberrations in Head and Neck Squamous Cell Carcinoma. JAMA Otolaryngol Head Neck Surg 2016;142:559-67. [PMID: 27077364 DOI: 10.1001/jamaoto.2016.0335] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 4.2] [Reference Citation Analysis]
|
| 571 |
Skinner HD, Chen Q, Elimova E, Wadhwa R, Song S, Ajani JA. Predictive Biomarkers for Therapy in Adenocarcinoma of the Upper Digestive Tract. Biomarkers in Cancer Screening and Early Detection 2017. [DOI: 10.1002/9781118468869.ch10] [Reference Citation Analysis]
|
| 572 |
Facompre ND, Sahu V, Montone KT, Harmeyer KM, Nakagawa H, Rustgi AK, Weinstein GS, Gimotty PA, Basu D. Barriers to generating PDX models of HPV-related head and neck cancer. Laryngoscope 2017;127:2777-83. [PMID: 28561270 DOI: 10.1002/lary.26679] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 573 |
Foy JP, Saintigny P, Goudot P, Schouman T, Bertolus C. The promising impact of molecular profiling on treatment strategies in oral cancers. J Stomatol Oral Maxillofac Surg 2017;118:242-7. [PMID: 28576460 DOI: 10.1016/j.jormas.2017.05.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 574 |
Hasegawa H, Kusumi Y, Asakawa T, Maeda M, Oinuma T, Furusaka T, Oshima T, Esumi M. Expression of von Hippel-Lindau tumor suppressor protein (pVHL) characteristic of tongue cancer and proliferative lesions in tongue epithelium. BMC Cancer 2017;17:381. [PMID: 28549422 DOI: 10.1186/s12885-017-3364-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 575 |
Chang J, Tan W, Ling Z, Xi R, Shao M, Chen M, Luo Y, Zhao Y, Liu Y, Huang X, Xia Y, Hu J, Parker JS, Marron D, Cui Q, Peng L, Chu J, Li H, Du Z, Han Y, Tan W, Liu Z, Zhan Q, Li Y, Mao W, Wu C, Lin D. Genomic analysis of oesophageal squamous-cell carcinoma identifies alcohol drinking-related mutation signature and genomic alterations. Nat Commun 2017;8:15290. [PMID: 28548104 DOI: 10.1038/ncomms15290] [Cited by in Crossref: 108] [Cited by in F6Publishing: 121] [Article Influence: 18.0] [Reference Citation Analysis]
|
| 576 |
Makarev E, Schubert AD, Kanherkar RR, London N, Teka M, Ozerov I, Lezhnina K, Bedi A, Ravi R, Mehra R, Hoque MO, Sloma I, Gaykalova DA, Csoka AB, Sidransky D, Zhavoronkov A, Izumchenko E. In silico analysis of pathways activation landscape in oral squamous cell carcinoma and oral leukoplakia. Cell Death Discov 2017;3:17022. [PMID: 28580171 DOI: 10.1038/cddiscovery.2017.22] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 577 |
Stucky A, Sedghizadeh PP, Mahabady S, Chen X, Zhang C, Zhang G, Zhang X, Zhong JF. Single-cell genomic analysis of head and neck squamous cell carcinoma. Oncotarget 2017;8:73208-18. [PMID: 29069864 DOI: 10.18632/oncotarget.18021] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 578 |
Ozawa H, Ranaweera RS, Izumchenko E, Makarev E, Zhavoronkov A, Fertig EJ, Howard JD, Markovic A, Bedi A, Ravi R, Perez J, Le QT, Kong CS, Jordan RC, Wang H, Kang H, Quon H, Sidransky D, Chung CH. SMAD4 Loss Is Associated with Cetuximab Resistance and Induction of MAPK/JNK Activation in Head and Neck Cancer Cells. Clin Cancer Res 2017;23:5162-75. [PMID: 28522603 DOI: 10.1158/1078-0432.CCR-16-1686] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 7.8] [Reference Citation Analysis]
|
| 579 |
Clark DJ, Mao L. Understanding the Surgical Margin: A Molecular Assessment. Oral Maxillofac Surg Clin North Am 2017;29:245-58. [PMID: 28528739 DOI: 10.1016/j.coms.2017.03.002] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 580 |
Kakizaki T, Hatakeyama H, Nakamaru Y, Takagi D, Mizumachi T, Sakashita T, Kano S, Homma A, Fukuda S. Role of microRNA-296-3p in the malignant transformation of sinonasal inverted papilloma. Oncol Lett 2017;14:987-92. [PMID: 28693263 DOI: 10.3892/ol.2017.6193] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 581 |
Wichmann G, Herchenhahn C, Boehm A, Mozet C, Hofer M, Fischer M, Kolb M, Dietz A. HLA traits linked to development of head and neck squamous cell carcinoma affect the progression-free survival of patients. Oral Oncol 2017;69:115-27. [PMID: 28559015 DOI: 10.1016/j.oraloncology.2017.04.017] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 582 |
Davidson MA, Shanks EJ. 3q26-29 Amplification in head and neck squamous cell carcinoma: a review of established and prospective oncogenes. FEBS J 2017;284:2705-31. [PMID: 28317270 DOI: 10.1111/febs.14061] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 583 |
Tabatabaeifar S, Larsen MJ, Larsen SR, Kruse TA, Thomassen M, Sørensen JA. Investigating a case of possible field cancerization in oral squamous cell carcinoma by the use of next-generation sequencing. Oral Oncology 2017;68:74-80. [DOI: 10.1016/j.oraloncology.2017.03.018] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 584 |
Perisanidis C. Prevalence of EGFR Tyrosine Kinase Domain Mutations in Head and Neck Squamous Cell Carcinoma: Cohort Study and Systematic Review. In Vivo 2017;31:23-34. [PMID: 28064216 DOI: 10.21873/invivo.11020] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 585 |
Bibault JE, Tinhofer I. The role of Next-Generation Sequencing in tumoral radiosensitivity prediction. Clin Transl Radiat Oncol 2017;3:16-20. [PMID: 29658008 DOI: 10.1016/j.ctro.2017.03.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 586 |
Kannan A, Hertweck KL, Philley JV, Wells RB, Dasgupta S. Genetic Mutation and Exosome Signature of Human Papilloma Virus Associated Oropharyngeal Cancer. Sci Rep 2017;7:46102. [PMID: 28383029 DOI: 10.1038/srep46102] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 587 |
Bradley G, Magalhaes MA, Hyrcza M. Mutational signatures in oral cancer indicate a complex role for tobacco smoke carcinogens. Oral Dis 2018;24:682-4. [PMID: 28295873 DOI: 10.1111/odi.12665] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 588 |
Ashford BG, Clark J, Gupta R, Iyer NG, Yu B, Ranson M. Reviewing the genetic alterations in high-risk cutaneous squamous cell carcinoma: A search for prognostic markers and therapeutic targets. Head Neck 2017;39:1462-9. [PMID: 28370784 DOI: 10.1002/hed.24765] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 589 |
Arunkumar G, Murugan AK, Nagarajan M, Ajay C, Rajaraman R, Munirajan AK. Absence of the frequently reported PIK3CA, CASP8, and NOTCH1 mutations in South Indian oral cancers. Oral Dis 2017;23:669-73. [PMID: 28181739 DOI: 10.1111/odi.12655] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 590 |
Wang T, Hu P, Li B, Zhang JP, Cheng YF, Liang YM. Role of Nrf2 signaling pathway in the radiation tolerance of patients with head and neck squamous cell carcinoma: an in vivo and in vitro study. Onco Targets Ther 2017;10:1809-19. [PMID: 28367064 DOI: 10.2147/OTT.S122803] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 591 |
Bauman JE, Duvvuri U, Gooding WE, Rath TJ, Gross ND, Song J, Jimeno A, Yarbrough WG, Johnson FM, Wang L, Chiosea S, Sen M, Kass J, Johnson JT, Ferris RL, Kim S, Hirsch FR, Ellison K, Flaherty JT, Mills GB, Grandis JR. Randomized, placebo-controlled window trial of EGFR, Src, or combined blockade in head and neck cancer. JCI Insight 2017;2:e90449. [PMID: 28352657 DOI: 10.1172/jci.insight.90449] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 592 |
Pandya C, Uzilov AV, Bellizzi J, Lau CY, Moe AS, Strahl M, Hamou W, Newman LC, Fink MY, Antipin Y, Yu W, Stevenson M, Cavaco BM, Teh BT, Thakker RV, Morreau H, Schadt EE, Sebra R, Li SD, Arnold A, Chen R. Genomic profiling reveals mutational landscape in parathyroid carcinomas. JCI Insight 2017;2:e92061. [PMID: 28352668 DOI: 10.1172/jci.insight.92061] [Cited by in Crossref: 51] [Cited by in F6Publishing: 55] [Article Influence: 8.5] [Reference Citation Analysis]
|
| 593 |
Oikawa Y, Morita KI, Kayamori K, Tanimoto K, Sakamoto K, Katoh H, Ishikawa S, Inazawa J, Harada H. Receptor tyrosine kinase amplification is predictive of distant metastasis in patients with oral squamous cell carcinoma. Cancer Sci 2017;108:256-66. [PMID: 27889930 DOI: 10.1111/cas.13126] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 594 |
Blaszczak W, Barczak W, Wegner A, Golusinski W, Suchorska WM. Clinical value of monoclonal antibodies and tyrosine kinase inhibitors in the treatment of head and neck squamous cell carcinoma. Med Oncol 2017;34:60. [PMID: 28315228 DOI: 10.1007/s12032-017-0918-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 595 |
Mészáros B, Kumar M, Gibson TJ, Uyar B, Dosztányi Z. Degrons in cancer. Sci Signal 2017;10:eaak9982. [DOI: 10.1126/scisignal.aak9982] [Cited by in Crossref: 68] [Cited by in F6Publishing: 69] [Article Influence: 11.3] [Reference Citation Analysis]
|
| 596 |
Vatte C, Al Amri AM, Cyrus C, Chathoth S, Acharya S, Hashim TM, Al Ali Z, Alshreadah ST, Alsayyah A, Al-Ali AK. Tyrosine kinase domain mutations of EGFR gene in head and neck squamous cell carcinoma. Onco Targets Ther 2017;10:1527-33. [PMID: 28352186 DOI: 10.2147/OTT.S132187] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 597 |
Guo T, Goldenberg D, Fakhry C. AHNS series: Do you know your guidelines? Management of head and neck cancer in the era of human papillomavirus: Educating our patients on human papillomavirus. Head Neck 2017;39:833-9. [PMID: 28263449 DOI: 10.1002/hed.24693] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 598 |
Yeudall WA, Shahoumi L. A fatter way to metastasize. Oral Dis 2018;24:679-81. [PMID: 28258602 DOI: 10.1111/odi.12664] [Reference Citation Analysis]
|
| 599 |
Bhat S, Kabekkodu SP, Jayaprakash C, Radhakrishnan R, Ray S, Satyamoorthy K. Gene promoter-associated CpG island hypermethylation in squamous cell carcinoma of the tongue. Virchows Arch 2017;470:445-54. [PMID: 28255813 DOI: 10.1007/s00428-017-2094-2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 600 |
Nowell CS, Radtke F. Notch as a tumour suppressor. Nat Rev Cancer 2017;17:145-59. [PMID: 28154375 DOI: 10.1038/nrc.2016.145] [Cited by in Crossref: 235] [Cited by in F6Publishing: 239] [Article Influence: 39.2] [Reference Citation Analysis]
|
| 601 |
Su SC, Lin CW, Liu YF, Fan WL, Chen MK, Yu CP, Yang WE, Su CW, Chuang CY, Li WH, Chung WH, Yang SF. Exome Sequencing of Oral Squamous Cell Carcinoma Reveals Molecular Subgroups and Novel Therapeutic Opportunities. Theranostics 2017;7:1088-99. [PMID: 28435450 DOI: 10.7150/thno.18551] [Cited by in Crossref: 71] [Cited by in F6Publishing: 81] [Article Influence: 11.8] [Reference Citation Analysis]
|
| 602 |
Kaka AS, Nowacki NB, Kumar B, Zhao S, Old MO, Agrawal A, Ozer E, Carrau RL, Schuller DE, Kumar P, Teknos TN. Notch1 Overexpression Correlates to Improved Survival in Cancer of the Oropharynx. Otolaryngol Head Neck Surg 2017;156:652-9. [PMID: 28195818 DOI: 10.1177/0194599816688178] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 603 |
Citron F, Armenia J, Franchin G, Polesel J, Talamini R, D'Andrea S, Sulfaro S, Croce CM, Klement W, Otasek D, Pastrello C, Tokar T, Jurisica I, French D, Bomben R, Vaccher E, Serraino D, Belletti B, Vecchione A, Barzan L, Baldassarre G. An Integrated Approach Identifies Mediators of Local Recurrence in Head and Neck Squamous Carcinoma. Clin Cancer Res 2017;23:3769-80. [PMID: 28174235 DOI: 10.1158/1078-0432.CCR-16-2814] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 604 |
Krishnan NM, Mohanraj I, Hariharan J, Panda B. CAFE MOCHA:An Integrated Platform for Discovering Clinically Relevant Molecular Changes in Cancer; an Example of Distant Metastasis and Recurrence-linked Classifiers in Head and Neck Squamous Cell Carcinoma.. [DOI: 10.1101/105577] [Reference Citation Analysis]
|
| 605 |
Yildirim M, Müller von der Grün J, Winkelmann R, Fokas E, Rödel F, Ackermann H, Rödel C, Balermpas P. Combined p16 and p53 expression in cervical cancer of unknown primary and other prognostic parameters : A single-center analysis. Strahlenther Onkol 2017;193:305-14. [PMID: 28144684 DOI: 10.1007/s00066-017-1102-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 606 |
Jeannon J, Tanaka A, Thavaraj S, Guerrero-urbano T, Mcgrath JA, Tavassoli M. ATR gene mutations in HPV negative oropharyngeal cancer. Oral Oncology 2017;65:121-3. [DOI: 10.1016/j.oraloncology.2016.12.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 607 |
Cao W, Liu JN, Liu Z, Wang X, Han ZG, Ji T, Chen WT, Zou X. A three-lncRNA signature derived from the Atlas of ncRNA in cancer (TANRIC) database predicts the survival of patients with head and neck squamous cell carcinoma. Oral Oncol 2017;65:94-101. [PMID: 28109476 DOI: 10.1016/j.oraloncology.2016.12.017] [Cited by in Crossref: 107] [Cited by in F6Publishing: 113] [Article Influence: 17.8] [Reference Citation Analysis]
|
| 608 |
Morris LGT, Chandramohan R, West L, Zehir A, Chakravarty D, Pfister DG, Wong RJ, Lee NY, Sherman EJ, Baxi SS, Ganly I, Singh B, Shah JP, Shaha AR, Boyle JO, Patel SG, Roman BR, Barker CA, McBride SM, Chan TA, Dogan S, Hyman DM, Berger MF, Solit DB, Riaz N, Ho AL. The Molecular Landscape of Recurrent and Metastatic Head and Neck Cancers: Insights From a Precision Oncology Sequencing Platform. JAMA Oncol 2017;3:244-55. [PMID: 27442865 DOI: 10.1001/jamaoncol.2016.1790] [Cited by in Crossref: 136] [Cited by in F6Publishing: 156] [Article Influence: 22.7] [Reference Citation Analysis]
|
| 609 |
Zhang M, Singh R, Peng S, Mazumdar T, Sambandam V, Shen L, Tong P, Li L, Kalu NN, Pickering CR, Frederick M, Myers JN, Wang J, Johnson FM. Mutations of the LIM protein AJUBA mediate sensitivity of head and neck squamous cell carcinoma to treatment with cell-cycle inhibitors. Cancer Lett 2017;392:71-82. [PMID: 28126323 DOI: 10.1016/j.canlet.2017.01.024] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 610 |
Ferrarotto R, Mitani Y, Diao L, Guijarro I, Wang J, Zweidler-mckay P, Bell D, William WN, Glisson BS, Wick MJ, Kapoun AM, Patnaik A, Eckhardt G, Munster P, Faoro L, Dupont J, Lee JJ, Futreal A, El-naggar AK, Heymach JV. Activating NOTCH1 Mutations Define a Distinct Subgroup of Patients With Adenoid Cystic Carcinoma Who Have Poor Prognosis, Propensity to Bone and Liver Metastasis, and Potential Responsiveness to Notch1 Inhibitors. JCO 2017;35:352-360. [DOI: 10.1200/jco.2016.67.5264] [Cited by in Crossref: 115] [Cited by in F6Publishing: 1] [Article Influence: 19.2] [Reference Citation Analysis]
|
| 611 |
Ausoni S, Boscolo-Rizzo P, Singh B, Da Mosto MC, Spinato G, Tirelli G, Spinato R, Azzarello G. Targeting cellular and molecular drivers of head and neck squamous cell carcinoma: current options and emerging perspectives. Cancer Metastasis Rev 2016;35:413-26. [PMID: 27194534 DOI: 10.1007/s10555-016-9625-1] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 612 |
Boscolo-Rizzo P, Da Mosto MC, Rampazzo E, Giunco S, Del Mistro A, Menegaldo A, Baboci L, Mantovani M, Tirelli G, De Rossi A. Telomeres and telomerase in head and neck squamous cell carcinoma: from pathogenesis to clinical implications. Cancer Metastasis Rev 2016;35:457-74. [PMID: 27501725 DOI: 10.1007/s10555-016-9633-1] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 5.7] [Reference Citation Analysis]
|
| 613 |
Ley J, Wildes TM, Daly K, Oppelt P, Adkins D. Clinical benefit of nanoparticle albumin-bound-paclitaxel in recurrent/metastatic head and neck squamous cell carcinoma resistant to cremophor-based paclitaxel or docetaxel. Med Oncol 2017;34:28. [PMID: 28078561 DOI: 10.1007/s12032-017-0884-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 614 |
Papillon-Cavanagh S, Lu C, Gayden T, Mikael LG, Bechet D, Karamboulas C, Ailles L, Karamchandani J, Marchione DM, Garcia BA, Weinreb I, Goldstein D, Lewis PW, Dancu OM, Dhaliwal S, Stecho W, Howlett CJ, Mymryk JS, Barrett JW, Nichols AC, Allis CD, Majewski J, Jabado N. Impaired H3K36 methylation defines a subset of head and neck squamous cell carcinomas. Nat Genet 2017;49:180-5. [PMID: 28067913 DOI: 10.1038/ng.3757] [Cited by in Crossref: 147] [Cited by in F6Publishing: 151] [Article Influence: 24.5] [Reference Citation Analysis]
|
| 615 |
Saladi SV, Ross K, Karaayvaz M, Tata PR, Mou H, Rajagopal J, Ramaswamy S, Ellisen LW. ACTL6A Is Co-Amplified with p63 in Squamous Cell Carcinoma to Drive YAP Activation, Regenerative Proliferation, and Poor Prognosis. Cancer Cell 2017;31:35-49. [PMID: 28041841 DOI: 10.1016/j.ccell.2016.12.001] [Cited by in Crossref: 113] [Cited by in F6Publishing: 113] [Article Influence: 18.8] [Reference Citation Analysis]
|
| 616 |
Pierssens DDCG, Borgemeester MC, van der Heijden SJH, Peutz-Kootstra CJ, Ruland AM, Haesevoets AM, Kessler PAWH, Kremer B, Speel EM. Chromosome instability in tumor resection margins of primary OSCC is a predictor of local recurrence. Oral Oncol 2017;66:14-21. [PMID: 28249643 DOI: 10.1016/j.oraloncology.2016.12.029] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 617 |
Velaithan V, Okuda KS, Ng MF, Samat N, Leong SW, Faudzi SM, Abas F, Shaari K, Cheong SC, Tan PJ, Patel V. Zebrafish phenotypic screen identifies novel Notch antagonists. Invest New Drugs 2017;35:166-79. [PMID: 28058624 DOI: 10.1007/s10637-016-0423-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 618 |
Tata P, Subramaniayan K, Suresh A, Gupta V, Bahadur U, Agrawal N. Biologic Basis of Personalized Therapy in Head and Neck Squamous Cell Carcinoma. Contemporary Oral Oncology 2017. [DOI: 10.1007/978-3-319-14911-0_12] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 619 |
Wagner J, Kline CL, El-deiry W. Resistance to TRAIL Pathway-Targeted Therapeutics in Cancer. Resistance to Targeted Anti-Cancer Therapeutics 2017. [DOI: 10.1007/978-3-319-56805-8_1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 620 |
Serrano C, Demetri GD. Cancer as a Paradigm for Translational and Clinical Biomedical Research. Clinical and Translational Science 2017. [DOI: 10.1016/b978-0-12-802101-9.00032-6] [Reference Citation Analysis]
|
| 621 |
Vazifedan V, Mousavi SH, Sargolzaei J, Soleymanifard S, Fani Pakdel A. Study of Crocin & Radiotherapy-induced Cytotoxicity and Apoptosis in the Head and Neck Cancer (HN-5) Cell Line. Iran J Pharm Res 2017;16:230-7. [PMID: 28496478] [Reference Citation Analysis]
|
| 622 |
Hoskins SP, Shyr D, Shyr Y. Sample Size Calculation for Differential Expression Analysis of RNA-Seq Data. Frontiers of Biostatistical Methods and Applications in Clinical Oncology 2017. [DOI: 10.1007/978-981-10-0126-0_22] [Reference Citation Analysis]
|
| 623 |
Monteiro L, Warnakulasuriya S. Genetic Aberrations and Molecular Pathways in Head and Neck Cancer. Squamous cell Carcinoma 2017. [DOI: 10.1007/978-94-024-1084-6_4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 624 |
Patel V, Wang Z, Chen Q, Rusling JF, Molinolo AA, Gutkind JS. Emerging Cancer Biomarkers for HNSCC Detection and Therapeutic Intervention. Contemporary Oral Oncology 2017. [DOI: 10.1007/978-3-319-14911-0_6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 625 |
Schache AG. Molecular Biology of Human Papillomavirus–Mediated Head and Neck Cancer. Maxillofacial Surgery 2017. [DOI: 10.1016/b978-0-7020-6056-4.00016-2] [Reference Citation Analysis]
|
| 626 |
Amornphimoltham P, Roth SJ, Ideker T, Silvio Gutkind J. Targeting the mTOR Signaling Circuitry in Head and Neck Cancer. Squamous cell Carcinoma 2017. [DOI: 10.1007/978-94-024-1084-6_7] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 627 |
Philips R, Pan Q. p53 in Head and Neck Squamous Cell Carcinoma. Squamous cell Carcinoma 2017. [DOI: 10.1007/978-94-024-1084-6_5] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 628 |
Jessri M, Mawardi H, Farah CS, Woo S. White and Red Lesions of the Oral Mucosa. Contemporary Oral Medicine 2017. [DOI: 10.1007/978-3-319-28100-1_16-1] [Reference Citation Analysis]
|
| 629 |
Nowell CS, Radtke F. The Two Faces of Notch in Solid Cancers. Notch Signaling 2017. [DOI: 10.1007/978-981-10-4971-2_6] [Reference Citation Analysis]
|
| 630 |
Adeegbe DO, Liu Y. Patient-Derived Xenografts in Oncology. Cancer Drug Discovery and Development 2017. [DOI: 10.1007/978-3-319-45397-2_2] [Reference Citation Analysis]
|
| 631 |
Dhanda J, Shaw RJ. The Molecular Biology of Head and Neck Cancer. Maxillofacial Surgery 2017. [DOI: 10.1016/b978-0-7020-6056-4.00014-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 632 |
Hess J. Predictive Factors for Outcome and Quality of Life in HPV-Positive and HPV-Negative HNSCC. HPV Infection in Head and Neck Cancer 2017. [DOI: 10.1007/978-3-319-43580-0_18] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 633 |
Tafe LJ. The Molecular Pathology of Head and Neck Squamous Cell Carcinoma. The Molecular Basis of Human Cancer 2017. [DOI: 10.1007/978-1-59745-458-2_32] [Reference Citation Analysis]
|
| 634 |
Kong AH. Liquid Biopsies in Head and Neck Cancer Patients. Current Clinical Pathology 2017. [DOI: 10.1007/978-3-319-55661-1_18] [Reference Citation Analysis]
|
| 635 |
Al-Amri AM, Vatte C, Cyrus C, Chathoth S, Hashim TM, Mohamed YS, Al Ali R, Alsaid A, Al Ali A. Novel mutations of PIK3CA gene in head and neck squamous cell carcinoma. Cancer Biomark 2016;16:377-83. [PMID: 26889984 DOI: 10.3233/CBM-160576] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 636 |
Ji RC. Lymph Nodes and Cancer Metastasis: New Perspectives on the Role of Intranodal Lymphatic Sinuses. Int J Mol Sci 2016;18:E51. [PMID: 28036019 DOI: 10.3390/ijms18010051] [Cited by in Crossref: 34] [Cited by in F6Publishing: 38] [Article Influence: 4.9] [Reference Citation Analysis]
|
| 637 |
Trivedi S, Rosen CA, Ferris RL. Current understanding of the tumor microenvironment of laryngeal dysplasia and progression to invasive cancer. Curr Opin Otolaryngol Head Neck Surg 2016;24:121-7. [PMID: 26963671 DOI: 10.1097/MOO.0000000000000245] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 638 |
Wei PJ, Zhang D, Xia J, Zheng CH. LNDriver: identifying driver genes by integrating mutation and expression data based on gene-gene interaction network. BMC Bioinformatics 2016;17:467. [PMID: 28155630 DOI: 10.1186/s12859-016-1332-y] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 639 |
Hoesli RC, Ludwig ML, Michmerhuizen NL, Rosko AJ, Spector ME, Brenner JC, Birkeland AC. Genomic sequencing and precision medicine in head and neck cancers. Eur J Surg Oncol 2017;43:884-92. [PMID: 28034498 DOI: 10.1016/j.ejso.2016.12.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 640 |
Hernandes C, Pereira AMS, Severino P. Compounds From Celastraceae Targeting Cancer Pathways and Their Potential Application in Head and Neck Squamous Cell Carcinoma: A Review. Curr Genomics 2017;18:60-74. [PMID: 28503090 DOI: 10.2174/1389202917666160803160934] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 641 |
Goh G, Walradt T, Markarov V, Blom A, Riaz N, Doumani R, Stafstrom K, Moshiri A, Yelistratova L, Levinsohn J, Chan TA, Nghiem P, Lifton RP, Choi J. Mutational landscape of MCPyV-positive and MCPyV-negative Merkel cell carcinomas with implications for immunotherapy. Oncotarget 2016;7:3403-15. [PMID: 26655088 DOI: 10.18632/oncotarget.6494] [Cited by in Crossref: 238] [Cited by in F6Publishing: 252] [Article Influence: 34.0] [Reference Citation Analysis]
|
| 642 |
Song B, Cui H, Li Y, Cheng C, Yang B, Wang F, Kong P, Li H, Zhang L, Jia Z, Bi Y, Wang J, Zhou Y, Liu J, Wang J, Zhao Z, Zhang Y, Hu X, Shi R, Yang J, Liu H, Yan T, Li Y, Xu E, Qian Y, Xi Y, Guo S, Chen Y, Wang J, Li G, Liang J, Jia J, Chen X, Guo J, Wang T, Zhang Y, Li Q, Wang C, Cheng X, Zhan Q, Cui Y. Mutually exclusive mutations in NOTCH1 and PIK3CA associated with clinical prognosis and chemotherapy responses of esophageal squamous cell carcinoma in China. Oncotarget. 2016;7:3599-3613. [PMID: 26528858 DOI: 10.18632/oncotarget.6120] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 643 |
Aster JC, Pear WS, Blacklow SC. The Varied Roles of Notch in Cancer. Annu Rev Pathol. 2017;12:245-275. [PMID: 27959635 DOI: 10.1146/annurev-pathol-052016-100127] [Cited by in Crossref: 342] [Cited by in F6Publishing: 367] [Article Influence: 48.9] [Reference Citation Analysis]
|
| 644 |
Kim YS, Kim C. The Prospect and Issue of Anticancer Therapy in Head and Neck Cancer. J Clin Otolaryngol Head Neck Surg 2016;27:239-245. [DOI: 10.35420/jcohns.2016.27.2.239] [Reference Citation Analysis]
|
| 645 |
Schiffman M, Doorbar J, Wentzensen N, de Sanjosé S, Fakhry C, Monk BJ, Stanley MA, Franceschi S. Carcinogenic human papillomavirus infection. Nat Rev Dis Primers 2016;2:16086. [PMID: 27905473 DOI: 10.1038/nrdp.2016.86] [Cited by in Crossref: 438] [Cited by in F6Publishing: 448] [Article Influence: 62.6] [Reference Citation Analysis]
|
| 646 |
Ribeiro IP, Barroso L, Marques F, Melo JB, Carreira IM. Early detection and personalized treatment in oral cancer: the impact of omics approaches. Mol Cytogenet 2016;9:85. [PMID: 27895714 DOI: 10.1186/s13039-016-0293-1] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 647 |
Ferrarotto R, Mitani Y, Diao L, Guijarro I, Wang J, Zweidler-McKay P, Bell D, William WN Jr, Glisson BS, Wick MJ, Kapoun AM, Patnaik A, Eckhardt G, Munster P, Faoro L, Dupont J, Lee JJ, Futreal A, El-Naggar AK, Heymach JV. Activating NOTCH1 Mutations Define a Distinct Subgroup of Patients With Adenoid Cystic Carcinoma Who Have Poor Prognosis, Propensity to Bone and Liver Metastasis, and Potential Responsiveness to Notch1 Inhibitors. J Clin Oncol 2017;35:352-60. [PMID: 27870570 DOI: 10.1200/JCO.2016.67.5264] [Cited by in Crossref: 105] [Cited by in F6Publishing: 113] [Article Influence: 15.0] [Reference Citation Analysis]
|
| 648 |
Peyser ND, Pendleton K, Gooding WE, Lui VW, Johnson DE, Grandis JR. Genomic and Transcriptomic Alterations Associated with STAT3 Activation in Head and Neck Cancer. PLoS One 2016;11:e0166185. [PMID: 27855189 DOI: 10.1371/journal.pone.0166185] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 649 |
Hess J, Unger K, Orth M, Schötz U, Schüttrumpf L, Zangen V, Gimenez-Aznar I, Michna A, Schneider L, Stamp R, Selmansberger M, Braselmann H, Hieber L, Drexler GA, Kuger S, Klein D, Jendrossek V, Friedl AA, Belka C, Zitzelsberger H, Lauber K. Genomic amplification of Fanconi anemia complementation group A (FancA) in head and neck squamous cell carcinoma (HNSCC): Cellular mechanisms of radioresistance and clinical relevance. Cancer Lett 2017;386:87-99. [PMID: 27867017 DOI: 10.1016/j.canlet.2016.11.014] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 650 |
Chang YS, Lin CY, Yang SF, Ho CM, Chang JG. High-resolution Melting Analysis for Gene Scanning of Adenomatous Polyposis Coli (APC) Gene With Oral Squamous Cell Carcinoma Samples. Appl Immunohistochem Mol Morphol 2016;24:97-104. [PMID: 26447891 DOI: 10.1097/PAI.0000000000000158] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 651 |
Cirillo N, Hassona Y, Celentano A, Lim K, Manchella S, Parkinson E, Prime S. Cancer-associated fibroblasts regulate keratinocyte cell–cell adhesion via TGF-β-dependent pathways in genotype-specific oral cancer. CARCIN 2017;38:76-85. [DOI: 10.1093/carcin/bgw113] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 4.9] [Reference Citation Analysis]
|
| 652 |
Ferrarotto R, Heymach JV, Glisson BS. MYB-fusions and other potential actionable targets in adenoid cystic carcinoma. Curr Opin Oncol 2016;28:195-200. [PMID: 26974847 DOI: 10.1097/CCO.0000000000000280] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 653 |
Ma L, Cui J, Xi H, Bian S, Wei B, Chen L. Fat4 suppression induces Yap translocation accounting for the promoted proliferation and migration of gastric cancer cells. Cancer Biol Ther 2016;17:36-47. [PMID: 26575609 DOI: 10.1080/15384047.2015.1108488] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 654 |
Wang Y, Yu S, Huang D, Cui M, Hu H, Zhang L, Wang W, Parameswaran N, Jackson M, Osborne B, Bedogni B, Li C, Sy MS, Xin W, Zhou L. Cellular Prion Protein Mediates Pancreatic Cancer Cell Survival and Invasion through Association with and Enhanced Signaling of Notch1. Am J Pathol 2016;186:2945-56. [PMID: 27639164 DOI: 10.1016/j.ajpath.2016.07.010] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 655 |
Simonik EA, Cai Y, Kimmelshue KN, Brantley-Sieders DM, Loomans HA, Andl CD, Westlake GM, Youngblood VM, Chen J, Yarbrough WG, Brown BT, Nagarajan L, Brandt SJ. LIM-Only Protein 4 (LMO4) and LIM Domain Binding Protein 1 (LDB1) Promote Growth and Metastasis of Human Head and Neck Cancer (LMO4 and LDB1 in Head and Neck Cancer). PLoS One 2016;11:e0164804. [PMID: 27780223 DOI: 10.1371/journal.pone.0164804] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 656 |
Worsham MJ, Chen KM, Datta I, Stephen JK, Chitale D, Gothard A, Divine G. The biological significance of methylome differences in human papilloma virus associated head and neck cancer. Oncol Lett 2016;12:4949-56. [PMID: 28101231 DOI: 10.3892/ol.2016.5303] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 657 |
Mandal R, Şenbabaoğlu Y, Desrichard A, Havel JJ, Dalin MG, Riaz N, Lee KW, Ganly I, Hakimi AA, Chan TA, Morris LG. The head and neck cancer immune landscape and its immunotherapeutic implications. JCI Insight 2016;1:e89829. [PMID: 27777979 DOI: 10.1172/jci.insight.89829] [Cited by in Crossref: 388] [Cited by in F6Publishing: 407] [Article Influence: 55.4] [Reference Citation Analysis]
|
| 658 |
Franco T, Trapasso S, Puzzo L, Allegra E. Electronic Cigarette: Role in the Primary Prevention of Oral Cavity Cancer. Clin Med Insights Ear Nose Throat 2016;9:7-12. [PMID: 27773997 DOI: 10.4137/CMENT.S40364] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 659 |
Sampath K, Robertson EJ. Keeping a lid on nodal: transcriptional and translational repression of nodal signalling. Open Biol 2016;6:150200. [PMID: 26791244 DOI: 10.1098/rsob.150200] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 660 |
Bhowmik A, Das S, Bhattacharjee A, Choudhury B, Naiding M, Ghosh SK, Choudhury Y. BRCA1 and MDM2 as independent blood-based biomarkers of head and neck cancer. Tumour Biol 2016. [PMID: 27714671 DOI: 10.1007/s13277-016-5359-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 661 |
Stoyanova T, Riedinger M, Lin S, Faltermeier CM, Smith BA, Zhang KX, Going CC, Goldstein AS, Lee JK, Drake JM, Rice MA, Hsu EC, Nowroozizadeh B, Castor B, Orellana SY, Blum SM, Cheng D, Pienta KJ, Reiter RE, Pitteri SJ, Huang J, Witte ON. Activation of Notch1 synergizes with multiple pathways in promoting castration-resistant prostate cancer. Proc Natl Acad Sci U S A 2016;113:E6457-66. [PMID: 27694579 DOI: 10.1073/pnas.1614529113] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 662 |
Tinhofer I, Stenzinger A, Eder T, Konschak R, Niehr F, Endris V, Distel L, Hautmann MG, Mandic R, Stromberger C, Weichert W, Budach V. Targeted next-generation sequencing identifies molecular subgroups in squamous cell carcinoma of the head and neck with distinct outcome after concurrent chemoradiation. Ann Oncol 2016;27:2262-8. [PMID: 27681865 DOI: 10.1093/annonc/mdw426] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 663 |
Hayes TF, Benaich N, Goldie SJ, Sipilä K, Ames-Draycott A, Cai W, Yin G, Watt FM. Integrative genomic and functional analysis of human oral squamous cell carcinoma cell lines reveals synergistic effects of FAT1 and CASP8 inactivation. Cancer Lett 2016;383:106-14. [PMID: 27693639 DOI: 10.1016/j.canlet.2016.09.014] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 664 |
Sakamoto K. Notch signaling in oral squamous neoplasia. Pathol Int 2016;66:609-17. [PMID: 27671927 DOI: 10.1111/pin.12461] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 665 |
Li Z, Gonzalez CL, Wang B, Zhang Y, Mejia O, Katsonis P, Lichtarge O, Myers JN, El-naggar AK, Caulin C. Cdkn2a suppresses metastasis in squamous cell carcinomas induced by the gain-of-function mutant p53 R172H: Mutant p53 and Cdkn2a deletion induce metastatic SCCs. J Pathol 2016;240:224-34. [DOI: 10.1002/path.4770] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 666 |
Kitade S, Onoyama I, Kobayashi H, Yagi H, Yoshida S, Kato M, Tsunematsu R, Asanoma K, Sonoda K, Wake N, Hata K, Nakayama KI, Kato K. FBXW7 is involved in the acquisition of the malignant phenotype in epithelial ovarian tumors. Cancer Sci 2016;107:1399-405. [PMID: 27486687 DOI: 10.1111/cas.13026] [Cited by in Crossref: 30] [Cited by in F6Publishing: 34] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 667 |
Faden DL, Arron ST, Heaton CM, DeRisi J, South AP, Wang SJ. Targeted next-generation sequencing of TP53 in oral tongue carcinoma from non-smokers. J Otolaryngol Head Neck Surg 2016;45:47. [PMID: 27640185 DOI: 10.1186/s40463-016-0160-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 668 |
Keysar SB, Le PN, Miller B, Jackson BC, Eagles JR, Nieto C, Kim J, Tang B, Glogowska MJ, Morton JJ, Padilla-Just N, Gomez K, Warnock E, Reisinger J, Arcaroli JJ, Messersmith WA, Wakefield LM, Gao D, Tan AC, Serracino H, Vasiliou V, Roop DR, Wang XJ, Jimeno A. Regulation of Head and Neck Squamous Cancer Stem Cells by PI3K and SOX2. J Natl Cancer Inst. 2017;109:djw189. [PMID: 27634934 DOI: 10.1093/jnci/djw189] [Cited by in Crossref: 69] [Cited by in F6Publishing: 74] [Article Influence: 9.9] [Reference Citation Analysis]
|
| 669 |
Wang Y, Yu S, Huang D, Cui M, Hu H, Zhang L, Wang W, Parameswaran N, Jackson M, Osborne B, Bedogni B, Li C, Sy MS, Xin W, Zhou L. Cellular Prion Protein Mediates Pancreatic Cancer Cell Survival and Invasion through Association with and Enhanced Signaling of Notch1. Am J Pathol 2016;186:2945-56. [PMID: 27639164 DOI: 10.1016/j.ajpath.2016.07.010] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 670 |
Kranjec C, Doorbar J. Human papillomavirus infection and induction of neoplasia: a matter of fitness. Curr Opin Virol 2016;20:129-36. [PMID: 27600900 DOI: 10.1016/j.coviro.2016.08.011] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 671 |
Bhide SA, Thway K, Lee J, Wong K, Clarke P, Newbold KL, Nutting CM, Harrington KJ. Delayed DNA double-strand break repair following platin-based chemotherapy predicts treatment response in head and neck squamous cell carcinoma. Br J Cancer 2016;115:825-30. [PMID: 27584664 DOI: 10.1038/bjc.2016.266] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 672 |
Chitsazzadeh V, Coarfa C, Drummond JA, Nguyen T, Joseph A, Chilukuri S, Charpiot E, Adelmann CH, Ching G, Nguyen TN, Nicholas C, Thomas VD, Migden M, MacFarlane D, Thompson E, Shen J, Takata Y, McNiece K, Polansky MA, Abbas HA, Rajapakshe K, Gower A, Spira A, Covington KR, Xiao W, Gunaratne P, Pickering C, Frederick M, Myers JN, Shen L, Yao H, Su X, Rapini RP, Wheeler DA, Hawk ET, Flores ER, Tsai KY. Cross-species identification of genomic drivers of squamous cell carcinoma development across preneoplastic intermediates. Nat Commun 2016;7:12601. [PMID: 27574101 DOI: 10.1038/ncomms12601] [Cited by in Crossref: 89] [Cited by in F6Publishing: 92] [Article Influence: 12.7] [Reference Citation Analysis]
|
| 673 |
Michmerhuizen NL, Birkeland AC, Bradford CR, Brenner JC. Genetic determinants in head and neck squamous cell carcinoma and their influence on global personalized medicine. Genes Cancer 2016;7:182-200. [PMID: 27551333 DOI: 10.18632/genesandcancer.110] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 674 |
Lan X, Gao H, Wang F, Feng J, Bai J, Zhao P, Cao L, Gui S, Gong L, Zhang Y. Whole-exome sequencing identifies variants in invasive pituitary adenomas. Oncol Lett 2016;12:2319-28. [PMID: 27698795 DOI: 10.3892/ol.2016.5029] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 675 |
Katzav S. Vav1: A Dr. Jekyll and Mr. Hyde protein--good for the hematopoietic system, bad for cancer. Oncotarget 2015;6:28731-42. [PMID: 26353933 DOI: 10.18632/oncotarget.5086] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 676 |
Gotea V, Gartner JJ, Qutob N, Elnitski L, Samuels Y. The functional relevance of somatic synonymous mutations in melanoma and other cancers. Pigment Cell Melanoma Res 2015;28:673-84. [PMID: 26300548 DOI: 10.1111/pcmr.12413] [Cited by in Crossref: 41] [Cited by in F6Publishing: 44] [Article Influence: 5.9] [Reference Citation Analysis]
|
| 677 |
Morita S, Nakamaru Y, Homma A, Yasukawa S, Hatakeyama H, Sakashita T, Kano S, Fukuda A, Fukuda S. Expression of p53, p16, cyclin D1, epidermal growth factor receptor and Notch1 in patients with temporal bone squamous cell carcinoma. Int J Clin Oncol 2017;22:181-9. [PMID: 27488595 DOI: 10.1007/s10147-016-1026-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 678 |
Upadhyay P, Nair S, Kaur E, Aich J, Dani P, Sethunath V, Gardi N, Chandrani P, Godbole M, Sonawane K, Prasad R, Kannan S, Agarwal B, Kane S, Gupta S, Dutt S, Dutt A. Notch pathway activation is essential for maintenance of stem-like cells in early tongue cancer. Oncotarget 2016;7:50437-49. [PMID: 27391340 DOI: 10.18632/oncotarget.10419] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 679 |
Lim YH, Fisher JM, Bosenberg MW, Choate KA, Ko CJ. Keratoacanthoma Shares Driver Mutations with Cutaneous Squamous Cell Carcinoma. Journal of Investigative Dermatology 2016;136:1737-41. [DOI: 10.1016/j.jid.2016.04.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 680 |
Adkins D, Ley J, Michel L, Wildes TM, Thorstad W, Gay HA, Daly M, Rich J, Paniello R, Uppaluri R, Jackson R, Trinkaus K, Nussenbaum B. nab-Paclitaxel, cisplatin, and 5-fluorouracil followed by concurrent cisplatin and radiation for head and neck squamous cell carcinoma. Oral Oncol 2016;61:1-7. [PMID: 27688097 DOI: 10.1016/j.oraloncology.2016.07.015] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 681 |
Mroz EA, Rocco JW. Intra-tumor heterogeneity in head and neck cancer and its clinical implications. World J Otorhinolaryngol Head Neck Surg 2016;2:60-7. [PMID: 28642939 DOI: 10.1016/j.wjorl.2016.05.007] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 682 |
Yu H, Takeuchi H, Takeuchi M, Liu Q, Kantharia J, Haltiwanger RS, Li H. Structural analysis of Notch-regulating Rumi reveals basis for pathogenic mutations. Nat Chem Biol 2016;12:735-40. [PMID: 27428513 DOI: 10.1038/nchembio.2135] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.9] [Reference Citation Analysis]
|
| 683 |
Birkeland AC, Swiecicki PL, Brenner JC, Shuman AG. A review of drugs in development for the personalized treatment of head and neck squamous cell carcinoma. Expert Rev Precis Med Drug Dev 2016;1:379-85. [PMID: 28251187 DOI: 10.1080/23808993.2016.1208050] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 684 |
Campbell NP, Hensing TA, Bhayani MK, Shaikh AY, Brockstein BE. Targeting pathways mediating resistance to anti-EGFR therapy in squamous cell carcinoma of the head and neck. Expert Rev Anticancer Ther 2016;16:847-58. [PMID: 27400139 DOI: 10.1080/14737140.2016.1202116] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 685 |
Chen LH, Hsu WL, Tseng YJ, Liu DW, Weng CF. Involvement of DNMT 3B promotes epithelial-mesenchymal transition and gene expression profile of invasive head and neck squamous cell carcinomas cell lines. BMC Cancer 2016;16:431. [PMID: 27391030 DOI: 10.1186/s12885-016-2468-x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 4.1] [Reference Citation Analysis]
|
| 686 |
Udager AM, Mchugh JB, Betz BL, Montone KT, Livolsi VA, Seethala RR, Yakirevich E, Iwenofu OH, Perez-ordonez B, Duross KE, Weigelin HC, Lim MS, Elenitoba-johnson KS, Brown NA. Activating KRAS mutations are characteristic of oncocytic sinonasal papilloma and associated sinonasal squamous cell carcinoma: KRAS -mutated oncocytic sinonasal tumours. J Pathol 2016;239:394-8. [DOI: 10.1002/path.4750] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 5.7] [Reference Citation Analysis]
|
| 687 |
Flores A, Grant W, White AC, Scumpia P, Takahashi R, Lowry WE. Tumor suppressor identity can contribute to heterogeneity of phenotype in hair follicle stem cell-induced squamous cell carcinoma. Exp Dermatol 2016;25:733-5. [PMID: 27095696 DOI: 10.1111/exd.13037] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 688 |
Nagarajan A, Malvi P, Wajapeyee N. Oncogene-directed alterations in cancer cell metabolism. Trends Cancer 2016;2:365-77. [PMID: 27822561 DOI: 10.1016/j.trecan.2016.06.002] [Cited by in Crossref: 103] [Cited by in F6Publishing: 109] [Article Influence: 14.7] [Reference Citation Analysis]
|
| 689 |
Sano D, Oridate N. The molecular mechanism of human papillomavirus-induced carcinogenesis in head and neck squamous cell carcinoma. Int J Clin Oncol 2016;21:819-26. [DOI: 10.1007/s10147-016-1005-x] [Cited by in Crossref: 46] [Cited by in F6Publishing: 52] [Article Influence: 6.6] [Reference Citation Analysis]
|
| 690 |
Monteiro de Oliveira Novaes JA, William WN Jr. Prognostic factors, predictive markers and cancer biology: the triad for successful oral cancer chemoprevention. Future Oncol 2016;12:2379-86. [PMID: 27329013 DOI: 10.2217/fon-2016-0168] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 691 |
Fuereder T. Immunotherapy for head and neck squamous cell carcinoma. Memo 2016;9:66-9. [PMID: 27429658 DOI: 10.1007/s12254-016-0270-8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 692 |
Byrd KM, Lough KJ, Patel JH, Descovich CP, Curtis TA, Williams SE. LGN plays distinct roles in oral epithelial stratification, filiform papilla morphogenesis and hair follicle development. Development 2016;143:2803-17. [PMID: 27317810 DOI: 10.1242/dev.136010] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 693 |
Zaoui K, Doll J, Stiebi P, Federspil P, Plinkert PK, Hess J. Diabetes mellitus als prognostischer Marker beim Oropharynx- und Larynxkarzinom. HNO 2016;64:479-86. [DOI: 10.1007/s00106-016-0177-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 694 |
Wirth M, Doescher J, Jira D, Meier MA, Piontek G, Reiter R, Schlegel J, Pickhard A. HES1 mRNA expression is associated with survival in sinonasal squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol 2016;122:491-9. [PMID: 27567696 DOI: 10.1016/j.oooo.2016.05.023] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 695 |
Aung KL, Siu LL. Genomically personalized therapy in head and neck cancer. Cancers Head Neck 2016;1:2. [PMID: 31093332 DOI: 10.1186/s41199-016-0004-y] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 696 |
Zhou G, Liu Z, Myers JN. TP53 Mutations in Head and Neck Squamous Cell Carcinoma and Their Impact on Disease Progression and Treatment Response. J Cell Biochem 2016;117:2682-92. [PMID: 27166782 DOI: 10.1002/jcb.25592] [Cited by in Crossref: 154] [Cited by in F6Publishing: 164] [Article Influence: 22.0] [Reference Citation Analysis]
|
| 697 |
Beck TN, Golemis EA. Genomic insights into head and neck cancer. Cancers Head Neck 2016;1:1. [PMID: 29034103 DOI: 10.1186/s41199-016-0003-z] [Cited by in Crossref: 47] [Cited by in F6Publishing: 53] [Article Influence: 6.7] [Reference Citation Analysis]
|
| 698 |
Ortiz-martínez F, Gutiérrez-aviñó FJ, Sanmartín E, Pomares-navarro E, Villalba-riquelme C, García-martínez A, Lerma E, Peiró G. Association of Notch pathway down-regulation with Triple Negative/Basal-like breast carcinomas and high tumor-infiltrating FOXP3+ Tregs. Experimental and Molecular Pathology 2016;100:460-8. [DOI: 10.1016/j.yexmp.2016.04.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 699 |
Michel L, Ley J, Wildes TM, Schaffer A, Robinson A, Chun SE, Lee W, Lewis J Jr, Trinkaus K, Adkins D. Phase I trial of palbociclib, a selective cyclin dependent kinase 4/6 inhibitor, in combination with cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma. Oral Oncol 2016;58:41-8. [PMID: 27311401 DOI: 10.1016/j.oraloncology.2016.05.011] [Cited by in Crossref: 59] [Cited by in F6Publishing: 65] [Article Influence: 8.4] [Reference Citation Analysis]
|
| 700 |
Zhang M, Biswas S, Qin X, Gong W, Deng W, Yu H. Does Notch play a tumor suppressor role across diverse squamous cell carcinomas? Cancer Med 2016;5:2048-60. [PMID: 27228302 DOI: 10.1002/cam4.731] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 701 |
Cacheux W, Rouleau E, Briaux A, Tsantoulis P, Mariani P, Richard-Molard M, Buecher B, Dangles-Marie V, Richon S, Lazartigues J, Jeannot E, Farkhondeh F, Sastre-Garau X, de La Rochefordière A, Labib A, Falcou MC, Stevens D, Roth A, Roman-Roman S, Mitry E, Bièche I, Lièvre A. Mutational analysis of anal cancers demonstrates frequent PIK3CA mutations associated with poor outcome after salvage abdominoperineal resection. Br J Cancer 2016;114:1387-94. [PMID: 27219019 DOI: 10.1038/bjc.2016.144] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 4.4] [Reference Citation Analysis]
|
| 702 |
Chen SJ, Liu H, Liao CT, Huang PJ, Huang Y, Hsu A, Tang P, Chang YS, Chen HC, Yen TC. Ultra-deep targeted sequencing of advanced oral squamous cell carcinoma identifies a mutation-based prognostic gene signature. Oncotarget 2015;6:18066-80. [PMID: 25980437 DOI: 10.18632/oncotarget.3768] [Cited by in Crossref: 35] [Cited by in F6Publishing: 42] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 703 |
Ye Q, Jiang J, Zhan G, Yan W, Huang L, Hu Y, Su H, Tong Q, Yue M, Li H, Yao G, Zhang Y, Liu H. Small molecule activation of NOTCH signaling inhibits acute myeloid leukemia. Sci Rep 2016;6:26510. [PMID: 27211848 DOI: 10.1038/srep26510] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 704 |
Guo T, Eisele DW, Fakhry C. The potential impact of prophylactic human papillomavirus vaccination on oropharyngeal cancer. Cancer. 2016;122:2313-2323. [PMID: 27152637 DOI: 10.1002/cncr.29992] [Cited by in Crossref: 55] [Cited by in F6Publishing: 61] [Article Influence: 7.9] [Reference Citation Analysis]
|
| 705 |
Flippot R, Malouf GG, Su X, Khayat D, Spano JP. Oncogenic viruses: Lessons learned using next-generation sequencing technologies. Eur J Cancer 2016;61:61-8. [PMID: 27156225 DOI: 10.1016/j.ejca.2016.03.086] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 706 |
Ludwig ML, Birkeland AC, Hoesli R, Swiecicki P, Spector ME, Brenner JC. Changing the paradigm: the potential for targeted therapy in laryngeal squamous cell carcinoma. Cancer Biol Med 2016;13:87-100. [PMID: 27144065 DOI: 10.28092/j.issn.2095-3941.2016.0010] [Cited by in F6Publishing: 16] [Reference Citation Analysis]
|
| 707 |
Petljak M, Alexandrov LB. Understanding mutagenesis through delineation of mutational signatures in human cancer. CARCIN 2016;37:531-40. [DOI: 10.1093/carcin/bgw055] [Cited by in Crossref: 74] [Cited by in F6Publishing: 71] [Article Influence: 10.6] [Reference Citation Analysis]
|
| 708 |
Shen J, Tsoi H, Liang Q, Chu ES, Liu D, Yu AC, Chan TF, Li X, Sung JJ, Wong VW, Yu J. Oncogenic mutations and dysregulated pathways in obesity-associated hepatocellular carcinoma. Oncogene 2016;35:6271-80. [PMID: 27132506 DOI: 10.1038/onc.2016.162] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 709 |
Lee SH, Do SI, Lee HJ, Kang HJ, Koo BS, Lim YC. Notch1 signaling contributes to stemness in head and neck squamous cell carcinoma. Lab Invest 2016;96:508-16. [PMID: 26927514 DOI: 10.1038/labinvest.2015.163] [Cited by in Crossref: 38] [Cited by in F6Publishing: 42] [Article Influence: 5.4] [Reference Citation Analysis]
|
| 710 |
Wagner VP, Webber LP, Salvadori G, Meurer L, Fonseca FP, Castilho RM, Squarize CH, Vargas PA, Martins MD. Overexpression of MutSα Complex Proteins Predicts Poor Prognosis in Oral Squamous Cell Carcinoma. Medicine (Baltimore) 2016;95:e3725. [PMID: 27258499 DOI: 10.1097/MD.0000000000003725] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 711 |
Kayamori K, Katsube K, Sakamoto K, Ohyama Y, Hirai H, Yukimori A, Ohata Y, Akashi T, Saitoh M, Harada K, Harada H, Yamaguchi A. NOTCH3 Is Induced in Cancer-Associated Fibroblasts and Promotes Angiogenesis in Oral Squamous Cell Carcinoma. PLoS One 2016;11:e0154112. [PMID: 27124156 DOI: 10.1371/journal.pone.0154112] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 4.9] [Reference Citation Analysis]
|
| 712 |
Rudy SF, Brenner JC, Harris JL, Liu J, Che J, Scott MV, Owen JH, Komarck CM, Graham MP, Bellile EL, Bradford CR, Prince ME, Carey TE. In vivo Wnt pathway inhibition of human squamous cell carcinoma growth and metastasis in the chick chorioallantoic model. J Otolaryngol Head Neck Surg 2016;45:26. [PMID: 27117272 DOI: 10.1186/s40463-016-0140-8] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 713 |
Zhao ZL, Zhang L, Huang CF, Ma SR, Bu LL, Liu JF, Yu GT, Liu B, Gutkind JS, Kulkarni AB, Zhang WF, Sun ZJ. NOTCH1 inhibition enhances the efficacy of conventional chemotherapeutic agents by targeting head neck cancer stem cell. Sci Rep 2016;6:24704. [PMID: 27108536 DOI: 10.1038/srep24704] [Cited by in Crossref: 58] [Cited by in F6Publishing: 63] [Article Influence: 8.3] [Reference Citation Analysis]
|
| 714 |
Bossi P, Alfieri S. Investigational drugs for head and neck cancer. Expert Opinion on Investigational Drugs 2016;25:797-810. [DOI: 10.1080/13543784.2016.1175435] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 715 |
Gasc C, Peyretaillade E, Peyret P. Sequence capture by hybridization to explore modern and ancient genomic diversity in model and nonmodel organisms. Nucleic Acids Res 2016;44:4504-18. [PMID: 27105841 DOI: 10.1093/nar/gkw309] [Cited by in Crossref: 58] [Cited by in F6Publishing: 59] [Article Influence: 8.3] [Reference Citation Analysis]
|
| 716 |
Psyrri A, Seiwert TY, Jimeno A. Molecular pathways in head and neck cancer: EGFR, PI3K, and more. Am Soc Clin Oncol Educ Book 2013;:246-55. [PMID: 23714515 DOI: 10.14694/EdBook_AM.2013.33.246] [Cited by in Crossref: 15] [Cited by in F6Publishing: 37] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 717 |
Kumar R, Juillerat-jeanneret L, Golshayan D. Notch Antagonists: Potential Modulators of Cancer and Inflammatory Diseases. J Med Chem 2016;59:7719-37. [DOI: 10.1021/acs.jmedchem.5b01516] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 718 |
Seldon CS, Colbert LE, Hall WA, Fisher SB, Yu DS, Landry JC. Chromodomain-helicase-DNA binding protein 5, 7 and pronecrotic mixed lineage kinase domain-like protein serve as potential prognostic biomarkers in patients with resected pancreatic adenocarcinomas. World J Gastrointest Oncol 2016; 8(4): 358-365 [PMID: 27096031 DOI: 10.4251/wjgo.v8.i4.358] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 719 |
Crabtree JS, Singleton CS, Miele L. Notch Signaling in Neuroendocrine Tumors. Front Oncol. 2016;6:94. [PMID: 27148486 DOI: 10.3389/fonc.2016.00094] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 6.1] [Reference Citation Analysis]
|
| 720 |
Li J, Batcha AM, Grüning B, Mansmann UR. An NGS Workflow Blueprint for DNA Sequencing Data and Its Application in Individualized Molecular Oncology. Cancer Inform 2015;14:87-107. [PMID: 27081306 DOI: 10.4137/CIN.S30793] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 721 |
Liu YF, Chiang SL, Lin CY, Chang JG, Chung CM, Ko AM, Lin YZ, Lee CH, Lee KW, Chen MK, Hua CH, Tsai MH, Chen YC, Ko YC. Somatic Mutations and Genetic Variants of NOTCH1 in Head and Neck Squamous Cell Carcinoma Occurrence and Development. Sci Rep 2016;6:24014. [PMID: 27035284 DOI: 10.1038/srep24014] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 722 |
Bradley PJ. Laryngeal cancer in nondrinker nonsmoker young patients: a distinct pathological entity? Current Opinion in Otolaryngology & Head and Neck Surgery 2016;24:140-7. [DOI: 10.1097/moo.0000000000000230] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 723 |
Tinhofer I, Budach V, Saki M, Konschak R, Niehr F, Jöhrens K, Weichert W, Linge A, Lohaus F, Krause M, Neumann K, Endris V, Sak A, Stuschke M, Balermpas P, Rödel C, Avlar M, Grosu A, Abdollahi A, Debus J, Belka C, Pigorsch S, Combs S, Mönnich D, Zips D, Baumann M. Targeted next-generation sequencing of locally advanced squamous cell carcinomas of the head and neck reveals druggable targets for improving adjuvant chemoradiation. European Journal of Cancer 2016;57:78-86. [DOI: 10.1016/j.ejca.2016.01.003] [Cited by in Crossref: 53] [Cited by in F6Publishing: 55] [Article Influence: 7.6] [Reference Citation Analysis]
|
| 724 |
Skinner HD, Giri U, Yang L, Woo SH, Story MD, Pickering CR, Byers LA, Williams MD, El-Naggar A, Wang J, Diao L, Shen L, Fan YH, Molkentine DP, Beadle BM, Meyn RE, Myers JN, Heymach JV. Proteomic Profiling Identifies PTK2/FAK as a Driver of Radioresistance in HPV-negative Head and Neck Cancer. Clin Cancer Res 2016;22:4643-50. [PMID: 27036135 DOI: 10.1158/1078-0432.CCR-15-2785] [Cited by in Crossref: 45] [Cited by in F6Publishing: 53] [Article Influence: 6.4] [Reference Citation Analysis]
|
| 725 |
Nakano T, Yamamoto H, Nakashima T, Nishijima T, Satoh M, Hatanaka Y, Shiratsuchi H, Yasumatsu R, Toh S, Komune S, Oda Y. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma. Human Pathology 2016;50:51-61. [DOI: 10.1016/j.humpath.2015.11.001] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 726 |
Guo T, Gaykalova DA, Considine M, Wheelan S, Pallavajjala A, Bishop JA, Westra WH, Ideker T, Koch WM, Khan Z, Fertig EJ, Califano JA. Characterization of functionally active gene fusions in human papillomavirus related oropharyngeal squamous cell carcinoma. Int J Cancer 2016;139:373-82. [PMID: 26949921 DOI: 10.1002/ijc.30081] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 5.4] [Reference Citation Analysis]
|
| 727 |
Van Allen EM, Lui VW, Egloff AM, Goetz EM, Li H, Johnson JT, Duvvuri U, Bauman JE, Stransky N, Zeng Y, Gilbert BR, Pendleton KP, Wang L, Chiosea S, Sougnez C, Wagle N, Zhang F, Du Y, Close D, Johnston PA, McKenna A, Carter SL, Golub TR, Getz G, Mills GB, Garraway LA, Grandis JR. Genomic Correlate of Exceptional Erlotinib Response in Head and Neck Squamous Cell Carcinoma. JAMA Oncol 2015;1:238-44. [PMID: 26181029 DOI: 10.1001/jamaoncol.2015.34] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 5.9] [Reference Citation Analysis]
|
| 728 |
Wu ES, Park JY, Zeitouni JA, Gomez CR, Reis IM, Zhao W, Kwon D, Lee E, Nelson OL, Lin HY, Franzmann EJ, Savell J, McCaffrey TV, Goodwin WJ, Hu JJ. Effect of actionable somatic mutations on racial/ethnic disparities in head and neck cancer prognosis. Head Neck 2016;38:1234-41. [PMID: 27028310 DOI: 10.1002/hed.24420] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 729 |
Dok R, Nuyts S. HPV Positive Head and Neck Cancers: Molecular Pathogenesis and Evolving Treatment Strategies. Cancers (Basel) 2016;8:E41. [PMID: 27043631 DOI: 10.3390/cancers8040041] [Cited by in Crossref: 68] [Cited by in F6Publishing: 74] [Article Influence: 9.7] [Reference Citation Analysis]
|
| 730 |
Wang Y, Springer S, Mulvey CL, Silliman N, Schaefer J, Sausen M, James N, Rettig EM, Guo T, Pickering CR, Bishop JA, Chung CH, Califano JA, Eisele DW, Fakhry C, Gourin CG, Ha PK, Kang H, Kiess A, Koch WM, Myers JN, Quon H, Richmon JD, Sidransky D, Tufano RP, Westra WH, Bettegowda C, Diaz LA Jr, Papadopoulos N, Kinzler KW, Vogelstein B, Agrawal N. Detection of somatic mutations and HPV in the saliva and plasma of patients with head and neck squamous cell carcinomas. Sci Transl Med 2015;7:293ra104. [PMID: 26109104 DOI: 10.1126/scitranslmed.aaa8507] [Cited by in Crossref: 272] [Cited by in F6Publishing: 288] [Article Influence: 38.9] [Reference Citation Analysis]
|
| 731 |
Knopf A, Lempart J, Bas M, Slotta-Huspenina J, Mansour N, Fritsche MK. Oncogenes and tumor suppressor genes in squamous cell carcinoma of the tongue in young patients. Oncotarget 2015;6:3443-51. [PMID: 25633809 DOI: 10.18632/oncotarget.2850] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 732 |
Peng HY, Jiang SS, Hsiao JR, Hsiao M, Hsu YM, Wu GH, Chang WM, Chang JY, Jin SL, Shiah SG. IL-8 induces miR-424-5p expression and modulates SOCS2/STAT5 signaling pathway in oral squamous cell carcinoma. Mol Oncol 2016;10:895-909. [PMID: 27038552 DOI: 10.1016/j.molonc.2016.03.001] [Cited by in Crossref: 41] [Cited by in F6Publishing: 46] [Article Influence: 5.9] [Reference Citation Analysis]
|
| 733 |
Al-Hebshi NN, Li S, Nasher AT, El-Setouhy M, Alsanosi R, Blancato J, Loffredo C. Exome sequencing of oral squamous cell carcinoma in users of Arabian snuff reveals novel candidates for driver genes. Int J Cancer 2016;139:363-72. [PMID: 26934577 DOI: 10.1002/ijc.30068] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 734 |
de Miguel-Luken MJ, Chaves-Conde M, Carnero A. A genetic view of laryngeal cancer heterogeneity. Cell Cycle 2016;15:1202-12. [PMID: 26940775 DOI: 10.1080/15384101.2016.1156275] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 735 |
Marur S, Forastiere AA. Head and Neck Squamous Cell Carcinoma: Update on Epidemiology, Diagnosis, and Treatment. Mayo Clin Proc 2016;91:386-96. [PMID: 26944243 DOI: 10.1016/j.mayocp.2015.12.017] [Cited by in Crossref: 611]& |
